|
|
·|û¡GCliff10135274 µoªí®É¶¡:2014/10/15 ¤W¤È 01:05:51
|
¥»ª©°w¹ï¯E¹©°ò¥»±°Q½×Àù¯gªvÀø¡B§K¬ÌÀøªk¡BÁ{§É¸ê°T¡F¯E¹©¦U¶µ²£«~¬ãµo¶i«×°lÂÜ°Q½×¡FÄvª§¹ï¤â°ÊºA»P¦U¤è¶i«×°lÂÜ¡C¦P®É¯Ç¤Jª©¡uOBI-822¡BOBI-833¥H¥~ªº²£«~¡vªº¤º®e¡C·q½Ð¦U¦ì¤j¤j´N¥H¤WijÃDªº°ò¥»±Ä~Äò´£¨Ñ´¼¼z¡C ¥un¨¥¤§¦³ª«¡A¥ß½×¦³¾Ú¡A¦hªÅ¬ÒÅwªï¡C ¥»ºô»{¬°©¹«áY¹J¨ìÃþ¦üªºª¬ªp¡A¥i¥H¥Ñ¸Ó¶}ª©¤§¥D¤H¨Ó§P©w¡A ¨Ò¦p¦¹ª©´N¥ÑCliff¤j¤j¨Ó§P©wµo¨¥¤º®e¬O§_²Å¦X¸Óª©¤º®e¡A Y¥D¤H»{©w¤£²Å¡A¦A¥Ñ¥»ºô¤©¥H§R°£¡A¦p¦ó¡HBYª©¥D
|
|
·|û¡GLeo10142037 µoªí®É¶¡:2016/4/7 ¤U¤È 10:26:33²Ä 1320 ½g¦^À³
|
¦Ñ·¨¤j ½Ð°Ý£¸Ó°ÝÃD ¹êÅç²Õ¤]¦³¥´cyclophosphamide ¨º¬O¤£¬O¥H«á¥ÎÃÄ ¤]³£n£¸°_¥´cyclophosphamide |
|
|
·|û¡G¦Ñ´10141055 µoªí®É¶¡:2016/4/7 ¤U¤È 09:41:38²Ä 1319 ½g¦^À³
|
·q·Rªº¹x¥Û¤j: ©êºp¬Q¤Ñªº¶º©±³s¤£¤WWiFi¡A¦Ñ´¸ÕµÛ¦^µª±zªº°ÝÃD¡AY¦³¤£¹ï¤§³B©|¬è¨£½Ì. 822¨ú±oÃÄÃÒ«áoff label useªº°ÝÃD 1. ¥Ñ©óÃÄÃҥӽЪº¾AÀ³¯g¬O¨ÅÀù¥|´Á¡A¨º»òÂå¥Í¬O§_¥i¥H¦Û¦æ«Øij¨ÅÀù¤G¤T´Á±wªÌ¨Ï¥Î¡H³o¼Ëªº°µªk¦b Âå¬É¬O§_±`¨£¡H 2. Ãļt¤£¯à«Å¶Ç¦¹ºØ°µªk¡A¨º»ò³oºØ¥ÎÃĤ覡¬O¦p¦ó¦ÛµM¶Ç¼½ªº¡H 3. ¶O¥Î¤è±¬O§_°·«O¤£¯àµ¹¥I¡H¯f¤HªººA«×¦p¦ó¡H 5. ¥H¶PÀù¥¦Ó¨¥¡A¦b¥xÆWªº¨Ï¥ÎªÌ¬O§_¤´µM¶°¤¤©ó¥|´Á±wªÌ¡AÁÙ¬O¦´Á±wªÌ¤]¦û¬Û·í¤jªº¤ñ¨Ò¡H¦³°µ¹L Á{§É¹êÅç¥Ó½ÐÂX¥R¾AÀ³¯g¶Ü¡H Ans.¦Û101¦~1¤ë1¤é¥Í®ÄHerceptinµ¹¥I³W©w×¥¿ 1. ¦´Á¨ÅÀù(99/1/1¡B99/8/1¡B99/10/1¡B101/1/1) (1)¥~¬ì¤â³N«e«á¡B¤Æ¾ÇÀøªk(³N«e»²§UªvÀø©Î»²§UªvÀø)ªvÀø«á¡A¨ãHER2¹L«×ªí²{(IHC 3+©ÎFISH+)¡A¥B ¨ãµÅ¤U²O¤Úµ²Âಾ¦ýµL»·³BŦ¾¹Âಾ¤§¦´Á¨ÅÀù±wªÌ¡A§@¬°»²§U©ÊªvÀø¥ÎÃÄ¡C(99/10/1¡B101/1/1) (2) ¨Ï¥Î¦Ü¦h¥H¤@¦~¬°(99/8/1)¡C 2. Âಾ©Ê¨ÅÀù (1)³æ¿W¨Ï¥Î©óªvÀø¸~½F²ÓM¤W¦³HER2¹L«×ªí²{(IHC 3+©ÎFISH+)¡A´¿±µ¨ü¹L¤@¦¸¥H¤W¤Æ¾ÇªvÀø¤§Âಾ©Ê¨ÅÀù ¯f¤H¡C(91/4/1¡B99/1/1) (2) »Ppaclitaxel©Îdocetaxel¨Ö¥Î¡A¨Ï¥Î©ó¥¼´¿±µ¨ü¹L¤Æ¾ÇªvÀø¤§Âಾ©Ê¨ÅÀù¯f±w¡A¥B¬°HER2¹L«×ªí²{ (IHC 3+©ÎFISH+)ªÌ¡C(93/8/1¡B95/2/1¡B99/1/1) (3) Âಾ©Ê¨ÅÀù¥BHER2¹L«×ªí²{¤§¯f¤H¡A¶È¥ý«e¥¼¨Ï¥Î¹L¥»ÃÄ«~ªÌ¤è¥i¨Ï¥Î¡C(99/1/1) 3. ¸g¨Æ«e¼f¬d®Öã«á¨Ï¥Î¡C ^^^^^^^^^^^^^^^^^^^^^^^^^^^^¾¨ºÞ²Ä1,2ÂI§i¶D§A¤F³£¥i¥H¥Î,¨º¬OÄF¿ï²¼¥Îªº!¤Ï¥¿°·«O¸p¼Ö±o°µ¦n¤H, »s³y¤@¤U¥xÆWªº°·«O¥]¤s¥]®ü,¨ä¹ê«ÂI¦b²Ä¤TÂI,n¨Æ«e¼f¬d®Öã,³o¸Ì±ªº¾Ç°Ý´N«Ü¤j¤F,n¤£n®Öã´N ¬Ý¼f¬d©eû·|ªº¤º³W(´N¬O¦U¦a¤èÂå®v¤½·|¨ü°·«O¸p©e°U³W©wªº),¬°¤F°·«O¯à¥ÃÄò¸gÀç,ÂIȤ£n³Qµ}ÄÀ¤Ó¦h, ¤Ó©ù¶QªºÀøªk,´N¬O¬Ý¬Ý²n¤@¤U´N¦n¤F,¦³Âå®v¥H¬°¦Û¤v¼F®`ªº,¤£ªA¤º³W¥H¤ä¥I¼Ð·Çªí¬°·Ç¨Ó¥Ó½Ðªº,¦´Á¨Å Àù°£«D»\¿ù³¹¤F§a!Âಾ©Ê·íµM¬O¨S¦³°ÝÃDªº!©Ò¥H,´Nºâ¼t°Ósupport§A°µclinical trial,¤S¦³¤°»ò¥Î©O? ÁÙ»Ýn¦A¥Ó½ÐÂX¥R¾AÀ³¯g¶Ü? ¦A¦^¨ì²Ä1,2,3ÃD¡A¨âÓ¦r¸Ñ¨M¸UÃø!-----¦Û¶O! ¥un¤£¥Î°·«Oªº¿ú,¯f®a¦³ª¾±¡¦P·N,¨S¦³¤°»ò¬O¤£¯à°µªº!©Ò¥H¨C·í¯f¤H°ÝÂå®v»¡³o¤@©wn ¶}¤M¶Ü?´N¨S¦³§Oªº¿ìªk¤F¶Üªº®ÉÔ,Âå®vÁ`¬O©ïÀY¬Ý¤F¬Ý¯f¤H©M®aÄÝ,±ý¨¥¤S¤îªº®ÉÔ,¥un¯f®a¦A»¡,¿ú¤£ ¬O°ÝÃD!Âå®v¤~·|§i¶D§A¤èªkªºì¦]¤F!-------¬Ý¨ì³o¸Ì¤d¸U¤£n¥H¬°Âå®v³g°]!¨ä¹ê¥u¬O©È³Â·Ð,¤£ ·Q·Sº×¤W¨,Âå®v¬OÁȤ£¨ì¤°»ò¿úªº(oncologistªº©â¦¨¬O¤º¬ìªº©â¦¨,«Ü¥i¼¦ªº,¤£¹L¤]¨S®t,¤Ï¥¿¥LÌ´N¬O °á°á®Ñ°Ê°Ê¼L¦Ó¤w,HAHA...),¿ú³£³QÃÄ°Ó©MÂå°|ÁȨ«! ¦ÛµM¶Ç¼½---¤f¦Õ¬Û¶Ç! °·«O¤£¯àµ¹¥I¡H¯f¤HªººA«×¦p¦ó¡H-----³o´N¬O°·«O¸p¼F®`ªº¦a¤è,¥H¤l¤§¥Ù§ð¤l¤§¬Þ,¬O±M·~ªº¼f¬d©eû¤£ 㪺,°·«O¦³³W©w¬O¥i¥H¥Ó½Ðªº!©`¦ó,n´L«±M·~!¼f¬d©eûªº¥ßÔ··íµM´N¬O¹ç¬°ÆN¤ü¤]n«O¦í°·«O¤£Ë... µ¥µ¥ªº±R°ª²z·Q§a! 4. ¥H±z°µ¬°Âå¥Íªº¥ß³õ¡A¦p¦ó«ä¦Òoff label useªº¿ï¶µ¡H Áp¦X¥ÎÃĬO¥t¤@Ó°ÝÃD¡C³\¦hÁp¦X¥ÎÃij£¥¿¦¡¥Ó½ÐÁ{§É¹êÅç¡A¦ý¬O¦bÁ{§É¹êÅçµ²ªG³QFDA»{¥i«e¡AÂå®v¬O§_¥i¥H¦Û¦æ¹ï¯S©w¯f¤H¹Á¸ÕÁp¦X¥ÎÃÄ¡H Âå¥Í¦p¦ó§PÂ_Áp¦X¥ÎÃĪº·ÀI©Ê¡H¹³822³oºØ§C°Æ§@¥ÎªºÃĪ«¡A¬O§_¦bÁp¦X¥ÎÃĤW¦³¸û§CªºªùÂe¡H ¦n¹³¤]¤w¦^µª¤F³oÓ°ÝÃD,¤S¦n¹³»¡¤F¤@°ï¼o¸Ü,Á`¤§,¦Ñ´¤]¤£ª¾¹D¦Û¤v¬O¤°»ò¥ß³õ¤F! ¥u¯à¬è¨D¯E¹©±N¨Ó¯àºâ¥xÆW«K©y¤@ÂI!À³¸ÓÅý¥xÆWªº¨ÅÀù¯f¤H³£§K¶O¥´!(¦Ü¤ÖÂಾ©Ê¨ÅÀùn§K¶O),¤£µM´N¥Õ §ë¸ê¯E¹©¤F! |
|
|
·|û¡G¦³FUªº¤H10136189 µoªí®É¶¡:2016/4/7 ¤U¤È 09:04:00²Ä 1318 ½g¦^À³
|
Cliff¤j~~ ·PÁ±zÅý¤j®a¾Ç²ß |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/4/7 ¤U¤È 08:41:04²Ä 1317 ½g¦^À³
|
Û´°±M®a·|ij µ¹¯E¹©¤T´ÁÁ{§É©ú½T¤è¦V udn.com/news/story/6/1614592 |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/7 ¤U¤È 05:46:14²Ä 1316 ½g¦^À³
|
«e«h¶K¤å1§ó¥¿±Ôz¦p¤U [¤½¥q¤G¤ëªk»¡] 1¬I¥´OBI822«á·|¹ïGlobo-H¨t¦CÁÞ§Üì²£¥ÍIgG IgM §ÜÅ骺¯f±w³£·|¦³«D±`ÅãµÛªºÁ{§ÉÀø®Ä¡C |
|
|
·|û¡Gªø¦¿11¸¹10136804 µoªí®É¶¡:2016/4/7 ¤U¤È 05:25:22²Ä 1315 ½g¦^À³
|
°O±o¶ÀÁ`¦b2/21»¡4/2¦on¸Û´°,¤Î3/31´£¨ì³\°Æ¸³¤w¸g¸©¹Û´°¥h»P¨ÅÀù±M®a·|°Ó¥¼¨Ó¥þ²y¤T´Áªº³W¹º¤è¦V,¤p§Ì«Ü·Q°Ý¤½¥q,¦ý¦Û¦¤±M·~¹ê¦b³h¥F,©È°Ý¤£¥XÓ©Ò¥HµM¨Ó,¬O§_¥i½ÐªO¤W¤j¤j°Ý¤@¤U,©Î¬O¤j®aı±o¥Ø«e¤£¤è«K°Ý©O? |
|
|
·|û¡Gªø¦¿11¸¹10136804 µoªí®É¶¡:2016/4/7 ¤U¤È 05:07:33²Ä 1314 ½g¦^À³
|
ª©¥D¤j,CLIFF¤j,·P®¦¦A·P®¦!! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/7 ¤U¤È 01:46:24²Ä 1313 ½g¦^À³
|
³Q¿ò§ÑªºÆp¥Û ¦U¦ì¤j¤j ¥¿¦bµo®i¤¤ªº·sÃÄ¡A¦³60¢H¥H¤W³£¬O³æ®è§ÜÅé 2¤ëªk»¡·|°£¤F»EµJ¦bOBI822¥~ ±i¸³´£¨ìOBI-888Àù¯g³æ®è§ÜÅé§K¬ÌÀøªkªº³¡¥÷¬Û·íºë±m: «Øij¦A«Å¥³o¤@¬q 1·|²£¥Í°w¹ïGlobo K ¨t¦C§Üì§ÜÅ骺¯f±w´N·|¦³«D±`ÅãµÛªºÀø®Ä ³o¤]ÃÒ©úOBI-888·|¦³XXXXXX 2¥¼¨Ó³W¹º¬ãµo SSEA3³æ®è§ÜÅé SSEA4³æ®è§ÜÅé 3Ó¤H»{¬°OBI-888Àù¯g³æ®è§ÜÅé,¨S¦³§ÜÅé¶q¤£ªº°ÝÃD ,¤S¦³ªñ¦üOBI822§ÜÀù¾÷¨î ,¦b§¡¬Û¤Æ§ÜÅ餧Àu¶Õ¤U (§C°Æ§@¥Î ´£°ªÀø®Ä )¤£¥i»´©¿³o¶µ¨t¦C²£«~ªº¼ç¤O°£¤FÀù¯g¥~³æ§Ü¥Î©ó¦ÛÅé§K¬Ì¯e¯fªºÃÄ«~¬Û·í¦h , ¤µ¦~¤»¤ëªÑªF·|¥i«Øij¯E¹©OBI-888³æ®è§ÜÅé¥Î©ó¬ãµo¦ÛÅé§K¬Ì¯e¯f¥HÂX¤j¾ÔªG Àù¯g³æ®è§ÜÅé§K¬ÌÀøªk(OBI-888) ¤½¥qºô¯¸¸ê°T OBI-888ÄÝ©óÀù¯g³Q°Ê§K¬ÌÀøªk¡A¬O§ÜGlobo H³æ®è§ÜÅé·sÃÄ¡A°w¹ïÀù²ÓMªí±¹L«×ªí²{¤§Globo HÁÞ§Üì¡A§Q¥Î³æ®è§ÜÅéÃĪ«¨ä°ª±M¤@©Ê¡B°ªµ²¦X¤Oªº¯S©Ê¡A¿Eµo§K¬Ì¨t²Î¡AÄè·ÀÀù²ÓM¡A¤j´T´£¤ÉÀù¯gªvÀø®ÄªG¡C OBI-888 Globo H³æ®è§ÜÅé·sÃÄ¥Dn¬O±Ò°ÊÅ餺¨âºØ§K¬Ì¤ÏÀ³: ÂǥѧÜÅé¨Ì¿à©Ê²ÓM¬r©Ê(ADCC)¤ÏÀ³¡B¬¡¤Æ¦ÛµM±þ¤â²ÓM¡A¥H¤Î¸ÉÅé¨Ì¿à©Ê²ÓM¬r©Ê(CDC) ¤ÏÀ³¡A¥H¹F¨ì¬r±þÀù²ÓMªº®ÄªG¡C §ÜGlobo H³æ®è§ÜÅé·sÃÄ¥i§@¤ÆÀø©Î©ñ®gªvÀøªºªþ¥[Àøªk¡A¥i°§C¤p¤À¤lÃĪ«¾¯¶q¡A§ïµ½¥Í¬¡«~½è¡C ³Q°Ê§K¬ÌÀøªk¡A¥ç¥i³yºÖµLªk¹ïÁÞ¬Ì](OBI-822©Î OBI-833)²£¥Í§ÜÅ骺¯f±w¡C §ó¥i±æ¹Å´f¤T³±©Ê±Ú¸s©MHerceptinµ¥ªvÀø¥¢±Ñ©Î´_µoªº¯f¤H¡C Global Cancer Monoclonal Antibodies Market - Growth, trend, and forecast (2015-2020) www.prnewswire.com/news-releases/global-cancer-monoclonal-antibodies-market---growth-trend-and-forecast-2015-2020-300232902.html |
|
|
·|û¡G99910140657 µoªí®É¶¡:2016/4/7 ¤U¤È 01:37:21²Ä 1312 ½g¦^À³
|
·PÁÂCliff¤jªº±Ð¨|¡A±Ð¾É«á¶i¤§¤ß¡C ·PÁª©¥»¹ï¯E¤Í¤@¤ÁªºÃöÃh«p·R¡C (ª¾ÃѬO¤O¶q)+(±M·~¬O§Þ³N)¯Ê¤F³o2¦X¤@......¤@¤Á¦ÊºA²×¨s¦^Âk¤@³õ¤Ûı¡C ¯E¹©¦¹§TÀ³¸Ó§Ö¸¨¹ê¤F¡I¦]¬°©Ò¦³ªº¥¿¥».........²×©ó¦b¦U¤è±¦h¶µªº®i¶}¤F¡I Cliff«e½úÁÂÁ±z¡C |
|
|
·|û¡G²L¯ó¦Ï10141546 µoªí®É¶¡:2016/4/7 ¤W¤È 11:39:48²Ä 1311 ½g¦^À³
|
·sª©¸¨¦¨~ ¥Ñ°J·PÁÂCliff¤j»Pª©¥D¤jªº¨¯³Ò¶O¤ß~ °ò¥»±ªº±´°Q¬O«ùªÑªø©ºªº³Ì¥Dn®Ú¾Ú¡A¦¹ª©ªº«n©Ê¤£¨¥¥i³ë¡A ·PÁ©Ҧ³µL¨p¤À¨Éªº²³¤jÌ~ |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/4/7 ¤W¤È 10:34:01²Ä 1310 ½g¦^À³
|
ÁÂÁÂCliff¤j¡C ·s¼ÐÃD§ó爲¶K¤Á©ú½T¡Cª©ÀY¤å²©ú§ãn¡CÃÙ¡I¬O¤p§Ì³o¼Ëªø§ë¤pªÑªF¾Ç²ß¸ò¶iªº¦n¦a¤è¡C¦AÁ¡C |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/4/7 ¤W¤È 09:52:53²Ä 1309 ½g¦^À³
|
Cliff¤j¤j, ·PÁ¤F |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/7 ¤W¤È 08:03:55²Ä 1308 ½g¦^À³
|
¦hÁª©¥D¤j¥É¦¨¡C |
|
|
·|û¡G¤s¤¤10141474 µoªí®É¶¡:2016/4/7 ¤W¤È 07:46:43²Ä 1307 ½g¦^À³
|
Cliff¤j OK for me. ÁÂÁ±z |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/4/7 ¤W¤È 12:35:26²Ä 1306 ½g¦^À³
|
Cliff¤j: ÁÂÁ±z !! ¦n´Á«Ý±zªº·sª©¦¤é¨ÓÁ{ !! ª©¥D¤j: ÁÂÁ !! ÁÂÁ !!! ÁÂÁ !!!! |
|
|
·|û¡G¥Ó¥|®ü10139653 µoªí®É¶¡:2016/4/6 ¤U¤È 09:34:09²Ä 1305 ½g¦^À³
|
Cliff¤j¡A¨S¨Æªº¡A§O»¡©êºp¡I ÁÂÁ±zªº¼ö±¡¤À¨É¡I |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/4/6 ¤U¤È 09:02:29²Ä 1304 ½g¦^À³
|
²³¤j¤jÌ¡A¸g¤p§Ì»Pª©¥D°Q½×«á¡A¦]¬°§âì¡u¯E¹©ªº²£«~»P¦UºØ°ò¥»¸ê®Æªº°Q½×¡vª©ªº9½g¶K¤å¨Ö¤J³oÓª©¦s¦³§Þ³N¤WªºÃø«×¡A©Ò¥H¨M©w·sªº¥»ª©±N§ó§ï¦p¤U¡G ª©ÀY¼ÐÃD¡G¡u¯E¹©²£«~½u»PÄvª§¹ï¤â¡v ª©ÀY¤å¡G¡u¥»ª©°w¹ï¯E¹©°ò¥»±°Q½×Àù¯gªvÀø¡B§K¬ÌÀøªk¡BÁ{§É¸ê°T¡F¯E¹©¦U¶µ²£«~¬ãµo¶i«×°lÂÜ°Q½×¡FÄvª§¹ï¤â°ÊºA»P¦U¤è¶i«×°lÂÜ¡C¦P®É¯Ç¤Jª©¡yOBI-822¡BOBI-833¥H¥~ªº²£«~¡zªº¤º®e¡C·q½Ð¦U¦ì¤j¤j´N¥H¤WijÃDªº°ò¥»±Ä~Äò´£¨Ñ´¼¼z¡A¥un¨¥¤§¦³ª«¡A¥ß½×¦³¾Ú¡A¦hªÅ¬ÒÅwªï¡C¡v ©Ò¥H¤p§Ì¦b¦¹ÂÔ¦Vì¡u¯E¹©ªº²£«~»P¦UºØ°ò¥»¸ê®Æªº°Q½×¡vª©ªº9½g¶K¤å§@ªÌ¡G ¡u·P°Ê£®¤j¡B¥Ó¥|®ü¤j¡B¤s¤¤¤j¡BµL¤j¤j¡BRock¤j¡B¼ï¤¤Áú¤j¡BÂÅÂI¤j¡B¥ôÄP¤¸¤j¡v¡A¥H¤Î¥xÁÞ¤j»¡©êºp¡A§Æ±æ§ïª©«á¦U¦ì¤j¤j¯à´N°ò¥»±Ä~ÄòÄéµ@¡A¤p§Ì©½¬°¶}ª©¤H¡A¨ì²{¦b¤~¾ã²zª©ÀY¤å¡A«D±`©êºp¡C ¤p§Ì±N¾¨§ÖÁpµ¸ª©¥D¡A¶i¦æ¾ã²z§ïª©¨Æ©y¡A³Ì§Ö¥i¯à©ú¤Ñ´N¥i¥H§¹¦¨¡C ¨¯Wªºª©¥D¡A³Â·Ð±z¤]ÁÂÁ±z¡I |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/4/6 ¤U¤È 01:27:56²Ä 1303 ½g¦^À³
|
¤s¤¤¤j 3/31ªk»¡·|«á¡A´CÅé¤@¾Ö¦Ó¤W¡A©Ò¥HµLªkªñ¨±i¸³¡A©Ò¥H¨S¦³¨ä¥Lªº¤º®e¡A¥ý«eªk»¡·|«á´£°Ý¡A¤p§Ì³£¦³po¤Wª©¡A±z¥i¥H°Ñ¦Ò |
|
|
·|û¡G¤s¤¤10141474 µoªí®É¶¡:2016/4/6 ¤U¤È 12:18:52²Ä 1302 ½g¦^À³
|
¦³«í¤j §Ñ¤F¦V±z½Ð±Ð¡A3/31·|«á±i¸³ÁÙ¦³¨ä¥Lªº«ÂI¶Ü?¥i¤£¥i¥H¸ò¤j¹Ù¤À¨É¤@¤U¡A¥ýÁ¤F¡C ¶Â½ü¤j ÁÂÁ±z¡A³o¥u¬O¤j®a³z¹L°Q½×±o¨ìªºµ²ªG¡C¤j®a³£¥XÂI¤O¡AºÃ°Ý´N·|¼á²M¡A«H¤ß´N·|¼W±j¡A¦p¦¹¦Ó¤w¡C ¤j®a¥[ªoÅo |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/6 ¤U¤È 12:15:47²Ä 1301 ½g¦^À³
|
¥H¥xÆW¥Ø«eªºÀô¹Ò¡A¥u©È¬Onµ¥ FDA ªº°Ê§@¡C©x¤£²á¥Í°Ú¡I |
|
|
·|û¡G¶Â½ü§B10141808 µoªí®É¶¡:2016/4/6 ¤W¤È 11:57:20²Ä 1300 ½g¦^À³
|
«D±`»{¦P ¤s¤¤¤j »¡ªk TFDA ·|Pending ¼fÃÄÃÒ ¤@©w·|¶}±M®a·|ij ¦Ó ±M®a¤@©w·|¥H ASCO¬Ýªk¬°¨Ì¾Ú ³o¬O·ÀI³Ì¤pªº°µªk ³o´N¬O¥xÆWªº¤å¤Æ Åwªï¨Ó¨ì°®q¡ã |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/4/6 ¤W¤È 11:48:57²Ä 1299 ½g¦^À³
|
¤s¤¤¤j ¤p§Ì»{¦P! ¥H¯f±w¤Î¯f±w®aÄݬ°¨ÌÂk,¤~¬O¤j¦³¬°¬F©²À³¸Ó°µªº¨Æ! |
|
|
·|û¡G¤s¤¤10141474 µoªí®É¶¡:2016/4/6 ¤W¤È 11:43:24²Ä 1298 ½g¦^À³
|
¦³«í¤j ¦Ü©óTFDA¡A¤p§Ì¤@ª½»{¬°¥D¨ÆªÌ·|¦bASCO«á¦A¨M©w¡A¥Ø«e¥ýPENDING¡A¦]¬°ASCO¦b520«á¡A¥B¤]¥i¬Ý¬ÝASCOªº¤ÏÀ³¡A¦pªG¼Æ¾Ú¯uªº¦p¼·¤j/¤Ñ©R¤j¤Î±zµ¥ªº±À¦ô¡A§Y¨Ï¥xÆW¥u¦³¤@¤d¦h¦WÀù¥½¯f¤H¡A·|¦³Áֽ׫P¨ÏTFDA©¹«e¶iªº¡C ªp¥B¹ïTFDA¦Ó¨¥¡A¦P·N³oÓÃÄ°ò¥»¤W¥u¦³¦n³B¨S¦³Ãa³B¡A¦]¨Ï¥Î©óÀù¥½¯f¤H¨¤W¡A¹ïTFDAµL¼vÅT¡A¦³¥iÀ°§UÀù¥½¯f¤H§ä¨ì¥X¸ô¡F¥t³o¬O³Ð·sÃĪ«¡ATFDA¦P·N¤]¹üÅãTFDAªº¼fÃįà¤O¡A¹ê¦b¬Ý¤£¥X¦³¦ó¤£¦P·Nªº²z¥Ñ¡C¥u¬O²{¦b³oӮɶ¡ÂI¡ATFDAªº¥ô¦ó°Ê§@³£·|³Qªx¬Fªv¤Æ¡AµLªk³Q¥¿½Tªº¸ÑŪ¤F¡C |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/4/6 ¤W¤È 11:30:03²Ä 1297 ½g¦^À³
|
¤s¤¤¤j ±z¨£¯º¤F¡I ¤£¹L¤Wz¤º®e¡A¤j³¡¤À³£¬Oªk»¡·|«á¦³¯E¤Í´£°Ý±i¸³ªº¦^ÂСA¨S¦³¦b¤½¥qªk»¡·|¼vµÀɤº¡I ¥t¤ÏÂÐÅ¥3/31ªk»¡¤º®e¡A¤p§Ì¤Ï¦Óı±oTFDA¦³«D±`¦hÅܳqªº§@ªk¡A§Ú·Q¥un¤£n¦³¬Fªv¦]¯À¤zÂZ¡A ©Î³\·|¦³¤p½T©¯¡A¥H¤W¤p§Ì©å¨£¡A¨Ñ±z°Ñ¦Ò¡I |
|
|
·|û¡G¤s¤¤10141474 µoªí®É¶¡:2016/4/6 ¤W¤È 10:58:18²Ä 1296 ½g¦^À³
|
¦³«í¤j ¬Ý¨Ó¬O¤p§Ì¹ïªk»¡ÁÙ¦³»~¸Ñ¡A·|¦A¦hÅ¥´X¦¸¡A±z¯u¬Oȱo¤p§Ì¾Ç²ßªº¹ï¹³¡C |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/4/6 ¤W¤È 10:50:43²Ä 1295 ½g¦^À³
|
¤s¤¤¤j ±i¸³¦³´£Y»Ý¥þ²y¤T´ÁÁ{§É¡A¤@©w¬O¥HÀù¥½¯f¤H§@¬°¦¬®×¹ï¶H¥B¤H¼Æ·|¸û349¤Ö(¼Ú¬ü¬°¥D)¡A¦Ü©ó«e´Á¯f±w¡A¥un¨ú±o¥¿¦¡ÃÄÃÒ¡A¥i¥H¥Îoff-label-use¤è¦¡¨Ï¥Î¡C ¤£¹L¸g¾ú¸Ñª¼¥¢±Ñªº±Ð°V¡A¤p§Ì«Øij§ÚÌ«O¦u¬°©y¡A¥ý¤£¹w´ÁFDA·|®ÖµoÃÄÃÒ¡A¬Û«H¤½¥q·|§V¤O¥hª§¨ú¡A¤p§Ì¬O¥H¤´»Ý°µ¥þ²y¤T´ÁÁ{§É°µ«ä¦Ò¡A¦ý¥i¥H½T©wªº¬O¦¹¦¸Á{§É¡A ¦¬®×·|§óºë·Ç¡AÀø®Ä·|§ó¦n¡A³t«×·|«D±`§Ö¡C ¥t±z´£ªº°¨°º¡A«üªº¬O833?ÁÙ¬O§Z±_Àù? ¦]¬°¤p§Ì©Òª¾833¥Ø«eªº¶i«×¬O©ó¥xÆW¤Î¬ü°ê®i¶}Á{§É¤@´Á¡A°¨°º¥Ø«e¶i¦æ822§Z±_Àù¤G´Á¶}©ñ©Ê¸ÕÅç¡A±i¸³»¡¹wp¦~¤¤·|¦³°¨°º¶i¤@¨Bªº®ø®§¡A¥H¤W¨Ñ±z°Ñ¦Ò¡I |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/6 ¤W¤È 10:40:02²Ä 1294 ½g¦^À³
|
APK¤j¡A ¤T´ÁÁ{§É¤£·|¯Ç¤J¦´Á±wªÌ¡A¦]¬°µL´c¤Æ®É¶¡¤Óªø¡A´Nºâ¥Dn«ü¼Ð¬OPFS¡AÁ{§É¹êÅç(±q¦¬¯f¤H¶}©l)³£·|©ì¨ì»·¶W¹L¤¦~¥H¤W¡CY°µOS´N¨S§¹¨S¤F¤F¡C ¤p§Ì¸ê°T¤£¦h¡AÁÙ¨S¨£¹LþÓÀùÃÒÃĪ«ªº¤T´ÁÁ{§É¯Ç¤J¦´Á¯f±wªº¡C |
|
|
·|û¡G¤s¤¤10141474 µoªí®É¶¡:2016/4/6 ¤W¤È 10:13:43²Ä 1293 ½g¦^À³
|
²³¤j¦w ¤p§Ìı±o¨Ì·Ó3/31ªk»¡µ²ªG¡A¥Ø«e³Ì¦³¥i¯àªº°µªk¬O¦VFDA¥Ó½ÐCONDITIONAL APPROVAL¡A¦ÓFDA APPROVEªº¾÷²v¤]«Ü°ª(±i¸³»¡ªºUNMET MEDICAL NEED)¡A¦ý·|ÁY¨Ï¥Î±Ú¸s©ó¥|´Á±wªÌ¡A¦P®É¤]·|ÂǥѲĤT´ÁÁ{§Éªº³]p(¥Ø«eÁÙn¦A¸ß°Ý¤½¥q±M®a·|ij¤§µ²ªG¦p¦ó³]p¡A³oÀ³¸Ó¤£¬O¾÷±K§a)¡A¬Ý¯à¤£¯àÂX®i¨ì¤G¤T´Á¯f¤H(¥ýÅçGH)¡C©Î¥ÑFDA¥HBTD¤è¦¡°Ñ»P¤T´Á¤§«ü¾É¡C ¥t±i¸³»¡833¤@´Á¥Ø«e«Ý°¨°º´£¨Ñ¼Æ¾Ú¶q§ÜÅé¡A«Øij¯E¤Í̤]¥i±N833¦C¤J¶i«×¤§°Q½×¡C ¥H¤WÓ¤H²L¨£¡CÁÂÁ ¤pÄ«ªG¤j ¥Ø«e§õ¤p©jÁÙ¥¼¦^ÂСAÀ³¸Ó¬O¤Ó¦£¤F¡A¤p§Ì·|¦A¸ß°Ý¤½¥q¦³Ãö±M®a·|ij¬O§_¥i¥H±Nµ²ªG¸òªÑªF¤À¨É¡C |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/6 ¤W¤È 08:54:50²Ä 1292 ½g¦^À³
|
¦Ñ´¤j¡A ¤p§Ìªº°ÝÃD¬O¦³Ãö822¨ú±oÃÄÃÒ«áoff label useªº°ÝÃD¡C 1. ¥Ñ©óÃÄÃҥӽЪº¾AÀ³¯g¬O¨ÅÀù¥|´Á¡A¨º»òÂå¥Í¬O§_¥i¥H¦Û¦æ«Øij¨ÅÀù¤G¤T´Á±wªÌ¨Ï¥Î¡H³o¼Ëªº°µªk¦bÂå¬É¬O§_±`¨£¡H 2. Ãļt¤£¯à«Å¶Ç¦¹ºØ°µªk¡A¨º»ò³oºØ¥ÎÃĤ覡¬O¦p¦ó¦ÛµM¶Ç¼½ªº¡H 3. ¶O¥Î¤è±¬O§_°·«O¤£¯àµ¹¥I¡H¯f¤HªººA«×¦p¦ó¡H 4. ¥H±z°µ¬°Âå¥Íªº¥ß³õ¡A¦p¦ó«ä¦Òoff label useªº¿ï¶µ¡H 5. ¥H¶PÀù¥¦Ó¨¥¡A¦b¥xÆWªº¨Ï¥ÎªÌ¬O§_¤´µM¶°¤¤©ó¥|´Á±wªÌ¡AÁÙ¬O¦´Á±wªÌ¤]¦û¬Û·í¤jªº¤ñ¨Ò¡H¦³°µ¹LÁ{§É¹êÅç¥Ó½ÐÂX¥R¾AÀ³¯g¶Ü¡H Áp¦X¥ÎÃĬO¥t¤@Ó°ÝÃD¡C³\¦hÁp¦X¥ÎÃij£¥¿¦¡¥Ó½ÐÁ{§É¹êÅç¡A¦ý¬O¦bÁ{§É¹êÅçµ²ªG³QFDA»{¥i«e¡AÂå®v¬O§_¥i¥H¦Û¦æ¹ï¯S©w¯f¤H¹Á¸ÕÁp¦X¥ÎÃÄ¡H Âå¥Í¦p¦ó§PÂ_Áp¦X¥ÎÃĪº·ÀI©Ê¡H¹³822³oºØ§C°Æ§@¥ÎªºÃĪ«¡A¬O§_¦bÁp¦X¥ÎÃĤW¦³¸û§CªºªùÂe¡H |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/6 ¤W¤È 08:33:36²Ä 1291 ½g¦^À³
|
Lu¤j¡A Roche³o¨âÓÃĤ£¯à»¡Äê¡A¥LÌ¥i»¡³£¬O¥Ø«eªº best-in-class ªºÃĪ«¡A»¡¥LÌ«ÜÄê¡A¹ï©ó¥Ø«e¥u¯à¨Ï¥Î³o¨ÇÃĪ«ªº¯f¤H¦Ó¨¥¨Ã¤£¤½¥¡C·íµM¡A¥L̤£¬O¯«ÃÄ¡A©Î³\822¯à°µ¨ì§ó¦n¡C¤£¹L¡A³o¬O»Ýn®É¶¡ÃÒ©úªº¡C822´Nºâ®³¨ìÃÄÃÒ¡AÁÙn¸g¹L¥|´ÁÁ{§É§ó¤jªº¼Ë¥»¼Æ¨ÓÃÒ©ú¥¦ªº¦³®Ä©Ê»PÅãµÛ©Ê¡CRocheªº¶PÀù¥¤]´¿¸g®³¨ì¹L¨ÅÀù¥H¥~ªº¨ä¥LÃÄÃÒ¡A¦ý«á¨Ó¤W¥«¤§«áÃÒ©ú®ÄªG¤£ÅãµÛ¤S³Q¨ú®ø¤F¡A¥u¦³¨ÅÀù¥ÎÃijo¤@¶ô¡A¸g¹LÁp¦X¥ÎÃĪºÀ°§U¶V½æ¶V¦n¡C |
|
|
·|û¡GLu10141514 µoªí®É¶¡:2016/4/5 ¤U¤È 10:38:33²Ä 1290 ½g¦^À³
|
www.ttcc.org.tw/wp-content/uploads/2011/05/%E6%AD%A3%E8%A6%96%E5%81%A5%E4%BF%9D%E7%B5%A6%E4%BB%98%E5%AF%A9%E6%9F%A5%E5%A4%B1%E8%A1%A1%EF%BC%BF%E5%85%AC%E8%81%BD%E6%9C%83APR29_2011.pdf ¶PÀù¥¤pÀÉ®×(ù¤ó) ªv¯fì²z¡G¬ù25~30%ªº¨ÅÀù±wªÌ¡A¨ä¨ÅÀù²ÓM¨ã¦³²Ä¤G«¬¤HÃþ¤W¥Ö¥Íªø¦]¤l±µ¨üÅé¡]HER2¡^¡A ´c©Ê«×°ª¡BÂಾ¤O±j¡A¶PÀù¥¥i§í¨îHER2¡A¦³®Ä¹w¨¾´_µo ¾¯«¬»ù®æ¡Gª`®g¾¯¡A¨C²~¬ù6.1¸U¤¸¡A¨C¦~ÃĶO¬ù80¸U¤¸ Àù«ä°±,Bevacizumab, Avastin¤pÀÉ®× ªv¯fì²z¡G§í¨îÀù²ÓMªº¦åºÞ·s¥Í¡AÀ³¥iÀ£¨îÀù²ÓMªº¥Íªø¡A¨Ã´î¤ÖÂಾªº²{¶H¡CÀù«ä°±¥i¥H¦³®Ä²¾°£¦å¤¤ªº¦åºÞ¤º¥Ö²ÓM¥Íªø¦]¤l¡A¥B¥b°I´Áªø¹F21¤Ñ¡C¹êÅç²Õ¤ñ¹ï·Ó²Õ¡A¼W¥[¤F4.1Ӥ몺¸~½FµL´c¤Æ¦s¬¡´Á¡]progression-free survival¡^¤Î5.4Ӥ몺¾ãÅé¦s¬¡´Á (overall survial)¡C¤j¸zÀù³Ì±`Âಾªº¦a¤è¬O¨xŦ¤ÎªÍŦ¡A¤j¸zÀùªº¯f¤H§Y¨Ï¨xÂಾ¡A¦pªG¯à¶}°®²bªº¸Ü¡A¥[¤W¤Æ¾ÇªvÀøªºÀ°¦£¡A¦³1/3ªº¯f¤H¥i¥H¬¡¶W¹L5¦~¡CÀù«ä°±Áö¯à¼W¥[¤j¸zÀù¯f¤H¹ï¤Æ¾ÇªvÀøªº¤ÏÀ³²v¡A©µªø¯f¤Hªº¥Í©R¡C ¾¯«¬»ù®æ¡G100 mg/vial¡× NT 17744(ù¤ó)¡Aª`®g¾¯¡C µ²½×¡G ù¤óÃļt³o2ÓÃijo»òÄê¡A¤]¯à½æ³o»ò¦n¡I ´Á«ÝOBI-822»°§Ö¤W¥«¡I¡I |
|
|
·|û¡GPT10139061 µoªí®É¶¡:2016/4/5 ¤U¤È 10:19:10²Ä 1289 ½g¦^À³
|
¦hÁ¤pÄ«ªG¤j^^ |
|
|
·|û¡G¤pÄ«ªG10141213 µoªí®É¶¡:2016/4/5 ¤U¤È 10:16:57²Ä 1288 ½g¦^À³
|
¤s¤¤¤j¡APT¤j: «Ü©êºp²{¦b¤~¬Ý¨ì±z̪º¯d¨¥¡A¤½¥q¤½ÃöÀ³¸Ó¬O§õ¤p©j¡A¦]¬°¤½¥q¤Hû¤£¦h¡A¥i¯à¤]µLªk¤@¤@¦^ÂСA¤£¹L¦³°ÝÃD±Hµ¹¥LÌ¡A¤½¥qÀ³¸Ó·|³B²z~ |
|
|
·|û¡G·P°Ê£®10141081 µoªí®É¶¡:2016/4/5 ¤U¤È 04:31:49²Ä 1287 ½g¦^À³
|
Cliff¤j ¯u¬O©êºp¡A²{¦b¤~¤Wºô¬Ý¨ì°T®§ ¨ºª©ì¥»¥u¬O¦]¬°Ä±±o¥xÁÞ¤jªº¤å³¹«Ü¦n ¦ý¦]¬°±`´²¦b¦Uª© ¦bªÑ»ù§C®É¹ï©ó·Q¦h½m½m°ò¥»¥\«×¹L§C¼é´Áªºª©¤Í¤£¬O«Ü¤è«K·j´M»P½Æ²ß ©Ò¥H¤~Âû±CÀ°¥xÁÞ¤j¶}¤F¨ºª© ¦ý¥xÁÞ¤j«á¨Óªí©ú¤F¨S¥²n¦A¶}·sª© ¹x¥Û¤j¤]«Øij¥i¥H±N¦¹ª©§ï¦W §Ú¤]ı±o«Ü¦n¡A©Ò¥H§Ú´N½Ðª©¥D§â¨º·sª©§R¤F ªø¦¿¤j«Øij§ïªº¦WºÙ«Ü¦n ±z©M¥xÁÞ¤j³£Ä±±o¦n´N¨S°ÝÃD¤F ¹ï¯E¤Í¦³À°§Uªº§Ú³£ÃÙ¦¨¡I |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2016/4/5 ¤W¤È 10:36:03²Ä 1286 ½g¦^À³
|
¤pªº¤]ÃÙ¦¨.. ªø¦¿¤j ¤Î Cliff¦Ñ®vªº«Øij |
|
|
·|û¡GµL¤j10141864 µoªí®É¶¡:2016/4/5 ¤W¤È 10:35:45²Ä 1285 ½g¦^À³
|
Cliff¤j ¤p§Ì§¹¥þ¤ä«ù,§Ú¬O¨Ó¾Ç²ßªº,¤×¨ä¬O¦n¦h¤j¤jªº»{¯u»P°ò¥»±ªº±M·~°l¨D,§Ú¥u¦³¨ü±Ðªº¥÷,¤w¸g«Ü·P®¦£°.. |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/4/5 ¤W¤È 12:48:09²Ä 1284 ½g¦^À³
|
´µ¤p¤å¤j¤Ó«È®ð¡AÁÂÁ±z¡C ½Ð¤j®a¦Aµ¥¤@¤U¡Aťť¨ä¥L¤j¤j·N¨£¡A¦Ü¤Ö¤]nµ¥·P°Ê£®¤jµoÁn¡AÁÙ¦³¥Xª©¤j¡]¤Ñ«G¤~¤U¯Z¡^·N¨£¡C ª©ÀY¤å¤º®e¿ù»~¤w¤[¡A¤p§Ì¤Ï¬Ù¤§¾l¡Aµo²{¨â¦~¦h¨Ó¡A±`±`¬O¶K¤F¤@½g¡A²q¤F¨â½g¡A³Ì«áµo²{¿ù¤F¤T½g¡K¡A¤µ«á¤p§Ìn§ó·V¨¥¡A¦P®É«ô°U¦U¦ì¥ý¶i¤£n¦A¥H¨ºÓ¡u£¦£´£½¡v¦r®M¦b¤p§ÌÀY¤W¡AY¦A¦³¤j¤j§â¨ºÓ¦r®M¦b¤p§Ì¦W«á¡A¤p§Ì·|¦Û¤v¦Û°Ê°±Åv¤@Ӥ뤣ã¶K¤å¡A«ô°U¦U¦ì¤F¡C ¥²´Iª©¤W¡A¤H¤H¥µ¥¡A¥un¨¥¤§¦³ª«¡A¥ß½×¦³¾Ú¡A¦hªÅ¬Ò¥i¡A§Æ±æ¶×»E§ó¦h¦³¥Îªº¸ê°T¡A§áÂàÓ§O§ë¸ê¤Hªº®z¶Õ¡C¥[ªo¡I |
|
|
·|û¡Gªø¦¿11¸¹10136804 µoªí®É¶¡:2016/4/4 ¤U¤È 11:52:54²Ä 1283 ½g¦^À³
|
¤Ó¿³¾Ä¤F,©Ò¥Hº|¬Ý¤F¯E§J¤j,©çÁ©çÁÂ! |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/4 ¤U¤È 11:38:17²Ä 1282 ½g¦^À³
|
ªø¦¿¤j¡A ±zÁÙº|¤FÓ¯E§J¤j¡A¥L¤]»{¦P¡C¤p§Ì¬O½M°_Àiªº¡A¦bª©¤Wºâ¬O«á¶i¡A¤£°÷¸ê®æ¸ò¥LÌ´X¦ì¨Ã¦C¡C |
|
|
·|û¡Gªø¦¿11¸¹10136804 µoªí®É¶¡:2016/4/4 ¤U¤È 11:11:53²Ä 1281 ½g¦^À³
|
¨S·Q¨ì¤p§Ì¤§©å¨£³ºµM·|±o¨ìCLIFF¤j,¥xÁÞ¤j,¹x¥Û¤jµ¥¤T¦ì¤j¯«ªº»{¥i,¯u¬O¤Ó¶}¤ß¤F,§ÚÁÙ´|¤F´|²´·ú¬Ý¦³¨S¦³¬Ý¿ù©O!^_^ ¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß¶}¤ß!!! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/4/4 ¤U¤È 10:47:05²Ä 1280 ½g¦^À³
|
Cliff¤j ªø¦¿¤j ¯E¹©²£«~½u»PÄvª§¹ï¤â³oÓ¼ÐÃD»Pª©ÀY¤å«Ü¤£¿ù §Æ±æ¥Î¥\ªB¤Í»P·QÁA¸Ñ°ò¥»±ªº¯E¤Íµ½¥[§Q¥Î¥»ª© 1°ò¥»±½d³ò¤ñì¨Ó§óÂX¤j 2¯à²`¤JÁA¸ÑÄvª§¹ï¤âªº¹ê¤O,ª¾¤vª¾©¼,¦Ê¾Ô¦Ê³Ó ±ø¤j5112ª©¤w»¡¥X¤è¦V:5112ª©¯d¤U¤£¤Ö«e½ú¯Ñ¯Ð¶K¤å ,«Øij±ø¤j±Nª©ÀY¤å§ó·s, ºÉ§Ö¤W¤u,¦³«Ü¦h¥i½Í ¤å¾Ç¸Öµü,²£«~¥«³õ,Á`Åé¸gÀÙ,¥Í§Þ²£·~, ...... ¯E¹©²á¤Ñ«Ç:¤H¬O·P©Êªº°Êª« ¥Ø«e¶K¤å¼ö«×³Ì°ª ¯E§J¤jªºÄw½Xª©»P²Ä¤Q¤HÆ[ÂI:¤è¦V©ú½T,¥]®e¨Ã»W ¾ú¥vª©: ¥²´Iºô«O¯d«Ü¦h«e½ú¯d¤Uªº¨¬¸ñ,¦b¾ú¥vª©¤Wº©¨B,¾ú¤[À±·s,¥O¤H¬y³s§Ñªð |
|
|
·|û¡G´µ¤p¤å10139040 µoªí®É¶¡:2016/4/4 ¤U¤È 10:44:45²Ä 1279 ½g¦^À³
|
ÁV¿| ¤Ö¥´¤F¤@Ó¤j¦r Cliff¤j¤j©çÁªü |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/4/4 ¤U¤È 10:39:41²Ä 1278 ½g¦^À³
|
Cliff ¤j: ¤ä«ù¨Ã·PÁ !!! |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/4 ¤U¤È 09:14:18²Ä 1277 ½g¦^À³
|
Cliff¤j¡A 1. ¦hÁ±z¹ï off label use ªºµªÂСC 2. ¦n¦W¦r¡A·PÁªø¦¿¤j¡C 3. ¤£¨£ªº¨ºÓª©°O±o¬O·P°Ê¤j¶}ªº¡AÀ³¸Ó¬OÅ¥¨ì¨âª©¦X¤@ªº·Qªk¡An§âª©¦WÅýµ¹±z¡A·í¤U´N½Ðª©¥Dµ¹Ãö¤F¡C©Ò¥HÁÙ¬On·PÁ·P°Ê¤j°_ªºÀY¡C «Øij©¹«á¦U¦ì¤j¤j¦³Ãö§Þ³N»P²£«~¤è±ªº¸ê°T³£¶°¤¤¨ì³oÓª©¨Ó¥æ¬y¡A¦hªÅ¬ÒÅwªï¡C |
|
|
·|û¡G´µ¤p¤å10139040 µoªí®É¶¡:2016/4/4 ¤U¤È 08:59:30²Ä 1276 ½g¦^À³
|
¤p§Ì¤ä«ùCliffªº«Øij |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/4/4 ¤U¤È 08:38:32²Ä 1275 ½g¦^À³
|
Cliff¤j ¤p§Ì°t¦X±zªº´£Ä³ ¤ä«ù¨ì©³ |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/4/4 ¤U¤È 06:25:45²Ä 1274 ½g¦^À³
|
Ãö©ó«¾ãª©±ªº´£Ä³¡A¤p§Ì«Øij¶¶±qªø¦¿11¸¹¤jªº´£Ä³°µ½Õ¾ã¡A ª©ÀY¼ÐÃD¡G¡u¯E¹©²£«~½u»PÄvª§¹ï¤â¡v ª©ÀY¤å¡G¡u¥»ª©°w¹ï¯E¹©°ò¥»±°Q½×Àù¯gªvÀø¡B§K¬ÌÀøªk¡BÁ{§É¸ê°T¡C¯E¹©¦U¶µ²£«~¬ãµo¶i«×°lÂÜ°Q½×¡FÄvª§¹ï¤â°ÊºA»P¦U¤è¶i«×°lÂÜ¡C¥»ª©¥ç¯Ç¤Jª©¡yOBI-822¡BOBI-833¥H¥~ªº²£«~¡z¤Î¡y¯E¹©ªº²£«~»P¦UºØ°ò¥»¸ê®Æªº°Q½×¡z¡C¤º®e¡A¤è«K¦U¦ì¬d¾\¤å¡v «Ø½Ð¥xÁÞ¤j¡B·P°Ê£®¤j¡B¹x¥Û¤j¡BQQ¤j¡B´µ¤p¤å¤j¡Bªø¦¿11¸¹¤j¡BµL¤j¡B¥Xª©¤j¡B«ù¤[ªº¯E§J¤j¤Î²³¤j¤j´£¨Ñ°ª¨£¡C ©_©Ç¡A¥´¦r¨ì¦¹¡A¤p§Ì¬ðµM§ä¤£¨ì¡y¯E¹©ªº²£«~»P¦UºØ°ò¥»¸ê®Æªº°Q½×¡zªºª©¤F¡A²´ªá¤F¶Ü¡H |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/4/4 ¤U¤È 05:56:55²Ä 1273 ½g¦^À³
|
¹x¥Û¤j¡G À³¸Ó¥i¥H¾A¥ÎOff-label use¡C½Ð°Ñ¦Ò¥H¤U¤º®e¡C ¦Ü©ó²Ä¤GÃD¡A¡u¦pªG¬O¥Î¥¿³WªºÁ{§É¹êÅç¡A¨CÓ·s¼Wªº¾AÀ³¯g»Ýnªá¦h¤Ö®É¶¡¡H¡v³oÓµª®×ª[²§©Ê¤j¡A¤£©ö¤@·§¦Ó½×¡C ¥xÆW¡G 2010¦~06¤ë02¤é¦æ¬F°|½Ã¥Í¸p¨ç¡]½Ã¸pÂå¦r²Ä0990262180¸¹¡^ ÃÄ«~¥é³æ®Öã¾AÀ³¯g¥~ªº¨Ï¥Î¡]Off Label Use¡^ì«h ¡]www.mch.org.tw/UserFiles/20091106005/%E8%97%A5%E5%93%81%E4%BB%BF%E5%96%AE%E6%A0%B8%E5%87%86%E9%81%A9%E6%87%89%E7%97%87%E5%A4%96%E7%9A%84%E4%BD%BF%E7%94%A8%EF%BC%88Off%20Label%20Use%EF%BC%89%E5%8E%9F%E5%89%87-99_06_02%E7%99%BC%E6%96%87.doc ¡^ ¡K¡KÃÄ«~¡u¥é³æ®Öã¾AÀ³¯g¥~ªº¨Ï¥Î¡vì«h¦p¤U¡G ¡]1¡^»Ý°ò©óªvÀø¯e¯fªº»Ýn¡]¥¿·í²z¥Ñ¡^¡A ¡]2¡^»Ý²Å¦XÂå¾Çì²z¤ÎÁ{§ÉÃIJz¡]¦X²z¨Ï¥Î¡^¡A ¡]3¡^À³¾Ú¹ê§iª¾¯f¤H¡A ¡]4¡^¤£±o¹H¤ÏÃÄ«~¨Ï¥Î·í®É¡A¤wª¾ªº¡B¨ã¤½«H¤OªºÂå¾Ç¤åÄm¡A ¡]5¡^¥ÎÃÄÀ³ºÉ¶q¥H³æ¤è¬°¥D¡A¦p¦P®É¨Ï¥Î¦hºØÃÄ«~¡AÀ³¯S§Oª`·N¨äºî¦X¨Ï¥ÎªºÀø®Ä¡BÃÄ«~¥æ¤¬§@¥Î©Î¤£¨}¤ÏÀ³µ¥°ÝÃD¡C ȱoª`·Nªº¬O¡G¡u¤£¾A¥Î¡uÃÄ®`±ÏÀÙªk¡v¡C¡v ¤£¹L¨ì¤F2011/04/19 ¡]www.tdrf.org.tw/ch/02_affair/aff_01_main.asp?bull_id=4233 ¡^ ¥ßªk°|¤TŪ³q¹LÃÄ®`±ÏÀÙªk³¡¤À±ø¤å×¥¿®×¡A¦³±ø¥ó©ñ¼e¡u¾AÀ³¯g¥~ÃÄ«~¨Ï¥Î(off-label use)¡v¤£±o¥Ó½ÐÃÄ®`±ÏÀÙªº¨î Off label useªºÛ²zì«h¡G°Ñ¦Ò ¡]blog.xuite.net/yahoo_32454/twblog/132639699-%E4%BB%BF%E5%96%AE%E6%A0%B8%E5%87%86%E9%81%A9%E6%87%89%E7%97%87%E5%A4%96%E7%9A%84%E4%BD%BF%E7%94%A8(Off-label+use)%E5%80%AB%E7%90%86%E6%BA%96%E5%89%87 ¡^ ¬ü°ê¡G 㤩Âå®v¨Ì¾ÚÃĪ«¨Ï¥Î¦w¥þ©Ê¤Î¦³®Ä©Êªº±M·~§PÂ_¹ï¤wÀòFDA®Ö㪺ÃĪ«°µoff label use¡A¦ý¸T¤îÃļt¹ï¥¼ÀòFDA®Ö㪺ÃĪ«¦æ¾P¡C ¡uWhile it¡¦s legal for doctors to use drugs off label, it¡¦s not legal for drug companies to market (advertise or promote) their drugs for off-label uses. Off-label marketing is very different from off-label use.¡v¡]www.cancer.org/treatment/treatmentsandsideeffects/treatmenttypes/chemotherapy/off-label-drug-use .¡^ 2008 NEJM¡G¡uRegulating Off-Label Drug Use ¡X Rethinking the Role of the FDA¡v¡uOff-Label Drug UseªººÞ²z-«·s«ä¦ÒFDA¦b³o¤è±ªº¨¤¦â¡v¡]www.nejm.org/doi/full/10.1056/NEJMp0802107¡^ ¹Ï:2001¦~ªº¦Ñ¸ê®Æ¡G¦UÃþÃĪ«On-label»POff-labelªº¨Ï¥Î¤ñ¨Ò¬O¦h¤Ö¡H¡]www.nejm.org/action/showImage?doi=10.1056%2FNEJMp0802107&iid=f01 ¡^ ^°ê¡G ¡]www.gmc-uk.org/guidance/ethical_guidance/14327.asp ¡^ |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/4 ¤U¤È 05:53:51²Ä 1272 ½g¦^À³
|
¯E§J¤j¡A¤p©_¤j¡A ¥H¤U¬O¤Ñ©R¤j©Ò´£¨Ñªº¸ê®Æ¡C www.academia.edu/21886518/Phase_II_Trial_of_Simple_Oral_Therapy_with_Capecitabine_and_Cyclophosphamide_in_Patients_with_Metastatic_Breast_Cancer_SWOG_S0430 ¹ï·Ó²Õcyclophosphamide°Ñ»P¹êÅç 96¤H , 1¦~ ¥¼´c¤Æ 22¤H (22/96=22.9%) 2¦~ ¥¼´c¤Æ 10¤H (10/96=10.4%) 3¦~ ¥¼´c¤Æ 2¤H (2/96=2%) 4¦~ ¥¼´c¤Æ 1¤H (1/96=1%) 5¦~ ¥¼´c¤Æ 0¤H outcomes in the Southwest Oncology Group S0430 trial. ¨â¦ì©Ò°µ¥Xªº¼ÒÀÀ¡A¹ï·Ó²ÕÀ³¸Ó¬O¨ì²Ä18Ó¤ë´N¥þ³¡PD¡C¦ý¬O«ö·Ó¤Ñ©R¤j©Ò´£¨Ñªº³oÓÁ{§É¹êÅçµ²ªG¡Acyclophospamide¥Î©ó¥|´Á¨ÅÀùªº¨Ï¥ÎªÌ¨ì²Ä24Ӥ뤴¦³11%©|¥¼PD¡CY¬O¨Ï¥Î³oÓ¹ï·Ó²Õ¥Í¦s¦±½u¡A¨ä¹ênÅý822ªºPFS¤£ÅãµÛ (P>0.05) ¥i¯à´NµL»Ý±N¹êÅç²Õªº¥ª¥bÃä¦p¦¹§Ö³t¦a¶i¤JPD¡A¦Ó¨â±ø¥Í¦s¦±½uªº¹ï·Ó¥i¯à§ó±µªñ©ó²Î¤@§ëÅU±i¸g²z©Ò´£¥Xªºª©¥»¡C |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/4/1 ¤W¤È 10:30:52²Ä 1271 ½g¦^À³
|
¤s¤¤¤j ¤p§Ì¬Oªù¥~º~,¤¬¬Û¤Á½R¡A§Æ±æ¯à¾Ç¨ì§ó¦h¡I ±z¤F¸Ñ«á¡AY¤p§Ì¦³¿ù»~ªº¦a¤è¡A½Ð¤£§[«ü¥¿¡A Åý¤p§Ì¦³§ó¦h¾Ç²ßªº¾÷·|¡A·P®¦¡I |
|
|
·|û¡G¤s¤¤10141474 µoªí®É¶¡:2016/4/1 ¤W¤È 10:09:48²Ä 1270 ½g¦^À³
|
¦³«í¤j ÁÂÁ±z¡A¤p§Ì¦A®ø¤Æ¤@¤U¡A¦³°ÝÃD¦A¦V¤j®a½Ð±Ð.ÁÂÁ |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/4/1 ¤W¤È 10:01:44²Ä 1269 ½g¦^À³
|
¤s¤¤¤j ¤p§Ì¸ÕµÛ¦^µª±zªº°ÝÃD,±z°Ñ¦Ò¬Ý¬Ý! ¥H¤U¬O±i¸³2/21ªk»¡·|«á±¹ï§ë¸ê¤H¸ß°Ý§ó²Ó³¡ªº¦^µª¨Ñ¤j®a°Ñ¦Ò Q1¥þ²y¤T´ÁÁ{§É¬O§_·|°µ3-5¦~? A¥Ø«e¤£°µÁr´ú,¦]¬°´N¥Ø«e¼Æ¾Ú a»PFDA½Í¦³¥i¯à¨ú±oconditional approval¦]¬°¦w¥þ¦³Àø®Ä b©¹¤T´Á¨«,¥i¯à°µ¤@¥bFDA´Nµ¹§A¹L c¤T´Á°µ¨ì©³ Q2¬¢½Í±ÂÅv±¡§Î¤Î«áÄò¨ä¥LÀù¯gÁ{§É¦ó®É®i¶}? Aµu´Á¤º´N·|¦³±ÂÅv,¤£·|»P¤jÃļt°µ¥þ±©Ê±ÂÅv(µø±ø¥ó¦Ó©w),¥Ñ©ó¼Æ¾Ú«D±`©ú½T,·|»P¤pÃļt©Î°Ï°ìÃļt°µÁ{§É¦X§@, ¤@¦¸§â10-14ºØÀù¯gÁ{§É¤@°_°µ,±q¤G´Á¶}©l,Y¼Æ¾Ú¦n,´N·|ª½±µ¶i¤J¤T´ÁÁ{§É ¥t²Î¤@©ó³Ì·sªº³ø§i¤¤¦³´£¨ì ¦Ü©ó¬ãµo®É¶¡©µªø¡B§ï¶}µo¨ä¥¦Àù¯g¡Kµ¥»¡ªk¡A¥ç¬O¹ï OBI-822 ªºÁ{§É³W¹º»P¤½¥qµ¦²¤¥¼¦³¥R¤Àªº¤F¸Ñ¡C¯E¹©ªí¥Ü¡A³z¹L OBI-822 ¥½´Á¨ÅÀù Phase2/3 ¸ÕÅç»P¸Ñª¼¡A°£¤FÃÒ¹ê¡u¦³²£¥Í§Ü Åé IgG¡BIgM ªº¤H´N«Ü¦³®Ä¤§¥~¡v¡A©|±o¨ì¬Û·í¦hªº¬ì¾ÇÃÒ¾Ú¡A ¨¬¥H¡¨°§C¡¨«áÄòÁ{§Éªº¦¬®×¤H¼Æ¡A¨Ã¡¨¥[³t¡¨«áÄò¨ÅÀù»P¦h¶µ Àù¯gªº¶}µo³t«×¡F¦¹¥~¡A¥ç¦³¥i¯à´N¥»¦¸ªº Phase2/3 ¥½´Á¨ÅÀù ¸ÕÅçµ²ªG¦V FDA ¥Ó½ÐÃÄÃҩάð¯}©ÊÀøªk¸ê®æ¡A¡¨¥[³t¡¨ÃĪ«ªº¤W ¥«¡A¦Ó«áÄò¨ä¥¦Àù¯gªºÁ{§É¡A±À´ú±N±Ä¶}©ñ©Êªº Phase2b/3 ³] p¡AY¦b Phase2b «KÆ[´ú¨ì¨}¦nÀø®Ä´N¥i¡¨¥[³t¡¨¨ú±oÃÄÃÒ¡A¨Ã ¨S¦³©Ò¿×©Ôªø¡B©µªø¡B©ñ±ó¨ÅÀù¶}µoªº±¡ªp¡C¡C ºî¦X¥H¤W¡A¤p§Ì»{¬° 1©Ò¦³Àù¯g³£¶·°µÁ{§É¥Bª½±µ¶i¤J2´Á¬Æ¦Ü2b¡A¤F¸ÑÁ{§ÉÀø®Ä«á¡AY²Å¦X¹w´Á¡A¥i¯à´N´`822¥¼¨Ó¬Û¦Pªº¼Ò¦¡¥Ó½ÐÃÄÃÒ¡A¥B¦]¬°FDA·~¤w¼f®Ö822¾÷Âà¡A©Ò¥H¨ä¥L¾AÀ³¯g¥un¦³¹FÀø®Ä«ü¼Ð¡A¥Ó½ÐÃÄÃÒÀ³¸Ó·|¥[³t 2¥t±i¸³¦^µªQ1aÀ³¸Ó´N¬Oª½±µ¨ú¦³±ø¥ó³\¥iÃÄÃÒ¡A¤§«á³z¹L§ó¦hªºªvÀø®×¨Ò,ÃÒ©úÀø®Ä¡A¦A¥Ó½ÐFull approval¡C 3°ß¤j¥ý«e¦³´£¨ì¡A¦p¸Ñª¼¹L¡A´X¥G¿w©w¥i¥H¥Hºu°Ê¦¡Àøªk¥Ó½Ð¡A¸É°µ¤p¤T´Á¡A(À³¸Ó´N¬O±i¸³©Ò»¡ªºb) ¦ý²{¦b¡A¥HÓ¤H¹ïFDAªºªk³WÁA¸Ñ¡A¤@¼Ë¥i¥H¥Ó½Ðºu°Ê¦¡Àøªk¡A¦A°µÓ¤p¤T´Á¡A¸É¼Æ¾Ú¡A 4ºu°Ê¦¡¼f¬d¡]Rolling review¡^¡AÃļt¥i¥H¦b·sÃĤW¥«³\¥i¥Ó½Ð¡]NDA, New Drug Application°e¼f¸ê®Æªº¤@³¡¤À§¹¦¨«á´N¥ý°e¥ó¡A¦Ó¤£¥Îµ¥¨ì°e¼f¸ê®Æªº¨C¤@Ó³¡¤À³£§¹¦¨«á¤~¯à°e¥ó¡C¤@¯ëªº·sÃĤW¥«³\¥i¥Ó½Ðªº¼f¬d³£¬On¨ìÃļt§â§¹¾ãªº¸ê®Æ³£°e¥ó«á¤~·|¶}©l¶i¦æ¼f¬d¡C ¥H¤W¬O¤p§Ì¬Ýªk¨Ñ±z°Ñ¦Ò |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/4/1 ¤W¤È 12:39:44²Ä 1268 ½g¦^À³
|
Cliff¤j¡A ¶¶µÛ¤s¤¤¤jªº°ÝÃD¡A¦pªG 822 ¤@¥¹¨ú±o¥|´Á¨ÅÀùªºÃÄÃÒ¡A¨º»ò§Z±_ÀùªºÂå¥Í¥i¤£¥i¥H¥Î off label ªº¤è¦¡¬°¥Lªº¯f¤H¨Ï¥Î 822 (À³¸Ó¬O¨ä¥LÃĪ«µL®Ä®É)¡H¯E¹©°£¤F¤£¯à«Å¶Ç¸ÓºØªvÀø¤è¦¡¤§¥~¡AÁÙ¦³¨º¨Ç¨î¡H ¦pªG¬O¥Î¥¿³WªºÁ{§É¹êÅç¡A¨CÓ·s¼Wªº¾AÀ³¯g»Ýnªá¦h¤Ö®É¶¡¡H |
|
|
·|û¡G¤s¤¤10141474 µoªí®É¶¡:2016/3/31 ¤U¤È 11:29:07²Ä 1267 ½g¦^À³
|
PT¤j ¤w¦AÐnµ¹§õ¤½Ãö¡A¤@¦³®ø®§·|¥ß°¨PO¤W¡A¸ò±z¦^³ø¤@¤U¡A±ß¦wÅo¡K |
|
|
·|û¡G¤s¤¤10141474 µoªí®É¶¡:2016/3/31 ¤U¤È 11:06:19²Ä 1266 ½g¦^À³
|
PT¤j PT¤j ¤p§Ìè¤~µo§¹«Hµ¹§õ¤½Ãö¡A¨SÃö«Y¡A¤p§Ì¦bµo¤@«Êµ¹¦o¬Ý¬Ý¤½¥q¤è±¥i¤£¥i¥H±µ¨üªÑªF«Øij³]¸mQ&A¡C ÁÂÁ±zªº«ü±Ð |
|
|
·|û¡GPT10139061 µoªí®É¶¡:2016/3/31 ¤U¤È 10:51:34²Ä 1265 ½g¦^À³
|
¤s¤¤¤j §Ú¬Oı±o¤j®a¦b°Q½×ªº¦P®É ¬O¤£¬O¤]«Ø¥ß¸ò¤½¥q¤º³¡·¾³qªººÞ¹D Åý¯E¤Íªº¬Ýªk¸ò¤½¥q»¡ªk(©Î³W¹º)¨Ã³¯¤ñ¸û(±zªºQ1) ¬Æ¦Ü¦³¤¬°Ê(±zªºQ2) ³o¼Ë¹ïÂùÃäÀ³¸Ó³£¬O¦³¯qªº. §Ú¤£¤Ó¦nªº°O¾Ð¬O°O±oCliff¤j,¤pÄ«ªG¤j,¦ü¥G¬O¥i¥H¸ò¤½¥q¤º³¡¹ï¤W¸Üªº. ¥t¥~,¦pªG¯uªº«Ø¥ß°_·¾³q¾÷¨î,·sªº±M¥Îª©±¥i¯à´N»Ýn¤F. ·íµM,¦b¤½¥q©xºô«Ø¥ß³o¼Ëªºª©±¤~¬O³Ì¦nªº--¦pªG¤½¥q¨S¤H¨S®É¶¡,§Ú·Q¶W¦h¯E¤Í¤]·|Ä@·N·í¸q¤uªº. |
|
|
·|û¡G¤s¤¤10141474 µoªí®É¶¡:2016/3/31 ¤U¤È 10:34:43²Ä 1264 ½g¦^À³
|
¦U¦ì«e½ú̱ߦw ¤p§Ì¦³Ó°ÝÃD·Q½Ð±Ð¤j¤jÌ¡A¦pªG822¨Æ«á§Àªº¼Æ¾Ú¡A¥H«eªºÃĪ«©Ò¨S¦³¡A¨ºFDA¦pªGµ¹¤©CONDITIONAL APPROVEªº¸Ü¬O¦b¤T´Á¹êÅ礤«Å¥¬µ¹¤©CONDITIONAL APPROVE©O??ÁÙ¬O¦b¤@¶}©l´N«Å¥¬µM«á¦A¸É¤p¤T´Á?? ¥t822»P833¾÷Âàì²z¬Û¦P¡A²{¦b¥u¦³³n±_Àù¹êÅ礤¡A¦pªGn¬O¥Î¤Q¦hºØÀù¯g¡A¬O¤£¬O¨C¶µ³£n¹êÅç©O?? ¦]¬°¾÷Âàì²z¬Û¦P¡A¹êÅç´Á¶¡·|ÁYµu¶Ü?? ±æ¤j¤j̦³ªÅ¥i¥H²o±Ð¤p§Ì¤@¤U¡AÁÂÁ |
|
|
·|û¡G·P°Ê£®10141081 µoªí®É¶¡:2016/3/31 ¤U¤È 05:13:26²Ä 1263 ½g¦^À³
|
¦pªG¥[p°²©ÊPD»P¨Ó¤£¤Î²£¥Í§ÜÅé³Q§PPD¹ê»Ú¤W·|¦³Àø®ÄªÌ ¦U«O¦u¦ô5% ¹ê»Ú¦³«Ü¦nÀø®Äªº¤ñ²v¥i¯à¥i¥H¹F¨ì¥|¦¨¥H¤W ¦pªG¦A©¹§ó«e´Á±À ¥i¯à¦³¦nÀø®Äªº¤ñ²v·|¶W¹L¤¦¨ Y¬O©¹¨ä¥LºØÀù¯g±À¶i ¤×¨ä¬O¤ñ¸û¤¿²r«¬ªºÀù¯gªº«D¥½´Á¥«³õ À³¸Ó¬O¦³«D±`¤jªºÀu¶Õ ©Ò¥H°£¤F¥Ø«e²Ä¤@¨Bªº¨ÅÀù¥½´Áªº³æ¿W¥ÎÃĤ§¥~ §Ú·Q¤§«e¥xÁÞ¤j©Ò´£ªºÁp¦X¥ÎÃÄ¥«³õÀ³¸Ó¤]«Ü¤j ¦ÓÂX¤Î¨ä¥LºØÀù¯g¥«³õ»P§ó«e´Á¥«³õªº¼ç¤O§ó¬OÃe¤j |
|
|
·|û¡G¤ß»·¦a¦Û°¾10141241 µoªí®É¶¡:2016/3/31 ¤U¤È 02:56:06²Ä 1262 ½g¦^À³
|
ÁÂÁ¹x¥Û¤j ¤Öºâ¤Fdrop out. ¦ý§Y¨Ï¬O¤w¸gPDªº¤H ¤]n¬Ý¬O´XÓ¤ë¤~PD ¦Aµ¥¨âÓ¤ë´Nª¾¹D¼Æ¾ÚÅ夣Åå¤H¤F |
|
|
·|û¡G·P°Ê£®10141081 µoªí®É¶¡:2016/3/31 ¤U¤È 02:25:42²Ä 1261 ½g¦^À³
|
¦pªG§Ú§â25%»P34%¨ú¤¤È À³¸Ó¬ù¬O±µªñ30% ¦Ó¥BÀ³¸Ó¤ñ¸û®e©ö¶W¹L30%³oÓ¤ñ²v ¤]´N¬O¹ï¥½´Á¨ÅÀù¥B²¾Â઺¯f±w ¦³«D±`ÅãµÛÀø®Äªº¤ñ²v¬O30%©Î¥H¤W ¤j®a¬Ý³oÃįण¯à½æ |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/3/31 ¤U¤È 02:17:26²Ä 1260 ½g¦^À³
|
¤ß»·¤j¡A ±zº|ºâ¤F drop out ¤H¼Æ¡C |
|
|
·|û¡G¤ß»·¦a¦Û°¾10141241 µoªí®É¶¡:2016/3/31 ¤U¤È 02:11:25²Ä 1259 ½g¦^À³
|
³o¼Ë¤]©Ç©Çªº 201505 LR PD-229. ¶ÀÁ`»¡«á¨Ó¨CӤ볣¥u¦³¤@¨âÓPD, ¬Æ¦Ü¨S¦³, ´Nºâ¨CӤ릳¤TÓPD¦n¤F ¨ì¤Q¤ëªº¸Ü, ºâ¤Ó¤ë 229+3x5=244 349-244=105 ¦³105Ó¤H¥¼´_µo ¤]²Å¦X¼·¤j100¤H¥¼´_µoªº¹Ú¹Ò |
|
|
·|û¡G·P°Ê£®10141081 µoªí®É¶¡:2016/3/31 ¤U¤È 01:58:50²Ä 1258 ½g¦^À³
|
©êºp¼g¿ù¤F ¬O¥¼PD¤H¼Æ³Ì¤Ö57©Î58¤H ³Ì¦hªº¸ÜÀ³¬O±µªñ80¤H |
|
|
·|û¡G¤ß»·¦a¦Û°¾10141241 µoªí®É¶¡:2016/3/31 ¤U¤È 01:56:33²Ä 1257 ½g¦^À³
|
Á`¦@¬O349¤H ¦Ó¤£¬O289¤H§a? ©Ò¥HÀ³¸Ó¬On±q229¦A©¹¤W¥[ ¥Î349¦©±¼, ¤~¬O¨SPDªº¤H¼Æ |
|
|
·|û¡G·P°Ê£®10141081 µoªí®É¶¡:2016/3/31 ¤U¤È 01:52:32²Ä 1256 ½g¦^À³
|
«ö·Ó±i¸³»P¶ÀÁ`¤µ¤Ñªº»¡ªk ¤K¤ë©³©Û¶}¸Ñª¼·|ij¬O¬O¦]¬°³Ì«á¤@¦ì¨ü¸ÕªÌ¤w¨ü¸Õ¤@¦~ ¦Ó¤£¬Oì¥ý¥t¤@Ó¹w³]ªº±ø¥ó289¤HPD 10¤ë©³Âê©w¸ê®Æ ¤£½×³Ì«á¤@¦ì¨ü¸ÕªÌ¬O¹êÅç²Õ©Î¹ï·Ó²Õ Y9¤ë10¤ë¦U¦³¤@¦ìPD ³Ì«á¥¼PD¤H¼ÆÀ³¸Ó¬O³Ì¦h57©Î58¦ì ¤À¥À¨ú232©Î233¤H ¹êÅç²Õ¥¼PDªº¤ñ²v³Ì¤ÖÀ³¸Ó±µªñ25% ¦Ó³o¨ä¤¤µ´¤j³¡¤Àªº¤HÀ³¬Oªø§ÀªÌ ¦U¦ì¤j¤j«ç»ò¬Ý |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/3/31 ¤U¤È 12:48:46²Ä 1255 ½g¦^À³
|
¤p§Ì ¨S¦³°ÝÃDªº ¶}©«¤£«n «nªº¬O¤j®aªº§ë¤J»P°^Äm n¦X¨Ö ¤è«K¤j®a°Q½× ¤p§Ì ¼Ö¨£¨ä¦¨ |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2016/3/31 ¤W¤È 10:42:00²Ä 1254 ½g¦^À³
|
Cliff ¤j.. ©êºp.¤pªºÅý±z»~·|¤F.¤pªº¥u¬O·Q"®ø¥¢"¥h¤W¤u¦Ó¤w. ¦Ü©ó«ç·|¥´¥X®ø¥¢.¬Ý¨Ó³Ìªñªº¨Æ¯u¶Ã¨ìÅý¤pªº¸ËÀu¶®¯}¥\.. ¤£¹L ªm¤j ¯uµ¹¤pªº±¤l.ªÅ©jµL®Ä.Åý¤pªº½Ð¥X¨Ó´«®ð¤F. ¤£ªP¶O¤pªº§t²\ºt¥X....«¢«¢. ÁÙ¤@¨Æ·Q³Â·Ð±z.Y¦³¹J¯Î°|ªø.½Ð¥NÂà¹F.. ¥xÆW´CÅé.¥Á¥Nªº·Qªk.¤£¬O¥xÆW©Ò¦³¤Hªº·Qªk.µL½×¯Î°|ªø¤U¤@¨B¦p¦ó. ¦³¤@¸s¤H¤F¸Ñ¥L¾D¨üªºµL²z¹ï«Ý.¨Ã¤ä«ù¥L.. ÁÂÁ ¥H¤U¼ÐÀY¥ý±H¦b³o¤F "¥x¸Ç¬üÄy¬ì¾Ç®a¯Î±Ò´fÀò±o¿Õ¨©º¸¼ú" ¥ý«e©È¤ÓÄÛ±i½ÐªO¥D§R±¼ªº¼ÐÀY.§Ön¥X²{¤F |
|
|
·|û¡GµL¤j10141864 µoªí®É¶¡:2016/3/31 ¤W¤È 10:08:11²Ä 1253 ½g¦^À³
|
Cliff¤j, ¥xÁÞ¤j, ¹x¥Û¤j, ·P°Ê¤j, ¦U¦ì¤j¤j: «e½ų́M©w´N¦n..¤p§Ì¥u¦³¾Ç²ß¨ü±Ð,¯u¬O·P®¦£°.. |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/3/31 ¤W¤È 09:35:07²Ä 1252 ½g¦^À³
|
ªø¦¿¤jªº«Øij¦³¨ä¹D²z¡C¦ý¬O³o°£¤Fn¥ý´L«±ø¤j»P¯E§J¤j¨â¦ìªº·Qªk¤§¥~¡AÁÙn¬Ýª©¥D¯à§_°t¦X¡Cì¦]¬O¯E¤ÍÌÀ³¸Ó§Æ±æ¨âª©¹L¥hªº¾ú¥v¸ê®Æ³£n¯à«O¯d¡A¨º»ò¨âª©¦X¤@´N»Ýnª©¥DÅý¤uµ{¤Hûªá¤£¤Ö®É¶¡¨Ó³B²z¡C ¥ý¬Ý¬Ý¯E«È¤j»P±ø¤jªº·N«ä§a¡I |
|
|
·|û¡Gªø¦¿11¸¹10136804 µoªí®É¶¡:2016/3/31 ¤W¤È 08:27:42²Ä 1251 ½g¦^À³
|
¤p§Ì²L¨£:4-5ª©µy¶û¹L¦h,«Øij3ª©: 1)Faith¤jªº²á¤Ñ«Ç: ¤Ñ«n¦a¥_ ¡K 2)¯E§J¤jªºÄw½X°lÂܯ¸»P±ø¤jªº5112¤¸¾ã¦X,©Î¥i§ï¦W¬°¯E¹©¦hªÅ½×¾Â¥H¼s¯ÇªÅ¤èÆ[ÂI,ÁקK¹L«×¼ÖÆ[: ±M°Q½×Äw½X, ¦hªÅ¾Ô±¡,§Þ³N±, ªÑ»ù±, ¸gÀÙ±µ¥µ¥ ¡K 3)Cliff¤jªº²{ª©,©Î¥i§ï¦W¬°¯E¹©²£«~½u»PÄvª§¹ï¤â:±Mªù°w¹ï¯E¹©°ò¥»±°Q½× °Q½×¤Wz§K¬ÌÀøªk,¤½¥q¤§¦U¶µ²£«~¬ãµo¶i«× Á{§É¸ê°T, Ävª§¹ï¤â»P¦U¤è¶i®i¡K. |
|
|
·|û¡G´µ¤p¤å10139040 µoªí®É¶¡:2016/3/31 ¤W¤È 07:30:31²Ä 1250 ½g¦^À³
|
QQ¤j ¤p§Ìı±o4) & 5) ¦X¦b4)ª©§Y¥i ¤Ó¦hª©Åª°_¨Ó¤]³Â·Ðªü |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/3/31 ¤W¤È 01:53:02²Ä 1249 ½g¦^À³
|
Cliff¤j, ¥xÁÞ¤j, ¹x¥Û¤j, ·P°Ê¤j, ¦U¦ì¤j¤j: Ãö©ó·sª©©Î×q©ñ¤j¦¹ª©, ¦³£¸¨Ç¤p¤p«Øij¨Ñ°Ñ. ¦]¬°Àù¯gªº§K¬ÌÀøªk¹ê¦b¬O¤Ó¦h¤¸, ¬J¼s¥B²`, ®É®É¤S¦³·sªº¸ê°T. ¯E¹©¬JµM¬O¥H¥þ²y¥«³õ¬°¥Ø¼Ð, ¦ÛµM°£¤FÀ³°Q½×¤½¥q¥»¨ªº¸ê°T, ·íµM¤]À³¯d·N·í¤U¦U°ê»Ú¤j¼tªº¶i«×, §K¬ÌÀøªkªºµo®i, Àù¯gªvÀøªº¶i®i©Î·sµo²{µ¥µ¥µ¥. ³o¦¸ªº¨Æ¥ó, ¨ä¹êCliff¤j¦b¤§«e´N¦³´£¥Ü¹L¸~½F®û¼íªº°ÝÃD., ¦Ñ¥v¤j¤]¸g±`¤À¨É«Ü¦h¨ä¥LÁ{§Éªº«n¸ê°T. ³o¨Ç³£«Ü«n¥B»P¯E¹©ªº²{¦b¤Î¥¼¨Ó²£«~¦³Ãö, ¦ý¤S«DÄݪ½±µ¬ÛÃö. §Ú²Ê²Lªº·Qªk, ¬O¤£¬Oª½±µ¦³Ãö¯E¹©°ò¥»±ªº°Q½×¥t¶}¤@ª©., ¦ÓCliff¤j¦¹ª©´N°Q½×¤À¨É¶¡±µ¬ÛÃöªº¨ä¥L¸ê°T ? ¦p¦¹¬O¤£¬O¤ñ¸û¯àÁקK¸U¤@¬~ª©ÄY«®Éªº§xÂZ ? ³o¼Ë§ÚÌ°ò¥»¤W´N¦³: 1) Faith¤jªº²á¤Ñ«Ç: ¤Ñ«n¦a¥_ ¡K 2) ¯E§J¤jªºÄw½X°lÂܯ¸: ±M°Q½×Äw½X, ¦hªÅ¾Ô±¡µ¥µ¥ ¡K 3) ±ø¤jªº5112¤¸: °Q½×§Þ³N±, ªÑ»ù±, ¸gÀÙ±µ¥µ¥¡K 4) Cliff¤jªº²{ª©: °Q½×¤Wz§K¬ÌÀøªk, Á{§É¸ê°T, ¦U¤è¶i®i¡K.. 5) ·sª©: ±Mªù°w¹ï¯E¹©°ò¥»±°Q½× 4) & 5) ªº¼ÐÃD¦A½ÐCliff¤j¤Î¦U¦ì¤j¤j°Q½×. ²³¤jªº·Qªk©O ? |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/30 ¤U¤È 10:22:41²Ä 1248 ½g¦^À³
|
¹x¥Û¤j ·P°Ê¤j 1 822 833 ¥H¥~ªº²£«~¦]¦³«Ü¦h822 833Ä_¶Q¸ê°T,Cliff¥S °ò¥»±«Ü±j¤S¬O«e½ú,½ÐCliff¥S§â¼ÐÃD»P¤º®e ¼W×ÂX¥R§Y¥i,¥H«á¦³Ãö¤½¥q¬ãµo²£«~ªº°ò¥»±¦U¦ì¤j¤j¶°¤¤¨ì³oª©¤À¨É,¼ÐÃD»Pª©±¤º®eÀ³¥ÑCliff¥S¨M©w 2 ±ø¤j5112ª©¥i·íºî¦Xª©¤è¦V¥Ñ±ø¤j¬É©w 3 ³oÓ·s¶}ª©«Øij§R°£ 4 ¦]¬°¦³¤H»{¬°¦b5112ª© ¶K¤å·|»~¾É§O¤H,©Ò¥H¤~¦³µL®a¥iÂk¤§·P,³o¥y¸Ü³ºµMÅý°ÝÃDÀò±o¸Ñ¨M ,²{¦b¦³®a¥iÂk¤F ¥H¤W«Øij¬O°ò©ó¤ÀÃþ±i¶K Åý¤j®a¤è«K·j´M¸ê°T ÁÂÁ¤j®a |
|
|
·|û¡G·P°Ê£®10141081 µoªí®É¶¡:2016/3/30 ¤U¤È 10:03:37²Ä 1247 ½g¦^À³
|
ª©¥D»¡¥i¥H§ó§ï¼ÐÃD ÁÙ¦³Cliff¤j»¡¬Ý¤j®aªº·N¨£ ¨º´N½Ð°Ý¦U¦ì¤j¤jªº·N¨£ ¤]¯S§O½Ð°Ý¥xÁÞ¤jªº·N¨£ ±z¨º¤@¥y¦³®aÂk¤£±o¹ê¦b¤Ó¨I«¤F |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/30 ¤U¤È 10:02:35²Ä 1246 ½g¦^À³
|
«Øij§â¥»ª©ª©ÀY¤å³¹§R°£¡A¤£n¦Aªu¥Î¡A¦]¬°»P888µLÃö¡C ·sª©ÀY¼ÐÃD/¤å³¹¥i±Ä¹x¥Û¤j«Øij¡C |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/30 ¤U¤È 09:56:05²Ä 1245 ½g¦^À³
|
·P°Ê£®¤j¡A¶}©ñ°Q½×¡AÓ¤HµL©w¨£¡A¥unÄݩʲM·¡©ö¿ë§Y¥i¡AÁÂÁ¡C |
|
|
·|û¡G·P°Ê£®10141081 µoªí®É¶¡:2016/3/30 ¤U¤È 09:45:00²Ä 1244 ½g¦^À³
|
Cliff¤j «D±`·PÁ±zªº¦^µª ¥i¯àn½Ð°Ýª©¥D¯à§_ª½±µ§ó§ï¼ÐÃD ÁÙ¦³Cliff¤jı±o¼ÐÃD§ï¦¨¦p¦ó¸û¬°«ê·í ¥iÀ°¦£§ó§ï¡A·Q¦nn§ï¤°»ò¼ÐÃD¦W¦A§iª¾§a~~BYª©¥D |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/30 ¤U¤È 09:39:08²Ä 1243 ½g¦^À³
|
¹x¥Û¤j¡A±z³o»ò¦³¤ß¡AºÙÆg³£¨Ó¤£¤Î¤F¡Aþ¨Ó¡uXX»°XX¡v¤§»¡¡I ¤p§ÌÃÙ¦P±zªº¥ß·N¡A¤£¹L¤£ª¾¹D§Þ³N¤W¦p¦ó¥hקï³oÓ°Q½×°Ïªº¼ÐÃD¡H ¨ä¹ê«á¨Ó·|§â822¬ÛÃöªº¶K¤å¤]¶K¦b¦¹ª©¹ê¦³W°J¡A¨ä¥Lª©¦U¦³ÄÝ©Ê¡A¬J¤£ºâ¬O¯Â²á¤Ñ¡A¤]¤£ºâ¬O°Q½×Äw½X±¡A±`¦³Á|ºæ«oµL¤Uºæ³Bªº§xÂZ¡A³Ì«á³y´N³oÓª©¤£Û¤£Ãþªº¤jÂøÀí¡A¨ä¹ê¶}ª©¤£¤[«á¤wµo²{ª©ÀY¤å³¹¤º®e¬O¿ù»~ªº¡A§Ú¦Û¤v¬Ý¤F¤]«Ü¤£³ßÅw¡C ¤£¹L³o¨Ç³£¤£«n¡A§Únªí¹Fªº¬O¡A¤@¥¹¶}¤F¦¹ª©´N¬OÄÝ©ó¤j®aªº¨Ï¥ÎªÅ¶¡¡A¤£¬OÓ¤H©Ò¦³¡A¤£¥²·Q¤Ó¦h¡A¤p§Ì³£¥i¥H±µ¨ü¡C ˬO©IÆ~¤j®a¾¨¶q¨¥¤§¦³ª«¡A¹ï©ó±ß¨Ó¤Wª©ªº¤j¤j¡Aµo°Ý«e¤£§«¥ý¦^ÀYª¦¤å¡A¦³¯qµL®`¡A§_«h¦³¥Îªº¸ê°T«Ü§Ö´N·|³Q²T¨S¡A¦ý¬O¥Ø«e±Ä¤À¶ªºª©±³]p¡A¹ï¦^ÀYª¦¤å¨Ã¤£¤è«K¡A¥H¤WÓ¤H¤§¨£¤£¯à¥Nªí/¥N´À¤j®aªº·N¨£¡A½Ð¤j®a¦A°Q½×¡C ÁÂÁ¹x¥Û¤j¡B·P°Ê£®¤j¡AÁÂÁ¤j®a¡C |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/3/30 ¤U¤È 07:07:28²Ä 1242 ½g¦^À³
|
Cliff¤j¡A ·P°Ê¤j·s¶}¤F¤@Óª©±¡y¯E¹©ªº²£«~»P¦UºØ°ò¥»¸ê®Æªº°Q½×¡z¡C¤p§Ì»{¬°¸Óª©»P¦¹ª©ªººë¯«¬Û¦P¡A³£¬O°Q½×°ò¥»±ªºÄ³ÃD¡A¦Ó¦¹ª©ªñ¨Óªº°Q½×ijÃD¤]¬O¥H822¬°¥D¡A¥H¦Ü©ó¦WºÙ»P¤º®e¤]¦³¨Ç®t²§¡C¬°¤FÁקK¸ê·½¤À´²¡B¯E¤Í̧ä¸ê®Æ»Pµo¨¥n¨âÀY¶]¡A©Ò¥H¤p§Ì¤æÁx«Øij±z±N¥»ª©ªº¦WºÙ°µÓקï¡A±N¨âª©¦X¤@¡A¹ê¦Ü¦WÂk¡A¤£ª¾±z·N¤U¦p¦ó¡H ±z¤£·|©Ç¤p§Ì¡y¤^¤¢»°¼q¤½¡z§a¡H |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/29 ¤U¤È 09:51:00²Ä 1241 ½g¦^À³
|
¸{·¦å«B¡A¿ù±þµL¶d¡A¾¤©ú«eªº¶Â·t¡A§¨ÂøÀb¤Hªº«sÀz¡C ³s¨H¤j¯¥¤]¨Óªî¤@¸}¡A¦h¤Ö¦~¨S§ë½ZÂå¾Ç´Á¥Z¤F¡H¤£ª¾¦³Late breaking abstract¡AÁÙn±i¸³®É¦^µª¡H¤£ª¾¦³º~¡AµL½×ÃQ®Ê¡HAACR¦Û1999¦~¡FASCO 2000¦~¤w¦³late breaking abstractªº¾÷¨î¡A¨ä®É©¼¤w±óÂå±q¬F6-7¦~¡K¡K¡A·G»á¦Ñ¨o¡A¥¼¯à¦A¶º¡A¦Ü¤Ö¤£¸Ó¶M®`«á½ú©¾¨}¡K¡K ·P°Ê£®¤j¡G ¤@¡B Q¡GYLR§P©wPD«á¡ACT©ÎPET´N¤@©w¤£·|°µ¤F¶Ü? A¡G¤w§PPDªÌ¡A¤£¦A°µ©â¦å¡BCT¡]©ÎPET¡^µ¥Àˬd¡A´N³Ñ°lÂÜOS¡A¥HOPT-822-001ªºpµe°lÂÜOS®É¶¡ªø¹F5¦~¡A§Y¨Ï±wªÌ¦A¥h±µ¨ü¨ä¥LÀøªk¤]µL§«¡C³q±`¨C3Ó¤ë¤@¦¸¥H¹q¸Ü§¹¦¨°l³X¡C ·|¤£·|³y¦¨ÄÌÂZ©Î¤£²z·|µ¥±¡§Î©O¡H°ò¥»¤W¦b¯Ç¤J¦¬®×«e¤w¸g¬ù©w¦n·|°µ³o¼Ëªº°lÂܰʧ@¡C Q¡GCRªº¸ê®Æ·|Åܬ°censored¡A¨ºCRºâ¬OPD¤F¶Ü¡H A¡Gcensored´N¬O¥¼©wªº·N«ä¡F¦ýPD´N¬O´c¤Æ¡]¤w¸g¹ï¦¹Á{§Épµe°µ¥X°^Äm¡^¡C¨âªÌ·N¸q¤£¦P¡C Q¡G¬°¦ó§ÚÌ·|»¡¤@¯ëLR»PCR·|¦³30%¥ª¥kªº®t¶Z¡H A¡G³o¬O¤H®a¤ÀªR¦h½gÁ{§É¸ÕÅ窺µ²ªG«áªºµo²{¡A°Ñ¦Ò¸ê®Æ¤@¤¤¤@^¡C ¤¤¡G¤ýª´-¡u¥HµL´c¤Æ¦s¬¡®É¶¡PFSµû¦ô§ÜÀùÃĪ«Àø®Äªº¦Ò¶q¡v¡]www.cde.org.tw/Content/Files/Knowledge/514d1769-1bc9-4bce-b414-9279a5de1b39.pdf¡^ ^¡G¡uEvaluation of Blinded Independent Central Review of Tumor Progression in Oncology Clinical Trials¡GA Meta-analysis¡v¡]dij.sagepub.com/content/early/2012/09/07/0092861512459733¡^¡GTherapeutic Innovation & Regulatory Science¡GSeptember 7, 2012 ³o¤@½g´¿©ó104/06/14¤U¤È 08:51:32¡u¯E¹©·|º¦¨ì5112¤¸¦¨¬°¥xÆW¤§¥ú¶Ü¡H¡v°Q½×¹L¡C ¤G¡B Q¡G¬°¦ó¯E¹©·|¥HÀù¥½¯f¤H¬°¥Dn¹êÅç¹ï¶H¡A¦Ó¤£¬O¥H¤T¡A¤G¡A¤@´Á¯f±w¬°¹ï¶H¡A¬O¦]¬°¹êÅ窺®É¶¡»P¤H¼Æµ¥ªº¦¨¥»¦Ò¶q¶Ü¡H A¡G´N¯f±¡¦Ó¨¥¡A¥½´Á¡]¥|´Á¡^Àù¯g±wªÌ¯f±¡¸û¦M«æ¡AªvÀø¿ï¶µ¤S¤Ö¡A¬O³Ì»Ýn±Ï§Uªº¹ï¶H¡]unmet medical needs¡^¡C ´Nªk³W¦Ó¨¥¡AFDA¬°³oÃþªºunmet medical needs¡Aq©w¤F³\¦h¼úÀyÀu´f±¹¬I¡AÅý¬ãµoªº·sÃÄ·ÀI°§C¡C ´NÃļt¦Ó¨¥¡A¥½´Á¡]¥|´Á¡^Àù¯g±wªÌ¦s¬¡´Á¸ûµu¡A¥i¨Ï¾ãÓÁ{§É¸ÕÅ秹¦¨ªº®Éµ{¾¨¶qÁYµu¡A³o¹ï¿N¿úªº·sÃĬãµo¤½¥q¦³²{¹êªº¦Ò¶q¦]¯À¡C ¦bOPT-822-001pµe¤¤¡A¦¬®×ªÌ±Æ°£±ø¥óùئ³¥H¤U¨â´Ú¡G ¡u¶Èµo¥Í°©Âಾªº±wªÌ¤£¯à¯Ç¤J¥»¸ÕÅç¡C¡v©Î¡u¦³¤¤¼Ï¯«¸gÂಾÃҾکίf¥vªº±wªÌ¡C¡v´N¬O¦]¬°¶Èµo¥Í°©Âಾªº±wªÌ³q±`¦s¬¡´Á¸ûªø¡A·|¨Ï¾ãÓÁ{§É¸ÕÅ秹¦¨ªº®Éµ{©Ô«Ü¤[¡F¦³¤¤¼Ï¯«¸gÂಾÃҾکίf¥vªº±wªÌ¡]´N¬O¸£³¡Âಾªº±wªÌ¡^¡A³q±`¦s¬¡´Á¸ûµu¡A¥i¯àµ¥¤£¨ì822µo´§ÃĮĴN¦¨¥P¤F¡A·|¨ÏPFS»POS³£Ãø¬Ý¡C ¤T¡A¤G¡A¤@´Á¯f±w©TµM¥«³õ¸û¤j¡A¦ý¬O¿v¹Ún½ñ¹ê¡AºK±o¨ìÁÙnºK±o¹ï¡A¤~¯à§]±o¤U¡C¤T¡A¤G¡A¤@´Á¯f±w¦s¬¡´Á¸ûªø¡A¾ãÓÁ{§É¸ÕÅ秹¦¨ªº®Éµ{·|©Ô«Ü¤[¡A¥ý±q¥|´ÁµÛ¤â¡AÃø«×¸û°ª¦ý¤Ï¦Ó¤ñ¸û¹ê»Ú¡C ³oÓ°ÝÃD¥i¥H°Ñ¦Ò³\°Æ¸³2/22ªºÃþ¦ü»¡ªk¡G¡u¯E¹©»¡©ú·|20160222 1:03:07-1:03:57 YK¦^µªªº¤º®e¡v¡]www.youtube.com/watch?v=so3T5YqGjtk ¡^ ¤T¡B Q¡GY822©Î833n¦p°|ªø©Ò¨¥¥Î©ó¹w¨¾¦¡¬Ì]ªº¥\¯à¡A¨ºÁ{§É¹êÅçÀ³¸Ó¦p¦ó°µ©O¡H¤]¨S¦³¯f¯g¡A©Ò¥H¤]¨S¦³PFS©MOS¡A«ü¼Ð·|¬O¬Æ»ò©O¡H·í¨S¦³¯f¯g®É¡A¦³·NÄ@¬I¥´ªº¤HÀ³¸Ó±q´X·³¶}©l¬I¥´©O¡H¡K¡K¡]²¤¡^ A¡G°Ñ¦Ò±i¸³2/22ªº»¡ªk¡G¡u¯E¹©»¡©ú·|20160222 37:13-38:13¤Î1:03:50¨â¬q¡v¡]www.youtube.com/watch?v=so3T5YqGjtk ¡^ Å¥»¡©ú¤Ñ¤S¦³·sÃz¼u¡F«á¤Ñ°|ªøn¹ï¥~»¡©ú¡BASCO¤]¥i¯à¦³·s¶i«×¡K¡K ¥Xª©¤j¡A¥B¯d¨B¡C ³\¤j¤j¡Anµ¥ASCOµoªí¯u¥¿¤º®e«á¦A»¡¤F¡C |
|
|
·|û¡G·P°Ê£®10141081 µoªí®É¶¡:2016/3/29 ¤U¤È 03:26:48²Ä 1240 ½g¦^À³
|
Cliff¤j ¤£«æ¡A¥u¬O¨º®É·Q¨ì¤@¨Ç°ÝÃD¦Ó¤w¡Aµ¥Faith¤j¤@°_¤]«Ü¦n ¤Ï¥¿²{¦b»¡¦A¦h¤]©è¤£¹L¦W¤Hªº¼L¯¥ ©`¦Ì¤j ÁÂÁ¦³§A̳o¨Ç¬Û«H¸gÀçªÌ»P°|ªøªººô¤Í¡AÁöµMªÑ»ù²Y·W«B¡AÁÙ¬O·Pı·Å·x ´Nºâ¯uªº³QÄF¤F¤]¦³¤H³ §ÚÁÙ¬O¿ï¾Ü¬Û«H¡A¬Ý¬Ý¦Û¤v²´¥ú¦p¦ó ¤Ï¥¿µª®×³Ì±ß¦A¨âÓ¤ë´N´¦¾å |
|
|
·|û¡Ganthony10142049 µoªí®É¶¡:2016/3/29 ¤W¤È 10:16:55²Ä 1239 ½g¦^À³
|
²³¦ì¤j¤j̦w¦n¡G©³¤U¬O¤p§ÌÓ¤Hªº²L¨£¡A½Ð«ü±Ð ¨Ì±i¸³§ë¸ê¤H»¡©ú·|«ü¥X..¤½¥q¦bÁ{§É¸ÕÅç¹Lµ{¤wª¾¹D¡¨ª¼ÂI¡¨..¦ý¨Ì±M®a«Øij±Nì¥HCR¸Ñª¼§ï¬°LR¸Ñª¼..¨ä¹ê´N¤w¸gª¾¹D¸Ñª¼¼Æ¾Ú¥¼¹F¼Ð¡A¦ý¾ãÓ¸ÕÅçµ²ªGÅã¥ÜOBI822¨ã¦³Àø®Ä¡A§YY¥HOS¼Æ¾ÚÅã¥Ü«h¹F¼Ð(«p§À)¡A¤½¥qÅ¥³o¦ì±M®a«Øij¹ç¥i¸Ñª¼¥¼¹LÃö¤]n±Nµ²ªG°e¤JASCO¡K³o¼Ë¬O§_½ä¤Ó¤j..¤£·|..¦]¬°CR¸Ñª¼¤]¬O¤£·|¹L¡K°Ñ¥[ASCO´£¤ÉOBI822ªº¯à¨£«× ¥u¬OÁֽפ@¬N¸õ²æÁA¸ÑOBI822ªºÀø®Ä¡A«o¤õ¿N¤¤¬ã°|¯Î°|ªø¡A¤@¦ì¨ã¦³±R°ª¾Ç³N¦¨´N¨Ã±N²¦¥Í©^Ämµ¹¥xÆWªº¬ì¾Ç®a¡A¡K¥xÆW³oÓªÀ·|¯f¤F §â¥xÆW¥¼¨Ó¥i¥H¦b¥@¬É¤Wµo¥úµo«Gªº²£·~¥´w¤F¡K¤£ª¾¯u¥¿ªº¥Î·N¦ó¦b¡K¡F¤¤¸Îì¨Óªº¦t©÷¤¤ºj«á¡A¤]¦¨¥\¤F¡K´¼Àº¦¨¥\¨ú±oÃÄÃÒ¡A¥xÆWªÀ·|ªºÁÖ½×¥i´¿§U¤@Áu¤§¤O?? |
|
|
·|û¡G©`¦Ì¤p¤k¤l10141142 µoªí®É¶¡:2016/3/29 ¤W¤È 12:24:45²Ä 1238 ½g¦^À³
|
Cliff¤j: Àµ½Ð±z¤£n¦b¦¹®É¹ï¦Û¤v³]!!! ·P°Ê£®¤j»Ýn±z¸Ñ´b!(¥L¤wµ¥±z3¤Ñ) ¦P¦¹®É¨è ¯E¹©,¯Eª©»P¯E¤Í§ó¬O»Ýn±z¤£¬O¶Ü??? ©`¦Ì«_¬N¤F. |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2016/3/28 ¤U¤È 11:53:42²Ä 1237 ½g¦^À³
|
¶WÆgªºCliff¤j.. ª©¥D¤j.. §Ú·Q¤pªm¤F(§t²\). ±z¥i¥H§i¶D¤pªº.. ¤pªmªº¤À¨¦³¦b§Ų́Ãä¶Ü... (¦n¹³¨S¦³¬Ý¨ì ±öªøªm) ¤pªº§i°h®ø¥¢.. |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/28 ¤U¤È 11:25:26²Ä 1236 ½g¦^À³
|
ÃÙ¦¨¤½¥q´£§i¡A¥H¥¿µøÅ¥¡I ³o¦¸Inspireºô¯¸¤Wªº·´Á½¤å¦r¡A3/24¦¤Wµo²{®É¡A¤EÂI¦h³qª¾¤½¥q¡C¡]¤½Ãö¥D¥ô¤£¦b¡A¦ý±µÅ¥ªº¦P¤¯°¨¤W¤Wºô¤F¸Ñ¡^¡CÀH§Y¤S³qª¾¦Ñ¥v¤j¡A¥L¥ß§YÂà³qª¾®ü¥~§ë¸êÃö«Y³B¡K¡K¡A¤µ©]·s»D¥X¨Ó¤½¥q¨M©w´£§i¡C²{¦bªººô¯¸¤w¤£¨£¸Ó¤å¡A¬Û«H³o·í¤¤ÁÙ¦³¨ä¥L¯E¤Í¦V¤½¥q¤ÏÀ³¹L¡C ³o¤w¸g¬O¸Óºô¯¸²Ä¤G¦¸¥X²{·´Á½¤å¦r¡A¥h¦~¤Q¤@¤ë¨º¤@§Ð¡A¾Ú§Ú©Òª¾¡A¦Ü¤Ö¦³¨â¦ì¸ê²`¯E¤Í¤Wºô§ÜijÀËÁ|¡A³Ì«áºô¯¸§R¤å¡A©Ò¥H¤£n©¿²¤¨C¤@¦ìªº¤O¶q¡C ªü©v¤j¡G ¥i°Ñ¦Ò¤U¤å¡G·q½Ð«ü¥¿ ¯E¹©°Q½×°Ï¡u¤é²±µû¦ô³ø§i¡vpage 6¡G103/07/20¡u¤W¤È02:11:34¡v¤Î¡u¤U¤È09:30:00¡v ·P°Ê£®¤j¡G ±zªº°ÝÃD¤p§Ì¤w³Æ¦n¦^ÂСA¦ý¬O Faith¤j¤£¦^¨Ó¡A±z»¡«ç¿ì¡H ¥LÀ³¸Ó·Qµ¥°|ªø¦^´_²M¥Õ¤§¤é¤~ªÖ¦^¨Ó¡A³o¤U¦³±oµ¥¤F¡K¡K |
|
|
·|û¡G¤pªü«¼10141843 µoªí®É¶¡:2016/3/28 ¤U¤È 09:07:27²Ä 1235 ½g¦^À³
|
¯E¤ÍÌ ½Ðª`·N²{¦b¤w¦³2¤H³Q¥éIDµoªí¨¥½×½Ðª`·N¦Û¤v¬O§_¦³³Q¥é ½Ð¤j®aÀ°¦£´£¿ô¥L¤H¡A©È¦³ªº¤H¨S¬Ý¨ì¦¹°T®§ ¤wµÛ¤â³B²z¡A¦P®É¦b¦¹©IÆ~·Q·o¶Ãªº·|û¡AYµo²{¬O»W·N¬°¤§¡A±Nª½±µ³B²z±b¸¹¤£¥t°µÄµ¥Ü¡Aª`·N¤F¡IBYª©¥D |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/3/28 ¤U¤È 05:50:34²Ä 1234 ½g¦^À³
|
¼F®`¼F®` ¹x¥Û¤j À³¸Ó¦³°á¹L¬ì¾Çõ¾Ç »P¬ã¨s¤èªk ¹L¥h³\¦h¤H¨Ï¥Î¥dº¸ ªi´¶ªº§_ÃÒ½× ·Q¥Î¥¢±Ñ¨Ò¤l¨Ó§_ÃÒ822µL®Ä «¢«¢ ¨º¬Oª¼¥ØµLµø7-80¤H¥¼PDªº¨Æ¹ê ¦Ó¥B§_ÃÒ½×¥u¾A¥Î¦b¨å½d¬ì¾Ç¤W 822 ÁÙ¬O·sÃÄ ¹êÅçµ²ªGÁÙ¨S³ø§i ¨º»Ýn§_ÃÒ «¢«¢«¢ |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/3/28 ¤U¤È 04:35:18²Ä 1233 ½g¦^À³
|
©P±Ð±Âªº»¡ªk°ò¥»¤W«½Æ¥L¤»¦~«eªº½×ÂI¡C¥L»¡¡A³oºØ¥ÎÁÞ¨Ó°µ§K¬ÌÀøªkªº¹Á¸Õ¹L¥h¨S¦³¤H¦¨¥\¹L¡A¦]¬°¡E¡E¡E¡C ¥Lªº»¡ªk¦b½×ÃÒ¹Lµ{³£¨S¦³¿ù¡A¦ý¬O¥L¦b°µµ²½×ªº®ÉԥǤF¥H°¾·§¥þªºÅÞ¿è¿ù»~¡C§O¤H¥Îªº¬O¤°»òÁÞ¤À¤l§Üì¡H¦pªG¥Î¤£¦PªºÁÞ§Üì¡A¦³¦ó¼vÅT¡A¥i¤£¥i¯à¦¨¥\¡H¦pªG§ïÅÜÁÞ»PKLHªº³sµ²¤ñ¨Ò¡A¥i¤£¥i¯à¦¨¥\¡H¥Î¦b¤£¦Pªº¯f¯g¡A¥i¤£¥i¯à¦¨¥\¡Hn»¡¯à¦¨¥\¡A¥u»Ýn¤@Ó¨Ò¤l¡Fn»¡¤£¥i¯à¦¨¥\¡An°µ§¹¥þ³¡ªº¥i¯à©Ê¤~¯àÃÒ©ú¦¹¸ô¤£³q¡C MIT´¿¸g¦³¤@¦ì±Ð±Â³o»ò¸ò¥Lªº¬ã¨s¥Í»¡¡An¦p¦ó¤~¯à®³¨ì¥Lªº³Õ¤h¾Ç¦ì¡C¡yn»ò§A§âªF¦è°µ¥X¨Óµ¹§Ú¬Ý¡A¦Ü©ó§A»¡¤£»¡±o¥X²z½×¬O¤°»ò¨SÃö«Y¡A§Ú³£·|µ¹§A¾Ç¦ì¡Cn»ò§AÃÒ©úµ¹§Ú¬Ý¡A³oӥؼЬOµ´¹ï¤£¥i¯à¹F¦¨ªº¡A§Ú¤]µ¹§A¾Ç¦ì¡C¡z¾Ç¥Íı±oÁÙ¬O«eªÌ¤ñ¸û¦³§Æ±æ¡A¦]¬°n¥Î½aÁ|ÃÒªk¨ÓÃÒ©ú¤@Ó©RÃD/¥Ø¼Ð¤£¥i¦æ¡A¦b¬ì¾Ç¤WªºÃø«×¤Ó¤j¤F¡C´Nºâ¥L¹Á¸Õ¤QºØ¤èªk³£¥¢±Ñ¤F¡A¤@©wÁÙ¦³¤QºØ¥i¯àªº¤èªk¥LÁÙ¨S¹Á¸Õ¹L¡A©Ò¥H«ÜÃøÃÒ©ú¤@ӥؼЬOµ´¹ï°µ¤£¨ìªº¡C ©P±Ð±Â¦]¬°¤£¬Û«H822·|¦¨¥\¡A©Ò¥H¥L¤£·|¥hª`·N822ªº¦¬®×¶i«×»PÃöÁä®ÉÂIªºPD¤H¼Æ (©Î¥¼PD¤H¼Æ)¡C¥L§óµ´¹ï¤£·|¹³¤p©_¤j¸ò¯E§J¤j¤@¼Ë¡Aªá´X¤Ñ®É¶¡¥h·Q¤@ӥͦs¦±½u¨Ó¦P®Éº¡¨¬¡yPFS¤£ÅãµÛ¡z»P¡y¥¼PD¤H¼ÆÁÙ¦³78¤H¡z³o¨âÓÃä¬É±ø¥ó¡C¯E¤Í̳£·|»¡¡G¦pªG©P±Ð±Âªº»¡ªk¬O¥¿½Tªº¡A¨º»òÁ{§É¹êÅ禦b2014¦~©³´N¸Óµ²§ô¤F¡A¤£¬O¶Ü¡H ´N¹³¯E¤ÍÌ·íªì¨S¦³·Q¨ì·|¦³¤p©_¤j©Ò±Àºâ¥X¨Óªº¥Í¦s¦±½u³oºØ±¡ªp¡A©P±Ð±Â¥i¯à¤]¨Sª`·N¨ì822¶W°ªªº¥¼PD¤H¼Æ¡C¨S¦³¤HÄ@·Nªá®É¶¡§äÃÒ¾Ú¦Û¤v¥´Áy¡A³o¬O¥¿±`ªº¡C§Ú̹ï©P±Ð±Â¤]¤£¥²¹LV¡A¤Ï¥¿¦A¤TÓ¤ë¤j®a´Nª¾¹D¬O«ç»ò¤@¦^¨Æ¤F¡C(³á¡A·d¤£¦n³o©P¥½´Nª¾¹D¤F¡I¡I) |
|
|
·|û¡G´¡ªá¤G10142127 µoªí®É¶¡:2016/3/28 ¤U¤È 12:36:18²Ä 1232 ½g¦^À³
|
ÁÂÁ ¦³«í¤j¡A¬Ý¹L¼v¤ù¤F¡A¤]¶Çµ¹ªB¤ÍÌÅý¥L̤F¸Ñ¡C |
|
|
·|û¡G¤p¯E°g10137673 µoªí®É¶¡:2016/3/28 ¤U¤È 12:05:11²Ä 1231 ½g¦^À³
|
¨rÆN¶°¹Î¤jÀò¥þ³Ó.´CÅé°OªÌ.¦W¼L¬O¦@¥Ç¶°¹Î. |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/3/28 ¤W¤È 11:55:42²Ä 1230 ½g¦^À³
|
´¡ªá¤j ©P±Ð±Â´£¥Xªº°ÝÃD,µª®×´N¦b¤å³¹¤ºªº¼v¤ù¤¤!¥i°Ñ¦Ò¬Ý¬Ý OBI-822 Mechanism of Action from Gus Adapon on Vimeo. |
|
|
·|û¡G¤pªü«¼10141843 µoªí®É¶¡:2016/3/28 ¤W¤È 11:14:28²Ä 1229 ½g¦^À³
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/27 ¤U¤È 10:43:42 ¤£¬È¯B¶³¾B±æ²´,¦Û½t¨¦b³Ì°ª¼h ¥þ²y¤W¤d¸UÀù¯g¯f±w®ï¤Á´Á¬ßªº perfect drug(¦w¥þ ¦³®Ä ¤è«K ¤£¶Q ¦n«~½è µL¬r¤ÑµM Àù¯g§K¬ÌÀøªk ªø´Á¦s¬¡ ¤£»ÝÅç¨È«¬ ¤£»ÝÅç§Üì) OBI822 ¹F¼Ð¼ç¤O¤Q¨¬ ¦U¦ì¤j¤j 1¯E¹©¤T´ÁÁ{§É¸ÕÅç¸Ñª¼¬O¤HÃþ¥v¤WÁÞ¬ì¾Ç»PÁ{§ÉÂå¾Çªº«¤jµo²{,¸Ñª¼ªì¨B¤ÀªRtoplineÁöµM¥DnÀø®Ä«ü¼Ð¨S¦³¹F¼Ð ,¦ý§â·|²£¥Í°w¹ïGlobo H ¨t¦CÁÞ§Üì²£¥ÍªºIgM IgG §ÜÅ骺¯f±w¥[¥H¸Ô²Ó²Îp¤ÀªR,²×©óµo²{¦³«D±`ÅãµÛªºÀø®Ä,³ø¯ÈÂø»x¹qµø´CÅé©Ò»¡ªº¸Ñª¼¥¢±Ñ,§¹¥þIÂ÷¨Æ¹ê,¥xÆW¯E¹©¥Í§Þ¥H¤TÓÁÞ¤À¤l¬°¼Ð¹vªºÃĪ«±N¦p¦P«eSi2Cº®uÅU°ÝĬÃh¤¯³Õ¤h2013¦~©Ò»¡:¥þ²y¥Í§Þ·sÃIJ£·~¤w¸g¶i¤J²Ä¤TÓ¦a¥½u¥@¥NThe Third Evolution of Global Pharma Horizons,Ä~¤Æ¾ÇÃÄ¡B³J¥Õ½èÃĤ§«á¡A¥]¬AÁÞ¤À¤l¬ã¨s©Ò¶}µoªº§K¬ÌÀøªk·sÃÄ¡A¥i¯à³Ð³y¤U¤@ªi·sÃIJ©R¡CÓ¤H»{¬°³o¬O¥xÆWªººaÄ£¤]¬O¥þ²y¤W¤d¸UÀù¯g¯f±w®ï¤Á´Á¬ßªº perfect drug(¦w¥þ ¦³®Ä ¤è«K ¤£¶Q ¦n«~½è µL¬rªñ¥G¤ÑµM,¤£»ÝÅç¨È«¬, ¤£»ÝÅç§Üì) OBI822 ¹F¼Ð¼ç¤O¤Q¨¬ 2ÃÄn²Å¦X¬ü ¥x ¼Ú·ù ªk³W³æ¦ì®ÖãÃÄÃÒªºªk³W¤~¬O«ÂI,¨ä¥¦¨º¨Ç543ªº©Ù¶Â¯Q¸é¾Ô¤w¸g¤£¬O«ÂI,¥t¥~¨Ì¾Ú¯E¤Í´£¨Ñ¬ÛÃöªk«ß¸ê°T¬Ý¤£¥X¤½¥q»P¯Î°|ªø¦³¹Hªkªº¦a¤è(½ÐÃz®Æªº¤H®³¥X¹H¤Ï¨º¤@±øªk«ß)¤W¶g©Ù¶Â¯Q¸é¾Ô¹F¨ì°ªÂI,¥¼¨Ó¤@¥ó¥ó©Ù¶Â¯Q¸é¾Ô¦pªG³Qµo²{¤£¬O¨Æ¹ê·|«ç¼Ë?¤j®anª`·N©Ù¶Â¤£¶^¥¼¨Ó¹J§Q¦h·|«ç¼Ë? 3¯E¹©3¤ë26¤éÁn©ú«ü¥X:¯E¹©¿ï¦b2¤ë19¤é©P¤¦¬½L«á±Ò°Ê¸Ñª¼§@·~¡A°£´£«e©ó2¤ë17¤é©P¤T³z¹L«°T¤½§i©Pª¾¡A¤º³¡¥]§tÁÙ¦b°ê¥~ªº¸³¨Æªø±i©À·O¡A¥H¤ÎÂí¦u°ê¤ºªº°Æ¸³¨Æªø³\¤Í®¥¡BÁ`¸g²z¶À¨q¬üµ¥°ª¼h¥DºÞ¡A¤]³£¬O¦b19¤é¤U¤È5®É³\¦¬½L³\¤[«á¡A¤~±oª¾¸Ñª¼¬ÛÃö¼Æ¾Ú¡C´«¨¥¤§¡A¯E¹©±q±Ò°Ê¸Ñª¼§@·~¡A¨ì2¤ë21¤é©P¤é¥¿¦¡¥l¶}¸Ñª¼°OªÌ·|¡A¥þµ{³£¦b«DªÑ¥«¥æ©ö¤é¶i¦æ¡A¥Øªº´N¬O¬°¤FÁקK¼Æ¾Ú¥~¬ª¡A¥H¤Îl¥Í¤º½u¥æ©öºÃ¼{¡A¤½¥q¤wµ½ºÉ¤@¤Á¹w¨¾³d¥ô¡C ¥H¤W¤À¨É¶È¨Ñ°Ñ¦Ò ½Ð¿W¥ß«ä¦Ò¬ã§P |
|
|
·|û¡G´¡ªá¤G10142127 µoªí®É¶¡:2016/3/28 ¤W¤È 11:03:36²Ä 1228 ½g¦^À³
|
ÁÂÁ ¤p¦Ì¦à¤j ·Q·Q¤j¡I |
|
|
·|û¡G¤p¦Ì¦à10141842 µoªí®É¶¡:2016/3/28 ¤W¤È 09:52:45²Ä 1227 ½g¦^À³
|
©P±Ð±Â¤å³¹¥Rº¡¤å¤H¬Û»´ªº±¡µ²¡Aþ¬O¤@ӾǬì¾Çªº¾ÇªÌÀ³¦³ªººA«×¡C ³J¥Õ½è©M¯×½è³£¦s¦bÁÞ¤À¤l¡A©Ò¥H¥ÎÁÞ¤À¤l°µ¼Ð¹v®ÄªG³Ó¹L³J¥Õ½è¡A°Æ§@¥Î¤]¤p¡C ©P±Ð±Âªº¨¥½×¬O®LÂλy¦B¡AÁöµM¶Q¬°±Ð±Â¡A¸ò§Ú¤@¼Ë¹ïÁÞ¤À¤l¬Oªù¥~º~¡A¦ý§ÚÄ@·N¥h¾Ç²ß¤F¸Ñ¡C |
|
|
·|û¡G·Q·Q10140340 µoªí®É¶¡:2016/3/28 ¤W¤È 07:50:39²Ä 1226 ½g¦^À³
|
´¡ªá¤j¡A ¦¹¤å³¹¤w¥Z¥X¤@¬q¡B³¡¥÷¯E¤Í¤w¦³°Q½×¹L³á¡ã ¥i·j´M¦¹¤å¤§«e©óºô¸ô¥Z¥X®É¶¡¡A¦^¨Ó§ä¯EªO¬Û¹ï®É¶¡¤å³¹ ·|¦³缐¯Á¡ã |
|
|
·|û¡G´¡ªá¤G10142127 µoªí®É¶¡:2016/3/28 ¤W¤È 01:54:24²Ä 1225 ½g¦^À³
|
¨D±Ð¦U¦ì¤j¤j¡G ©P¦¨¥\±Ð±Â¦A«×¥H ¤@Ó°ê¤ý·s¦çªº¦A²{¡A¥H¯E¹©¬°¨Ò¡A»¡©ú¥xÆW¦b·sÃĶ}µoªº°ò¥»°ÝÃD www.storm.mg/article/84065 ¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K¡K ³o½g¬OªB¤Í¶Ç¨Óªº¡A¨ä¤¤ ¡§ªvÀø©Ê¬Ì]³q±`¬O³J¥Õ½è¡A¥¦¦b¨Åé¸Ì°£¤F»¤µo¯S©w§ÜÊ^¥~¡A§ó«nªº¬OÁÙn¯à»¤µo¯S©w¬r±þ¢â²ÓM¡C¤@¯ë»{¬°³o¨Ç¯S©wªº¬r±þ¢â²ÓM¡A¬O®ø·À±a¦³³o¨Ç§Ü쪺Àù²ÓM³Ì«nªºªZ¾¹¡COBI-822¬O³\¦hÀù²ÓM³£¦³ªº§Üì¡A¦ý¥¦¤£¬O³J¥Õ½è¦Ó¬OÁÞÃþ¤À¤l¡¨¡C ¥i¥HÀ°§Ú¸ÑÄÀ ³o½×z ¦³¿ù»~¶Ü¡HÁÂÁµ´³»Áo©ú¤j¤jÌ¡I |
|
|
·|û¡G·P°Ê£®10141081 µoªí®É¶¡:2016/3/26 ¤U¤È 09:56:13²Ä 1224 ½g¦^À³
|
Cliff¤j±z¦n ¤@¦ì¤£»{¯uªº¯E¤Í½Ð±Ð±z´XÓÄø°ÝÃD¡AÁٽбz¼·¤¾¦^ÂСA·PÁ¡I ¤@¡D YLR§P©wPD«á¡ACT©ÎPET´N¤@©w¤£·|°µ¤F¶Ü?CRªº¸ê®Æ·|Åܬ°censored¡A¨ºCRºâ¬OPD¤F¶Ü¡H¬°¦ó§ÚÌ·|»¡¤@¯ëLR»PCR·|¦³30%¥ª¥kªº®t¶Z¡H ¤G¡D ¥HÃIJzªº¾÷¨î¦Ó¨¥¡AÀù¥½¯f¤HÀ³¸Ó¤ñ¸û¾A¦X¥Î³Q°Ê¦¡§K¬ÌÀøªk¡A¦]¬°¤ñ¸ûºë·Ç§Ö³t¡A¥D°Ê¦¡§K¬ÌÀøªk¦]¬°¤ÏÀ³®É¶¡¸ûºC¡A¤S»Ýn¯f±wªº§K¬Ì¨t²Î¤ÏÀ³n¥¿±`¡A°ò¥»¤W¦³®Äªº¤ñ²vÀ³¸Ó¬O¤ñ³Q°Ê¦¡®tªº¡A¦ý¬°¦ó¯E¹©·|¥HÀù¥½¯f¤H¬°¥Dn¹êÅç¹ï¶H¡A¦Ó¤£¬O¥H¤T¡A¤G¡A¤@´Á¯f±w¬°¹ï¶H¡A¬O¦]¬°¹êÅ窺®É¶¡»P¤H¼Æµ¥ªº¦¨¥»¦Ò¶q¶Ü¡H¦]¬°¶V¦´ÁÀ³¸Ó§K¬Ì¤O¶V¥¿±`¡A¦³®Ä¤ñ²v¶V°ª°Ú¡A¦Ó¥B¨S¬Æ»ò°Æ§@¥Î¤S¤£¥²¦³¶}¤M³Î°£¾¹©x»P¤ÆÀøªºµhW¡AÀ³¸Ó¬O¤ñ¥½´Áªº¼ç¦b¥«³õ¤j¤Ó¦h¤F°Ú ¤T¡D Y¢·¢±¢±©Î¢·¢²¢²n¦p°|ªø©Ò¨¥¥Î©ó¹w¨¾¦¡¬Ì]ªº¥\¯à¡A¨ºÁ{§É¹êÅçÀ³¸Ó¦p¦ó°µ©O¡H¤]¨S¦³¯f¯g¡A©Ò¥H¤]¨S¦³¢Þ¢Ô¢á©M¢Ý¢á¡A«ü¼Ð·|¬O¬Æ»ò©O¡H¹w¨¾©Êªº¥«³õ¤]·|¬O¤@Ó«Ü©_§®¡]©_©Ç¡^ªº¥«³õ¡A¦]¬°¨S¦³¥Í¯fªº¨Æ¹ê¡A©Ò¥H¤@¯ë«OÀI¤]¤£·|µ¹¥I¡A·í¨S¦³¯f¯g®É¡A¦³·NÄ@¬I¥´ªº¤HÀ³¸Ó±q´X·³¶}©l¬I¥´©O¡H¢³¢¯·³¡H¢´¢¯·³¡H¢µ¢¯·³¡H¦]¬°¬Ì]¤£¬O²×¥Í¦³¥Î¡A¥i¯à¨C¦~©Î¨â¤T¦~ÁÙn¸É¥´¡A©Ò¥HÀ³¸Ó´X·³¶}©l¥´¤]¬O¤@ªù¾Ç°Ý°Ú¡A¦Ó¥B¦pªG»ù®æ¬O¥x¹ô¢°¢¯¢¯¸U¥H¤W¡A³oÁÙ¯u¤£¬O¤@¯ë¤H¨S¬O¥´±o°_ªº¡AÀ³¸ÓÁÙ¬On¦³¿ú¤H§a¡A¤£¹L¦]¬°¥¦¾AÀ³¤Q´XºØÀù¯g¡A¦Ó¥B¼ç¦b«È¤á¬O¦b¥þ²y¡A°ò¼Æ¹ê¦b«D±`¤j¡A©Ò¥H´Nºâ¦Ê¤À¤ñ«Ü§C¡A¨ä¹ê¼ç¦bªº¥Ø¼ÐÁ`¼Æ¤]¬O«D±`¥iÆ[¤~¬O¡I |
|
|
·|û¡G«ù¤[ªº¯E§J10140191 µoªí®É¶¡:2016/3/26 ¤U¤È 07:07:12²Ä 1223 ½g¦^À³
|
ªü©v¤j ¤Þ¥Î¸g¨å½×¤å´Á¥Z ¸Ñ»¡²M·¡ ¤j¤j·PÁ |
|
|
·|û¡Gªü©v10140551 µoªí®É¶¡:2016/3/26 ¤U¤È 05:35:04²Ä 1222 ½g¦^À³
|
www.pnas.org/content/110/7/2517.full.pdf ³o½g¤å³¹Á¿ªº¬Oglobo H¡A¸üÅé³J¥Õ»P¦õ¾¯ªº¬Ì]¹êÅç¡C²Ä¤@§@ªÌ¬OYen-Lin Huang¡A¦ý¤]¥]§t¤F¯Î±Ò´f¡C ¤º®e«Ü¦h¡A²³æ»¡¤@¤U¤j·N¡A¬ã¨sªÌ¹Á¸Õ¤F¤£¦Pªº¸üÅé³J¥Õ¥]¬AKLH¡Aµ²®Ö±ìµß¬r¯À¡A¯}¶Ë·¬r¯À»P¥ÕµUÃþ¬r¯À¡]DT¡^µ¥¡A»PGlobo H°µµ²¦X¡A¨ä¤¤KLH³J¥Õ¦]µ²ºcÃö«Y¡A³æ¤@¸üÅé¥i¥H³s±µ¬ù700ÓGlobo H¼Æ¶q³Ì¦h¡ADT¤Ï¦Ó³Ì®t¡A¥u¯à³sµ²2-4Ó¡C¦ý¹êÅçµ²ªG¡A¯à²£¥Í³Ì¦h§ÜÅ骺¤Ï¦Ó¬OGlobo H-DT¡A¨ä¦¸¤~¬O822¡C ¦A¨Ó¬O¦õ¾¯ªº³¡¤À¡A°£¤F¨m¯ÀQS-21¡A±q®üºø´£·Ò¥X¨Óªº£\-GalCer¡AÁÞ¯×Ãþ¡Ð¹êÅçÃÒ©ú¥i¤ÞµoNK²ÓM»PT²ÓMªº§K¬Ì¤ÏÀ³¡A¨äl¥Í¥XC34¡A·f°t¸üÅé³J¥Õ¥i²£¥Í¤j¶qªºIgG¤ÏÀ³¡A¦A¨Ó´N¬O¦Ñ¹«Á{§É¹êÅ窺³¡¤À¡A¼Æ¾Ú½Ð°Ñ¾\¹Ï¡K ¾ãӰʪ«¹êÅçÅã¥Ü¨Ï¥ÎDT·í¸üÅé¡A·f°tC34¥i²£¥Í³Ì¦hªº§ÜÅé¤ÏÀ³¡C ¦A¨Ó´N¬O±µ¦X¤ñ¨Ò¡A¨Ï¥Î1mgªºDT¡A·f°t¤£¦P¾¯¶qªºGlobo H¡A²£¥ÍDT-GH 1.6, 5.1, 9.8»P 15.6¡A¼Æ¦r¶V¤jªí¥ÜDT±µ¦XªºGlobo H¶V¦h¡A¦³½ìªº¬O±µªº¦h¤£¥Nªí§K¬Ì¤ÏÀ³±j¡A¦b¨ä¥L±ø¥ó¤£ÅܤU¡A³Ì«á°µ¥X¨Ó¡A¯à²£¥Í³Ì¦hIgGªº¬ODT-GH 5.1³o²Õ¡C ©Ò¥Hªk»¡·|±i¸³Á¿ªº¡AKLH¥u±µ75±øGlobo H¡A¨S±µº¡¡AÓ¤H±À´ú¬O¡A¯E¹©«°µ°Êª«¹êÅç¡Aµo²{³oÓ¤ñ¨Ò¡A¤Ï¦Ó¥i¥H²£¥Í³Ì¦hªºIgG§ÜÅé¡A©Ò¥H¥Î¦bÁ{§É¤W¡C |
|
|
·|û¡G©`¦Ì¤p¤k¤l10141142 µoªí®É¶¡:2016/3/26 ¤U¤È 04:57:34²Ä 1221 ½g¦^À³
|
Cliff¤j: ·P¿E±zªº¤å!!! ¤×¨ä¦¹®É¦¹¨è. ©`¦Ìª¾¹D±zªº¥Î¤ß,¦ý©`¦Ì»{¬°: µL½×Faith¤j¥X¤£¥X²{,±z³£¤£¯à¨IÀq. ¦]¬° ±z ¬O§ÚÌ·q¥õªºCliff¤j! ·«BÄÆ·n¤¤,®eÅý¯EªÙ«H®{Ì ¯¸¦bJustice Cliff¤W µ¥«Ý¬üÄR¾¤©úªº¨ì¨Ó~~~ |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/3/26 ¤U¤È 04:39:10²Ä 1220 ½g¦^À³
|
Cliff ¤j¤j: ÁÂÁ±z¦³ÃöCR/LRªº¸ÔºÉ¸Ñ»¡, ³o¼Ë´N«D±`²M·¡¬ÛÃö¬yµ{¤F. ·PÁÂ. «ô°U±z§O¼ç¤ô, ¤j¹Ù³£»Ýn±z«ùÄòªº¶}ÄÀ. ¥~±ªº··«B«BÁ`¦³¹L¥hªº®ÉÔ, ¯u¬Û·U±È·U©ú. §Ú¤@¦ì¦Ñ«e½ú»¡¥´±q¥L¶iªÑ¥«¨Ó, ¨S¬Ý¹L³o»ò°®²bªº¤@®a¤½¥q. ¾¤©ú¦±ß·|¨Óªº. ±zªº¶K¤å¦b«Ü¦h®ÉÔ³£¥i¦LÃÒ¤½¥qªº°µªk¦³¨ä¨Ì¾Ú¤Î¦Ò¶q, §Ṳ́£©ú¥Õªº, ¦b ±z¸Ñ»¡«á´N²M·¡¤F. ¦b³o··«B«Bªº®ÉÔ, §óÅã¬Ã¶Q. ±z«ç§Ô¤ß¼ç¤ô ? ?? ¤æÁx ªº»¡, ±z§óÀ³¦h¦hµo¤å¤~¬O, ¦nÅý¤j®a³o¬q¤é¤l§V¤O¾Ç²ß. «ô°U, «ô°U. |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/26 ¤U¤È 03:37:11²Ä 1219 ½g¦^À³
|
Cliff¤j®¦®v ÁÂÁ±zµN¤F¤@¹D¬ü¹ ¤pªº¹ê¦b¤Ó¾j¤F¡A³s¦Y¦n´X¸J °ß±©¤j¤Î Faith ¤j³£ ÁÙ¦b×¦æ ±z¤]§O¨I¼ç¤£»¡¸Ü ¤j®a³£»Ýn±z¹ª»R«H¤ß¤h®ð ½Ð±z¦h¦h¤W¨Óµ¹¤j¹Ù¥´®ð ¤£µM¦b´CÅ骺ÅF¬µ¤U ¤j®a³£§Ön¼ì´²¤F ¦³¿à±z±a»â¤j®aéwx¤ß ¤pªº¥N¤j®aÀµ°U±z¤F ÁÂÁ±z¡I |
|
|
·|û¡GAming10141623 µoªí®É¶¡:2016/3/26 ¤U¤È 01:47:53²Ä 1218 ½g¦^À³
|
angelcity.idv.tw/world/sc15.htm ¼çרº»ò¤[¡A°ß±©¤j©MFaith¤j¦³¤ÑÁÙ·|¦A¦í¶i¨Ó§a!¥L̸ò²³¤j¦³¬ùªº |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/3/26 ¤U¤È 01:30:19²Ä 1217 ½g¦^À³
|
°Ñ¤@©@¤j ¤p§Ì»{¦P±zªºÆ[ÂI¡IÅwªï¥[¤J¯E¤Í¤j®a®x! ¤p§Ì´£¨Ñ¥t¤@±¦V«ä¦Ò¡A¨Ñ±z°Ñ¦Ò!¥un¦h¤è¸êª÷¹ê¤O°÷¡AY¦]§ï¦¨LR³y¦¨¸Ñª¼¥¼¹LÃö¡A°£¥i°Ñ¥[ASCO¼W¥[¤½¥q°ê»ÚÃn¥ú«×¥~ ¡A³Ì«nªº¬O¥i¥H§l¯Ç§ó¦h¤£Ã©wÄw½X¡A¥unOBI822¥¼¨Ó¦³¬G¨Æ¡A¹ï¦h¤è¦Ó¨¥¡A¥i¿×¶ë¯Î¥¢°¨¡A²jª¾«DºÖ¡I |
|
|
·|û¡G°Ñ¤@©@10141487 µoªí®É¶¡:2016/3/26 ¤U¤È 01:07:28²Ä 1216 ½g¦^À³
|
·PÁÂCliff¤jªº»¡©ú¡C¤p§Ì¤]»{¦P¤j¤j̪º¤À¨É¡C ¦ý¬O¦³¥t¤@·Qªk´£¨Ñ°Ñ¦Ò¡CÃö©ó°ß¤j´£ªºLR©MCRªº°ÝÃD¡AÀ³¸Ó¤£¬O¦bÃĪº°ÝÃD¡A¦Ó¬O¬Fªv¤W©M¾Þ§@±ªº¦Ò¶q¡A³o¤]¬O°ß¤j´£«áÄòªº½¹½º®ÄÀ³¡C ¦]¬°¾Ú°ß¤j¹Î¶¤ªºµû¦ô¡A¥ÎCR¸Ñª¼¥i¯à§CªÅ¸¹Lªº¾÷·|°ª¡A³o¼Ë¸Ñª¼´Nºâ¦¨¥\¡A©Î³\¥i´î¤Öªñ¨Óªº¯ÉÂZ¡C¤]³\¹ï¤½¥q¦Ó¨¥¬O¤Ö±¼¤FASCOÃn¥úªº°ÝÃD¡A¦ý³Ì¤jªº§Q¦hÀ³¸Ó¬OFDAÃÄÃÒ¡A¦³¨S¦³ASCOÀ³¸Ó¨S¼vÅT¡C¸Ñª¼¹L¹ï¦h¤è¦Ó¨¥¡A¥i¥H¬Ù±¼ªñ¨Óªº³\¦hªÅ¤èÀ£¤O¡A¤×¨äªÑªF¸s¤S²o¯A¨ìÁ`²Î®a±Ú¡B°|ªø¿Ë¤H¡A¸Ñª¼¥¢±Ñ¡B¤º½u¥æ©ö³o¤S¬O«Ü¦n¾Þ§@ªºÄ³ÃD¡A¹ï¤½¥q°ò¥»±©Î³\¨S¼vÅT¡A¦ý¹ï¦h¤è½T¬O«Ü¤jªºÀ£¤O¡C ¥H¤W²L¨£¡A¤À¨É¡AY¦³¤£·í¤§³BÁٽШ£½Ì¡C |
|
|
·|û¡G´µ¤p¤å10139040 µoªí®É¶¡:2016/3/26 ¤U¤È 12:54:19²Ä 1215 ½g¦^À³
|
Cliff¤j¤jÆg °ß¤j,ªm¤j «B¹L¤Ñ´¸,¥X¨Ó³z³z®ð§a |
|
|
·|û¡G¤p·s10141589 µoªí®É¶¡:2016/3/26 ¤U¤È 12:51:31²Ä 1214 ½g¦^À³
|
¯E¹©³Ì²× 2Ó¤ë«áªÑ»ù±N¤ÏÀ³¬O OBI 822 ¬O§_¦³Àø®Ä ¦³Àø®Ä,²{¦b·ÑÅé³øªº³o¨Ç¤H§Y¨Ï¤£²M¥Õ,ªÑ»ù¤´·|¸õ¤É¨ìÀ³¦³ªº»ù®æ µLÀø®Ä,²{¦b·ÑÅé³øªº³o¨Ç¤H§Y¨Ï²M¥Õ,ªÑ»ù¤´·|±Y¶^¨ìÀ³¦³ªº»ù®æ ©Ò¥H²{¦b·ÑÅé³øªº(¥þ³£¬O¹L¥h¾ú¥vªºÄw½X¤ÀªR),¹ï¯E¹©³£¬O°²Ä³ÃD, ¦Ó¥B·ÑÅé³ø«á¤Ï¦Ó¨Ï¤W³øªºÄw½X§ó¤£´±¦AÀH«K½æ¤F(¥H§K¦A¤W³ø),¤Ï¦Ó¦³Âê½Xªº§@¥Î www.youtube.com/watch?v=KhEovD63b_8&feature=youtu.be |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/3/26 ¤U¤È 12:43:50²Ä 1213 ½g¦^À³
|
ÁÂÁÂCliff¤j»¡©ú,Æg!Æg!Æg! °ß¤j,ªm¤j,§Ö¦^¨Ó°Õ!¯EªÙ¤§®{Ì,¯uªº«Ü»Ýn±z̪º«ü¾É! |
|
|
·|û¡G¤p¸ê¤k10141851 µoªí®É¶¡:2016/3/26 ¤U¤È 12:28:16²Ä 1212 ½g¦^À³
|
Cliff¤j¡ãµLÓÆgµLÓ+1⋯ ¯uªº«Ü·PÁ±z¡ã¤j®a¥[ªo¡B¯E¹©¥[ªo!!! |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2016/3/26 ¤U¤È 12:25:27²Ä 1211 ½g¦^À³
|
Cliff¤j¡AÆg¡I§Ú¥Ã»·¬O±zªº¯»µ·¡A°ß±©¤j©MFaith¤j¡A¥ð®§°÷¤F¡A´N¯B¤W¤ô±§a¡I¤j®a³£«Ü·Q©À±zÌ¡C |
|
|
·|û¡G¤p®æ10136562 µoªí®É¶¡:2016/3/26 ¤U¤È 12:17:15²Ä 1210 ½g¦^À³
|
Cliff¤j Æg+++++++++++++++1 |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/26 ¤U¤È 12:07:22²Ä 1209 ½g¦^À³
|
°ª¤¤^¤å½Ò®É¡A¦Ñ®v´£¨ì¤@¦ì¬ü°ê¦ÑµP³ß¼@ºtûBob Hope¡]1903.5.29-2003.7.27¡^Á`µ¹¤H̱a¨Ó§Æ±æ¡A ¡uWhere there is ¡yHope¡z¡Athere is hope¡C¡v §â³o¥y¸Ü®M¥Î©ó²{¦b¡AÁöµM¬Û¶Z¼Æ¤Q¦~¡A¤´µM²§¦±¦P¤u¡A»á³ôª±¨ý¡C °ß±©¤j¡A¸Ñ®M¤F¡A¥i¥H¦^¨Ó¤F¡C Faith¤j¡A¡uWhere there is Faith¡Athere is faith¡I¡v¡A°£¤F¥²n®É·|¦^À³¤µ±áªº¶K¤å¥~¡A¤p§Ì´N¦¹³¬¼L...till you come back¡C |
|
|
·|û¡GIriswu10136250 µoªí®É¶¡:2016/3/26 ¤W¤È 11:45:58²Ä 1208 ½g¦^À³
|
¤pªü«¼¤j,¨S¨Æªº,¤j®a¥[ªo. |
|
|
·|û¡G¤pªü«¼10141843 µoªí®É¶¡:2016/3/26 ¤W¤È 11:11:42²Ä 1207 ½g¦^À³
|
Cliff¤j ·PÁ±z¾A®É¦a´£¨ÑÄ_¶Qªº¸ê°T Iriswu¤j ¤§«e¦h¦³«_¥Ç¡A©êºp! |
|
|
·|û¡GIriswu10136250 µoªí®É¶¡:2016/3/26 ¤W¤È 11:09:42²Ä 1206 ½g¦^À³
|
Cliff ¤j, +++++1 |
|
|
·|û¡G¤H¤ß¯u½ÆÂø10142070 µoªí®É¶¡:2016/3/26 ¤W¤È 10:47:58²Ä 1205 ½g¦^À³
|
¹ï³o¥y¸Ü,«Ü´Á¬ß! §xªêª@¤Ñ®É¡A¶Àªe¥ç¦³¼á²M¤é¡A§Æ±æ´CÅé/µû½×ªÌ¯à¦b¤ô¸¨¥Û¥X®É¡A¦n¦n¦aÁÙ¤H²M¥Õ¡A¤@¦p²{¦b°l±þ®É¨º¼Ë¦a½æ¤O¡C ¦ý¥H¥xÆWªº¤ô¥,À³¸Ó¬O¤£¥i¯à!! |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/26 ¤W¤È 10:46:43²Ä 1204 ½g¦^À³
|
¤Ó¤[¨S¶K¤å¡A¤@¶K´Nº|¡A§ó¥¿¦p¤U¡G¡]ÁÙ¬O¾A¦X¼ç¤ô¡^ Subjects will be stratified into: - Hormone Therapy User ¡V With Evidence of Disease (PR/SD) - Hormone Therapy User ¡V Without Evidence of Disease (CR) - Hormone Therapy Non-User ¡V With Evidence of Disease(PR/SD) - Hormone Therapy Non-User ¡V Without Evidence on Disease(CR) |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/26 ¤W¤È 10:37:39²Ä 1203 ½g¦^À³
|
¸Ñª¼«áÃĮĤ豷·«B«B¡A²{¦b§è¤W°|ªøºØºØ¤w¸g¬O¸{·¦å«B¡AÓ¤H·P¨ì«D±`µh¤ß¡BÃø¹L¡A´X½g¥´¦nªº¦r¹ê¦b¤£Ä@¦A¶K¡]³sµnª©¬Ý¤å³£µS¿Ý¡^¡K¡K¡A´N¤£¯àµ¥·í¨Æ¤H¦^¨Ó»¡©ú«á¦A½×¶Ü¡H ¤@ª½¦³Ánµ³d©Ç·íªì±M®a·|ij«á¬°¦ón§ï±ÄLR¼Æ¾Ú¡H¦pªG´«¦¨CR¥hª§¨ú¥HOSµ²ªG¥Ó½ÐÃÄÃÒ´N·|¹L¡A¬O¦p¦¹Â²³æ¶Ü¡HÓ¤H¤£»{¬°¡C §K¬ÌÀøªkªvÀøÀù¯g¬OÓ·s»â°ì¡AY¦A¶i¤@¨B½×¥D°Ê§K¬ÌÀøªkªvÀøÀù¯g§ó¬O¸gÅ禳¡]Herceptin¬O³Q°Ê§K¬ÌÀøªk¡^¡A¥þ¥@¬É³£¦bºN¶H¡A³sFDA³£¦b²Ö¿n¼f¬d¸gÅç¡A§Æ±æ±q³o´X¦~¥XÄlªº´XÓÁ{§É¸ÕÅçµ²ªG¨Ó¤F¸Ñ¥¦ªº¯S©Ê¡A¤]µo²{¤@¨Çªº½T²§©ó¶Ç²Î¶Ç²ÎÁ{§É¸ÕÅçµ²ªG¡A©Ò¥H¤~¨º»ò¦³¼u©Ê¦aµoµ¹ÃÄÃÒ¡A¤£¹L¤]«]©óMelanomaªº¸gÅç¸û¦h¡]«eÁ`²Î¥d¯S¬O¤@¦ìlucky case¡^¡Asolid tumorªº¸gÅç«Ü¤Ö¡A¦óªpGlobo HÄÝ©ó·sªºÁÞ§Üì¡C³o³¡¤À¦Ñ¥v¤j¤j¤w¦³¼Æ½gºëÅP¤ÀªR¡A¬Ý¤£À´ªº¤Hn¦Û¤v¸ò¤W¡AÁÙ¤£ª¾¹Dªº¤H«Øij»°ºò¦^ÀYª¦¤å¡A¤£¦A±Ôz¡C §PPD¡G LR¡GÁ{§É§P©w¡]clinical progression¡^©Îimage study CR¡Gimage study °²³]¬Y¨ü¸ÕªÌ¥Ò©ó3/1°µCT¡]©ÎPET¡^¡ALR§P¨SÅܤơF¹w©w¤U¦¸6/1·|¦A°µCT¡]©ÎPET¡^°lÂÜ¡F¦ý¬O5/1´N³QLRÁ{§É§P©w¡]clinical progression¡^§P¬°PD¡A«hLR¡GPD 3/1°µªºCT¡]©ÎPET¡^¡A°e¦ÜCR§P¤]»{¬°¨SÅܤơF¦ý±µ¤U¥hªº6/1¥¼¦A°µCT¡]©ÎPET¡^¡Ano new CT¡]©ÎPET¡^film ¥iŪ¡A«hCR¡Gcensored ¾Ú±xDr. Hope S. Rugo¥H¸gÅç´£¿ô¡GY³o¼Ëªºcensored casesY¤Ó¦h®É·|¼vÅT¾ãÓÁ{§É¸ÕÅ窺power¡A¤~§ï¥HLR data °µ¬°¸Ñª¼§PŪ¨Ì¾Ú¡C¡]©Ò¥H°ß±©¤jªº§ë¸ê¹Ù¦ñ»{¬°¤½¥q¸Ó¦³¤Hn¬°¦¹¤U¥xt³d¡A¨ä¹ê¬O¤@Ó¤£¦s¦bªºÄ³ÃD¡CRugo¤U¥x¡H¨ºASCOÅý¶À±Ð±Â¡H±i¸³¦Û¤v¥hpresent¡H®ÄªG¦³¨S¦³®t§O©O¡H¡^¡C¥H¦o¨Ý¦hÓ¨ÅÀù·sÃĪºconsultant¡AY¤£±Ä«H¦oªº¸gÅç´£¿ô¡A¸U¤@«áªG¥X¿ù¡Aþ¦ì¤½¥qªº¤H´±©Ó¾á¡H·íµM°¨º¬O¤¡A³Ì«áµ²½×·íµM¬O±Ä«H±M®a«Øij¡A©Ò¥H¤£¸Ó¥H¸Ñª¼µ²ªG¥¼¹F¼Ð¨Ó°µ°¨«á¯¥ªºµû½×¡C ·|¤£·|®³CR data¥h¸òFDA°µ«áÄòªº¨ó°Ó¡H´N¦]¬°¤Wz¦Ò¶q¡A©Ò¥H¥i¯à¤£·|ÅܨÓÅÜ¥h¡A¤@¤ULR¤@¤UCR¡A°ò¥»¤W·|¥H³Ì¦³§Q¤è¦¡¥h°µ¡C «Ü¦h§K¬ÌªvÀøªºÁ{§É¸ÕÅç¤w¥HHazard Ratio¨ú¥Nmedian PFS¡C p¹º®Ñ´¿´£¨ì¨ü¸ÕªÌªº¦¸¸s¡G¡]¸Ñª¼«áÁÙ·|¦A°l¥[þ¨Ç¨ä¥L¦¸¸s°µ¤ÀªR¡H¦³«Ý´¦¾å¡^ Subjects will be stratified into: - Hormone Therapy User ¡V With Evidence of Disease (PR/SD) - Hormone Therapy User ¡V Without Evidence of Disease (CR) - Hormone Therapy Non-User ¡V With Evidence of Disease(PR/SD) ɨé©ñªÅ³¡¤À¡A¾Ú¤F¸Ñ¤]¤w´x´¤¬Û·í½u¯Á¡A¹ï¶H¤]¦³½ü¹ø¡A¤½¶}½×¾Â¤£©y¸m³ñ¡AÀR«Ý½Õ¬d¡C§xªêª@¤Ñ®É¡A¶Àªe¥ç¦³¼á²M¤é¡A§Æ±æ´CÅé/µû½×ªÌ¯à¦b¤ô¸¨¥Û¥X®É¡A¦n¦n¦aÁÙ¤H²M¥Õ¡A¤@¦p²{¦b°l±þ®É¨º¼Ë¦a½æ¤O¡C |
|
|
·|û¡Gseafood10141960 µoªí®É¶¡:2016/3/23 ¤U¤È 11:27:14²Ä 1202 ½g¦^À³
|
´¿¥ß©eþ¦³·d¤£²Mª¬ªp ¥¦´N¬O¬G·N©Ù¶Â®âÅB·d¬Fªv°«ª§ n°«¯ä°««±¯Î °««±¥xÆW³Ç¥Xªº¬ì¾Ç®a «±¥xÆWªº¥Í§Þ²£·~°««± ·s¬F©²ªº¸gÀÙÄ@´º ¶¶«KÂಾ°ê¥ÁÄÒ¤£·íÄÒ²£¸ÜÃD À°°ê¥ÁÄÒÄÒ²£¦h©ì©µ¤@¨Ç®É¶¡¦n¤°·h¹B³B²z±¼§K³Q¥R¤½ |
|
|
·|û¡Gªü®¶10139782 µoªí®É¶¡:2016/3/23 ¤U¤È 11:12:31²Ä 1201 ½g¦^À³
|
¯Î±Ò´f½G¤F¦n¦h¦n¦hªº©e©} ¤@ÓÀù¯g¯f±wI«áÂ꺬O¤@Ó®a®xªºµh¹ý¤ß´v ³o¼Ë¤@Ó±M¦í¦b¾Ç³N¬ã¨s ¯àÀ°§U¨C¤@Ó®a®x ¥þ¤HÃþªº°¶¤j¾ÇªÌ «on±Á{·d¤£²M·¡ª¬ªpªº´¿»Ê©v¥ß©e ®LÂΤ£¥i»y¦B ¥LµL¨pªº©^Äm «o¤´n¾D¨ü³oºØ¬Fªv¯}®` ¥L¤@©w«ÜÃø¼õ ´¿»Ê©v¥ß©e¤@©w¤£ª¾¹D³o¹ï¥þ¤HÃþ¦³¦h¤jªºÀ°§U ¥L¥¿¦b´Ý»ÅµL±¡ªº §ã±þ¤@Ó¬°¤F¥þ¤HÃþªº¨CÓ®a®x§K©óÀù¯g«Â¯Ù¹Ú¹½ªº°¶¤H §Ú¬°¯Î·P¨ì¤ß¯k¤£¤w ¤p²Ä¸÷½Ð¦U¦ì¤j¤jµo´§¥¿¸q·P §Ú°£¤F¯à¦b´¿»Ê©vªºfb¤W¡¨·F³ì¡¨¤§¥~ §Ú¬O«ÜµL§Uªº ´°½Ð¤j®aÀ°À°¦£ ¤H¦h´N¦³¤O¶q À°À°¯Î±Ò´f À°À°§A§Ú³£¥i¯à·|±Á{¨ìªºÀùÃҫ¯٧a ´¿»Ê©v¥ß©e¤Ó´Ý»Å¤Ó´Ý§Ô¤F.. ¤Ó´Ý§Ô¤F...... |
|
|
·|û¡G¥¬µÜ®¦10140670 µoªí®É¶¡:2016/3/19 ¤U¤È 03:16:38²Ä 1200 ½g¦^À³
|
Cliff ¤j¡AÁÂÁ§A´£¨Ñ¹ïASCOªºÆ[ÂI¡I §Ú·Q¤µ¤Ñ822¸Ñª¼«á¥¼¹F¼Ð¡A¦ý¼Æ¾Ú¼È¤£¤½¶}¡A¬Æ¦Ü¥Ñì¥ý³W¹ºªºCR´£¦¸Ñª¼¥ÎLRªº¼Æ¾Ú¨Ó¸Ñª¼¡A ¤½¥qªº·Qªk»P§@¬°³£³ò¶¦b°Ñ¥[ASCO¦~·|¡A¦Ó¥B¤½¥q¤]¤@¦AÀç³y822ªº¼Æ¾Úµ´¹ï¯à°Ñ¥[ASCO¦~·|¡C ¬Q¤Ñ§Ì§Ì±µ¨ü³X½Í¡AÁÙ¬O±j½Õ¦]¬°n°Ñ¥[ASCO¡A©Ò¥H¼Æ¾Ú¼ÈµLªk¤½¥¬¡C ±q2/22»¡©ú·|«á¡A§Ú»{¬°¦³Ãöª`©Î¬O¦b¸ê¥»¥«³õ¬¡°Êªº°ê¤H¡A¤j·§³£»{©w¤F¯E¹©À³¸Ó¡B¤@©w·|°Ñ¥[ASCO¦~·|¡A ¦]¬°³o¬O¤½¥q©Ò§Î®Ò¦¨ªºª^³ò¡C ©Ò¥H®³¨ìASCO¦~·|ªºªù²¼(³Ì¦n¤£¬O¶KÀð¾À¨º¤@Ãþªº)¡A§Ú·Q¥«³õ´N·|·§¬A±µ¨ü»P»{¦P¯E¹©¸gÀç¹Î¶¤©Ò»¡¹Lªº¸Ü¡A ¤Ï¤§¡A§Ú·Q§ë¸êªÌ©ÎªÀ·|¤j²³¡A¹ï¯E¹©¤½¥q»P¸gÀç¹Î¶¤ªºµû»ù®£±N·|¦³¤j´T¡B¤j´T¡B¤j´Tªº¶S§C§a¡I¡H ³o¨âºØµ²ªG¦ÛµM·|¤Ï¬M¨ìªÑ»ù¡A´T«×¦h¹è¨C¤H¸ÑŪ»P§PÂ_©Î¦³¤£¤@§a¡I |
|
|
·|û¡GQQ10140589 µoªí®É¶¡:2016/3/19 ¤W¤È 10:50:26²Ä 1199 ½g¦^À³
|
Cliff ¤j¤j: ÁÂÁ±z¤À¨É¸ê®Æ. ªu¸ô¥H¨Ó, ¨ü±z«ü¾É¬Æ¦h, «D±`·PÁ±z !!! |
|
|
·|û¡G²L¯ó¦Ï10141546 µoªí®É¶¡:2016/3/18 ¤U¤È 11:07:17²Ä 1198 ½g¦^À³
|
Cliff¤j¡A ÁÂÁ±zªºµ½¤ß«Øij¡ã±zÁö»¡ªº©e°û¡A¦ý¨ä¹ê¤w¦b°ª³B¬}±x¤F³\¦h²{¶H¡A¤]²z¸Ñ¥«³õªº¤ß²z¼h±¡AASCO©Î³\¬O¤@¶µ«ü¼Ð¡A¦ý¤£©y¹L«×´Á«Ý¡A³Ì¦n¤]§Ñ¤F´Á«Ý¡A¥«³õ¦Û·|¦³©Ò¤ÏÀ³¡C¦ÓÃö©ó¨º¨Ç¸Ñª¼®Éªº¤ù¬q°T®§¡A·í®É¦b¤@¤ù²V¶Ã¤¤¡A¦hªÅÂø³¯¡A©Î³\¤j¹Ù¥]¬A§Ú¤]·Q¸Õ¹Ï§ä¥Xµïµ·°¨¸ñ»P¨¥¤U¤§·N¡A¥H¸Ñ¤ß¤¤ºÃ´b¡B¥H¥Ü¤½¥q²M¥Õ¡A¹Lµ{¤¤Ãø§K¦³¤£¤Öªº±À½×¡A©|µLªk½T»{¯u¹ê¡A©Ò¥H¥u¯àºâ¬O¤@ºØ½m²ß¡A¤ß¤¤·í¶·«O¯d¤~¦n¡A¦]¬°«ÜÃø¤£»P¨Æ¹ê¦³©Ò¥X¤J§r! ³o¤]¬O¦Û¤v±`¦b¸¨µ§®É·Pı¨ì¨âÃø¤§³B¡C ¦¹¦¸¸Ñª¼«á¡AÁöµM¥«³õ·N¨£¯É³¯¡A¦ý¬O¤½¥q¤½¥¬ªº°T®§¤w¸û¸Ñª¼«e§ó¦h¡A¨ä¹ê·Pı¬O¤ñ¸Ñª¼«e§ó¥[½ñ¹ê¤F¡I³Ñ¤U¯à°µªº¡A©Î³\«K¬O@¤ßªº¦uÔ¥L¤j¦ò¥[«ù¥Lªº¨º¤@¤Ñ¤F^^ |
|
|
·|û¡GFaith10138335 µoªí®É¶¡:2016/3/18 ¤U¤È 04:16:15²Ä 1197 ½g¦^À³
|
Cliff¤j ÁÂÁ±z¤F¡I |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/18 ¤U¤È 04:04:53²Ä 1196 ½g¦^À³
|
²L¯ó¦Ï¤j¡A§ï¤é¥t¤å§@ÂСA¤p§Ì¤Z¤H¡AµLªk¨Cxx¤ÀÄÁ¥´¥X¼Æ¦Ê¦r¡C Faith¤j¡A¨S¿ù´N¬O³oÓ¡A¬O¤p§Ì°O¿ù¤é´Á¡AÀ³¸Ó¬O2014©~¨½¤Ò¤H¡u¤Æ¡v¾ÇÀç¡C¨ä¹ê¤W¤@½g¤¤¥¡¤é³øªº³ø¾É¡]2014/07/07¡^´N¬O³ø¾É³o¤@«h®ø®§¡C ²³æ¦a»¡¡A98%ªº»¡ªk¸Ñª¼«e°|ªø´N»¡¹L¡]2014¡^¡F §d©v¯q³Õ¤h©Ò»¡ªºªñ¥G100%À³¸Ó´N¬O¥Ñ³oÓ98%©µ¦ù¨Óªº¡F 80%ªº»¡ªk¬O¸Ñª¼«á°|ªø¦^µª´CÅé±Ä³X®É»¡ªº¡F ¡u¶W¹L80%¡v«h¬O±i¸³¦b2/22¸Ñª¼«á»¡©ú·|¤¤¡A¶¡±µ·N«üªº»¡ªk¡A¥L»¡Y§â²£¥ÍIgM©ÎIgGªº¨ü¸ÕªÌ³£p¤J¡A·|¶W¹L°|ªø»¡ªº¨ºÓ¼Æ¦r¡]80%¡^¡C ¨ä¹ê³£¸Ñª¼¤F¡A¥u¬Oê©óASCO¤§¬G¡A§A§Ú²{¦b³£¤£¯àª½±µ¬Ý¨ì¼Æ¾Ú¡A¥Ø«eµ¥«Ý³Ó¹L²q´ú¡C ¥H¤U¬O§ÚÓ¤H¬Ýªk¡A¤£¨£±o¥¿½T¡G 1.ASCO¤½¥¬ªº¼Æ¾Ú¥i¯à¨S¦³¹w´Áªº¨º»ò¦h¡A¯u¥¿¸ÔºÉªº¦¸¸s²Õ¤ÀªRµ²ªG¡A¥i¯àn¦bNEJM¤~¬Ý±o»ô¥þ¡C 2.¤£¤@©wn«D±`º}«Gªº¼Æ¾Úµ²ªG¤~¯à¤WASCOªº¤fÀY³ø§i¡F¤Ï¹L¨Ó»¡¡A¯à¤WASCO¤fÀY³ø§iªº¤º®e¤]¤£¤@©w¬OÀø®Ä«D±`¦nªºÁ{§É¸ÕÅçÃĪ«¡An¬Ý³o·sÃĦ³¨S¦³¶}©Ý§ÜÀù·s»â°ì¡H¹ï·í¤µÀù¯gªvÀø¦³¨S¦³±a¨Ó¡u·s¡vªº±Ò¥Ü¡H·íµM³Ì¦n¬O³oÓ·sÃÄ¥»¨ªºÀø®Ä´NÅã¥Ü«Ü¦n¡A¤£¦n¤]¨SÃö«Y¡A¥un¯à«ü¤Þ¥X§ÜÀù·s»â°ì·s¤è¦V¡AÅý«á¤H¥i¥HÄ~Äò¬ã¨s¤U¥h¡A´N¦³³QASCO±µ¨üªº¾÷·|¡C ·íµM¥H³o¼Ëªº±ø¥ón¨D¨Ó¬Ý822¡A¤£ºÞ¸Ñª¼¦¨±Ñ¡Aµn¤WASCO¤fÀY³ø§iªº¾÷·|«D±`¦a°ª¡A©Ò¥H±i¸³¤~»¡¡AY¨S³QASCO±µ¨ü¡A¥Lªº²´¯]¤l·|±¼¥X¨Ó¡C¡]universal tumor Ag/ tumor Ag absent in normal cell/low side effect/target to cancer cell and cancer stem cell¡K¡K¡^ ´N¹³µo²{¥É¤sªº¤H¡A¤£¥²µn³»´N¨¬¥H¦W¯d«C¥v¡A¦pªG¥¦¥¿¦n¤]¬Oµn³»ªº²Ä¤@¤H·íµM³Ì¦n¡AY¥u¬O¯Âµo²{³o®y·s¤s¤]¤£¿ù¡A¤@¼Ë·|³Qµn¤W³ø¯ÈÀY±ø¡C¤é«áY¥t¦³¥L¤Hµn³»¦¨¥\¡A¦A¥Zµn¤@¦¸´N¬O¡C 3.¤WASCO¤fÀY³ø§i¤£µ¥©óFDAÃÄÃÒ¡F¦ý¬O¦³ÃÄÃÒ¤~¦³¥«³õ»ùÈ¡C©Ò¥H¦³¿³½ì°Ñ»P822±ÂÅv½Í§PªºÃļt¡A¤×¨ä¬O¤jÃļt¡A¦³¦Û¤vªº¤@®Mµû¦ô·sÃÄ»ùȪº¤èªk¡A¤£¥²¤]¤£¤@©w·|°Ñ¦ÒASCOªºµ²ªG¡CASCOªº¤º®e¬Oµ¹¥Ø«e¬Ý¤£¨ì¸Ñª¼¼Æ¾Úªº¥Î¥\§ë¸ê¤H̥ΨӮǺV°¼À»¤F¸Ñ³oÓ·sÃĨ쩳ÆF¤£ÆFªº°Ñ¦Ò¡C 4.¤@¯ë§ë¸ê¤H¹ïASCOªº·P¨ü¤£¦p¹ïFDA¨Ó±o¦³·P¡C¸òFDA¬ÛÃöªºÄ³ÃD©Î¶i®i¹ïªÑ»ù¤ñ¸û¦³Ãö¡A¨Ò¦p®³¨ìFDAÃÄÃÒ¡BÀòBTD»{ÃÒ¡BÀòFDA®Öã¶i¤JPhase III¡K¡Kµ¥¡C©Ò¥H6¤ëASCO«áªÑ»ù·|¤£·|º¦È±oÆ[¹î¡C 5.ASCOªº¥\¯à·íµM¬O¦³¡A³Ì¤jªº´N¬OÅý¥Ø«e¦b°ê»Ú¤W¤´ÀqÀqµL¦Wªº¡u¯E¹©¡v»P¡uGlobo H¡vÀò±o³Ì¨Î§K¶O«Å¶Çªº¾÷·|¡C¡]¤j¼q®ð³õ±j¡A¤j¦òªk¤O°ª¡A¥°ªk®ÄªG¦ÛµM¦n¡^ |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/18 ¤U¤È 03:02:01²Ä 1195 ½g¦^À³
|
Rabbit¤j «D±`»{¦PRabbit¤jªº½×z»P´L«§O¤HÁô¨pÅvªº »ùÈ ¤p¹xµ£¤j ±q¬Ý¼v¤ùµo²{¹p®gµ§«ü¦V²Ä¤G¥N¡A°|ªø¹w¨¾»P¦´ÁÀ³¸Ó¬O«ü²Ä¤G¥N¡A²Ä¤@¥N¤]¥i¥H©¹¤¤¦´Á±À¶i¡A·íµMn¸g¹LÁ{§É¸ÕÅç¹F¼Ð¤~¥i¥H¥Î¡A³Ì¦nªº±¡ªp¬O¬ü°êFDA¹ï¨ÅÀù¥H¥~ªº¾AÀ³ÃÒ¥H¬O§_¯à²£¥Í¨¬°÷§ÜÅé¨Ó°µ¬°®ÖãÃÄÃÒªº¼Ð·Ç¡A³oºØ¥i¯à©Ê¤£¯à±Æ°£¡A«ÜÃþ¦ü¥Î¥Íª«¼Ð»x°µ¬°®Ö㪺´À¥N«ü¼Ð¤@¼Ë¡C |
|
|
·|û¡Grabbit10136567 µoªí®É¶¡:2016/3/18 ¤U¤È 02:06:14²Ä 1194 ½g¦^À³
|
Hi ¦U¦ì¡A §Ú«D±`¤Ï¹ï¥h¥´ÂZ¯f¤H¡A§Y¨Ï²{¦b¤j®a«öÆgÅý¦o ÃhºÃ¡A¦ý¦Ü¤Ö¨S¨º»ò¤j»¶»¶ªº¡A ¦ý´Nºâ¬O¬O«Ü¿Ë¤Á¦a¸ß°Ý¡A°²³] 1/2 ¾÷·|¡AºtÅܦ¨Åý¦o¤£°ª¿³ ®`¦o¤ß±¡¤£¦n¡A ¤ß±¡¤£¦n·|Åý¦o¤£§Ö¼Ö¡A¨Å餣§Ö¼Ö §K¬Ì¤O·|¤U°¡A §K¬Ì¤O¤U° ·|¦M¤Î¦oªº NED¡A NED ¼vÅT PFS¡A PFS ¼vÅT OS¡A³Ì«á¼vÅT¨ì¦oªº¥Í©R¡C ·íµM¡AÁä½L¬O§Aªº¡AOK¡A¦aº»¤]§Aªº©Ô |
|
|
·|û¡G²L¯ó¦Ï10141546 µoªí®É¶¡:2016/3/18 ¤U¤È 01:50:29²Ä 1193 ½g¦^À³
|
Cliff¤j¡A¤£¦n·N«ä!½Ð±z²¾¾r¦¹ª©¡C¬Ý¨ì±z¤W¨Ó¯u¦n¡A·PÁ±z´£¨Ñªº°T®§¡ã¹Lµ{¤¤©Î¦³¤£¦¨¼ôªº·Qªk»P±À½×¡AÁÙ»Ýn±z¦h«ü¥X¨Ã×¥¿¤F¡C°w¹ï±z¦b5112ª©´£¨ìªº·Qªk¡A§Ú¤]¤À¨É¤@ÂI¦Û¤vªº©å¨£¡AY¦³¿ù»~¡A½Ð±z¤£§[«ü¥¿³á¡I ¡@ ±z´£¨ì¤w¸g98%¥H¤W¨ÅÀù¯f¤H§t¦³Globo-h³o 3ºØÁÞ¤À¤l¡AÀ³¬O¤TÁ`§EÂå®v¦b2008¦~µoªíªº½×¤å¡A¨Ã«D¦¹¦¸¸Ñª¼¤~µo²{ªºµ²ªG¡C°O±o±z¤§«e¦b¹j¾ÀªO»P¤p©_¤j¡B¥xÁÞ¤j¦³°w¹ï¦¹½×¤å¬ã¨s¹L¡A¨º½g¤å³¹À³¬O¤@Ó«nªºµo²{°ò¦¡AÁöµMÀËÅé¸û¤Ö¡A¦ý¤w¸g¬Ý¨£¤Fglobo-h seriesÓ§Oªí²{ªºÁͶըóz¹L²Îp¤ÀªR¦Ó¤F¸Ñ¤£¦P±Ú¸s»P¤À¥¬¤§ÃöÁp©Ê¡C ¦Ó¤Þ°_§Ú¶i¤@¨Bª`·Nªº¡A«h¬O¦¹¦¸¸Ñª¼«áªºªk»¡·|¡A±i¸³´£¨ì¤£»Ý¿z¿ï¯f±w¡Aì¦]¤D¬O¦]¬°¨ÅÀù¯f¤H¨äglobo-h series ªºÈÐÁp¶°ÈдX¥G¥i¹F100%¡A³o¦ü¥G¬O¤§«e2008¦~ªº³ø§i¨S¯S§O´£¨ìªº³¡¤À¡]ÁÙ¬O§Ú¦³²¨º|¡H¡^¡A¤§«e½×¤å¦ü¥G¥Dn°w¹ïªº¬Oglobo-h¡BSSEA-3¡BSSEA-4Ó§Oªº¤À§G¤ñ¨Ò±¡§Î¡A»P¦¹¦¸»¡ªkµy¦³¤£¦P¡C¦Óªk»¡·|«á´X¤Ñ§d©v¯q¥ý¥Í§ë®Ñ¤¤®É¹q¤l³ø·í¤¤¤]´£¥X¹ï¾G±Ð±Â¸ÑŪ¿ù»~ªº¼á²M¡A¤å¤¤»¡¹D¡G ¾G±Ð±Â´£¨ì¡G¡u¤¤¬ã°|¥HGlobo-H¶i¦æ§K¬Ì¬V¦âªº¤åÄm¥iµo²{Globo-H¦bÀù¯g²Õ´¥u¦³14%¦Ü75%ªºÀù²ÓMªí²{¡A§Y¨Ï³o¨Ç²ÓM¥þ³Q±þ¦º¡AÁÙ¦³¤@¥bªº²ÓM¦s¬¡¡C¡v³o»P§Ú̪º¬ã¨s¬O¤£¬Û²Åªº¡Cº¥ý¯E¹©Á{§É¸ÕÅç¨Ï¥Îªº¬Ì]Globo-H KLH¨ä»¤µoªº§ÜÅé¡A¤£¶È¯à±þ¦º±a¦³Globo-HªºÀù²ÓM¡A¤]¯à±þ¦º±a¦³¬ÛÃöÁÞ¤À¤lSSEA3¤ÎSSEA4ªºÀù²ÓM¡]PNAS 2013¡^¡C¦b§Ú̪º¥t¤@½g¬ã¨s¤¤¡A§Ú̵o²{¨ÅÀù¤Î¨ä¥L14ºØÀù²ÓM¤W¶W¹L98%¬Ò¦Ü¤Ö§t¦³¦¹¤TºØÁÞ¤À¤lªº¨ä¤¤¤@ºØ¡]PNAS 2014¡^¡A¦Ó¦b¨ÅÀù·F²ÓM¤W¡A§Ú̬Ʀܵo²{´X¥G100%¬Ò¦Ü¤Ö§t¦³¦¹¤TºØÁÞ¤À¤lªº¨ä¤¤¤@ºØ¡A¤]´N¬O»¡¦¹¬Ì]²£¥Íªº§ÜÅ馳¾÷·|±þ¦º¥þ¼ÆªºÀù²ÓM©ÎÀù·F²ÓM¡A¦Ó«D§@ªÌ©Òz³Ì¦h¶È¯à±þ¦º¤@¥b¡C ±q§d¥ý¥Íªº§ë®Ñ¤º®e¨Ó¬Ý¡A¥L̵o²{¨ÅÀù¤Î¨ä¥L14ºØÀù²ÓM¤W¶W¹L98%¬Ò¦Ü¤Ö§t¦³¦¹¤TºØÁÞ¤À¤lªº¨ä¤¤¤@ºØ¡]PNAS 2014¡^¡AÀ³¬O¦b«á¨Ó2014¦~µoªíªº¤åÄm¤¤§ó¥[½T¥ßªº¡A¦Ó«á¤å±µµÛ´£¨ìÈЦb¨ÅÀù·F²ÓM¤W¡A§Ú̬Ʀܵo²{´X¥G100%¬Ò¦Ü¤Ö§t¦³¦¹¤TºØÁÞ¤À¤lªº¨ä¤¤¤@ºØÈСA¥L¨Ã¥¼¼Ð¥Ü¤åÄm¥X³B¡A¤£ª¾¬O©|¥¼µoªíÁÙ¬O«ü2014¦~ªº³o½g¤åÄm¡A¦]©|¥¼¬dÃÒ¡A¨Ã¤£²M·¡¡C¦Ó¦¹¦¸OBI-822ªº¸Ñª¼µ²ªG¡A©Î³\©IÀ³¤F³o½×¤åªºµo²{¡C¦]¦¹¡A§d¥ý¥Í´£¥X¥LÌ¥ý«e¬ã¨sªºµ²ªG¬°¯E¹©ÅG»é¡A¦Ó±i¸³¦b¸Ñª¼®É«hµoªí¤FÁ{§É¹êÅ窺µo²{»{¬°¤£¶·¿z¿ï¯f±w¡A¦¹¥~¡A¦b¹ï¥~¸ê³ø§iªºPPT¤¤¤]¤£¦P¥H©¹ªº¬Ý¨ì¥H²ÓM®è»PÀù²ÓM¦P®É¨Ö¥Îªº¤è¦¡¨Ó´yz¤À¥¬¤ñ¨Ò¡A¦]¦¹¡A¤è±À½×¦¹¦¸ªº¸Ñª¼¬O¥HÁ{§É¡]¼Ë¥»¼Æ¦h¡^ªº¹êÅç¼Æ¾Ú¨Ó¦LÃÒ½T¥ß¹êÅç«Ç¡]¼Ë¥»¼Æ¤Ö¡^·í¤¤©Ò±o¨ìªº¤À¥¬µ²ªG¡A³o¬O¥Ø«e¦Û¤v²Ê²Lªº²z¸Ñ¡C ¨ä¹ê¡A¤§«e¬°¤F§ä2014¨º½g¤åÄm§Ú¦³¼g«Hµ¹§d¥ý¥Í¡A¤£¹L¡A¥Ø«e¬°¤î¨Ã¨S¦³±o¨ì¦^À³¡C¦ý¬Q¤Ñ¬Ý¨ì¯Î°|ªø¦b·R¦]´µ©ZªººtÁ¿¡A«o¦ü¥Gµo²{¤F¥LªºÂܸñ¡A¤£ª¾¬O§_¬O³o½g¡H·í¤¤¬Ý¨ìªí®æ¤¤¥ÎÁp¶°ªº¤è¦¡¨Óªí¥Üµ²ªG¡A¤£¹L¡A¤Ó¦h±M·~ªº»y·J¡AÂ÷¥H«e©Ò¾Ç¤Ó¤[¡AÁÙ¨Sªk§Ö³t®ø¤Æ¡AYCliff¤j¦³¥ô¦óµo²{©Î·Qªk¡A¦A½Ð±z¤À¨ÉÅo¡I·PÁ±z¡ã www.pnas.org/content/111/7/2482.full.pdf |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/3/17 ¤U¤È 05:55:31²Ä 1192 ½g¦^À³
|
¥xÆW¦³³\¦h¤H½èºÃ¯Î°|ªø¤£À³¸Ó¹ï¯S©wªÑ²¼µo¨¥Å@½L¡C«ç»ò³o¦^¯Î°|ªøÅ@½LÅ@¨ì¥H¦â¦C¥h¤F¡H ³á¡IÀ³¸Ó¯E¹©ªº¥~¸ê§ë¸ê¤H´N¬O¥H¦â¦Cªº§ë¸ê°òª÷§a¡I ÁÙ¬O¤p§ÌªºÅÞ¿èþ¸Ì¥´µ²¤F¡H |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/3/17 ¤U¤È 03:14:29²Ä 1191 ½g¦^À³
|
¥xÁÞ¤j¤j§A¦n, ¤½¥q¤T¥P ¬O¤½¥q¤H¤h ¬O"·í¨Æªº§Q¯qÃö«Y¤H" ¦]¦¹©Ò»¡ªº¸Ü ¥´¥´§é «O¦u¤U §Ú»{¬°¬Ook ½Ö¥s¤T¥P¦b¼p©Ð ¤£¯à©È¼ö ¾Ú»¡©È¼ö §O¶i¼p©Ð «¢«¢ ¬Û¤Ïªº §Ú¹ï¯Î §Ú·í¥L¯« ¨Sªk¤l ¤H®a¬OÅv«Â°Ú ¥Ñ¥L¤f¤¤»¡¥Xªº¸Ü ÁÙ¬O«Ü¥¿±ªº¸Ü §Ú¬O¦n¼ÖC ¦Ü¤Ö §Ú»{ª¾ ¯ÎÀ³«D"§Q¯qÃö«Y¤H" ²Ä¤T¤è ÁÙ¬OÅv«Â ¤S¬Ý¨ì¤SÅ¥¨ì "¤£«O¦u"ªº¸Ü ¼K¼K ¶W¼Ö µ¥«Ý ¨Ã´Á«Ý ³Ì³Ì²×¬O¦nµ²ªG ¤w¤W¬O§Úªº·Qªk ¼Ö |
|
|
·|û¡G·Q·Q10140340 µoªí®É¶¡:2016/3/17 ¤U¤È 02:53:04²Ä 1190 ½g¦^À³
|
¤p§Ì¤£¦¨§÷...¤S¨Ó¤À¨É¥v¤j¤À¨Éªº¤å³¹ ³o®É«á¦h¦h¤À¨É,¥v¤j±zÀ³¤£¤Ï¹ï:) ÃöÁäÂI(¹ï©óYervoy§K¬Ì¤äÀøÃĪ«) 1: ±qPRÅܦ¨CRªº¯f¤Hªá¤F30Ó¤ë¡A³Ì¤[ªº¬Oªá¤F70Ó¤ë¤~±qPRÅܦ¨CR! 2 :ªø¹F6Ó¤ë¤~¥iÆ[¹î¨ì¸~½FÅܤp! (882Æ[¹î´Á¬O¤E©P..¤ñ°_Yervoyªº6Ó¤ë¤~Åܤp..³o?!) (ÁÙ¬O®³¨ìÃÄÃÒ°Õ) 2011¦~§å㪺Yervoy³Q°Ê§K¬ÌÃĪ«: ¦³Ãöipilimumab¥Î©ó¶Â¦â¯À½Fªº¬ã¨s¡A¨ä¸~½F ¤ÏÀ³²v¤j¬ù¥u¦³10-15%¡A¸~½F§¹¥þ®ø¥¢(complete response, CR)ªº¾÷·|§ó§C¡A¬ù¬°1-2%¡A¥B¹F¨ì¤ÏÀ³ªº ®É¶¡¸û¶Ç²Î¤ÆÀø©Î¬O¹TÓi»Ä¿E酶§í¨î¾¯(tyrosine kinase inhibitor, TKI)¬°ºC¡A¬Æ¦Üªø¹F6Ó¤ë¤~¥iÆ[¹î¨ì¸~½FÅÜ ¤p¡AµM¦Ó¦³¤ÏÀ³ªº¯f¤H¡A±`±`¥i¥H¬Ý¨ì¨ä¤ÏÀ³ªº®É¶¡ «Üªø¡A¦³¾÷·|¥i¥H¹F¨ìªø´Áªº¸~½F±±¨î(10)¡C§K¬Ì¬ÛÃö ªº°Æ§@¥Î¤j·§°ª¹F60%¡A¦Ó¸ûÄY«(Grade 3-4)ªº°Æ§@¥Î «h¦³15-25%¥ª¥k¡C ¥t¥~¤@½g¹ï©óYervoyªº³ø§i: CTLA-4¡@Blockade with Ipilimumab: Long-term Follow-up of 177 Patients with Metastatic Melanoma¡A©µªø°lÂܱµ¨üIpilimumabªvÀøªº¯f¤H¡Aì¨Ó¥u¦³15¦ìPR¡B5¦ìCRªºªì¨B³ø§i¡A»®µMµo²{¼W¥[¬°18¦ìPR¡B15¦ìCR¡A±qPRÅܦ¨CRªº¯f¤Hªá¤F30Ó¤ë¡A³Ì¤[ªº¬Oªá¤F70Ó¤ë¤~±qPRÅܦ¨CR.... ------------ ¥H¤W¤À¨É |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/17 ¤U¤È 02:33:20²Ä 1189 ½g¦^À³
|
chen6053¤j OBI822³oÁûÃĨ쩳¬O ¨}ÃÄ §®ÃÄ ¯«ÃÄ §Ú»{¬°³£¹ï n¬ÝªvÀø´Á§O ¹ï¹w¨¾»P¤¤¦´Á¨ÅÀù¦o¬O§®ÃÄ ¯«ÃÄ ¹ïÂಾ©Ê¨ÅÀù¦o¬O¨}ÃÄ Ó¤H±À´ú¥ý«Ü¦³«~½èªº¼µ5-8 ¦~ µ¥«Ý²Ä¤G¥NOBI833¨ÅÀùÃĪº½Ï¥Í §Y®É±Ï´© ²×µ²¨ÅÀù ¯Î°|3¤ë14¤é¦b¥H¦â¦C2016¦~·R¦]´µ©ZÁ¿®yªººtÁ¿ ¦³¤U±³o¥y¸Ü´N°÷¤F ¨ä¥Lªº¥H«á¦b°Q½× the result phase 3 in Taiwan was just disclosed.It shows very effective,if the patients has a immune response to the vaccine. |
|
|
·|û¡G·Q·Q10140340 µoªí®É¶¡:2016/3/17 ¤U¤È 01:56:56²Ä 1188 ½g¦^À³
|
Á ¤ß»·¤j´£¿ô ~ |
|
|
·|û¡G¤ß»·¦a¦Û°¾10141241 µoªí®É¶¡:2016/3/17 ¤U¤È 01:46:25²Ä 1187 ½g¦^À³
|
·Q·Q¤j 833¤~¬OC34³á |
|
|
·|û¡Gchen605310138636 µoªí®É¶¡:2016/3/17 ¤U¤È 01:37:41²Ä 1186 ½g¦^À³
|
¥xÁÞ¤j¤j, ¯Îªº¥Î»y¤]¬O«Ü"¤£«O¦uC" ÁÙ¦n ¥xÆW¥u·|¾x¥x¥Íªº ¤£µM¤SºG¤F |
|
|
·|û¡Ganthony10142049 µoªí®É¶¡:2016/3/17 ¤U¤È 01:37:35²Ä 1185 ½g¦^À³
|
¦U¦ì¤j¤j¤È¦w¡GÁöµMÅ¥¤£À´¡A¦ý¥uı±o¯Î°|ªø¯uªº¬O»OÆW¤§¥ú¡I¡I |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/17 ¤U¤È 01:27:34²Ä 1184 ½g¦^À³
|
¤p¹xµ£¤j the result phase 3 in taiwan was disclosed. It shows very effective,if the patients has a immune response to the vaccine. and i think its probably much more long-lasting and could be very effective for early stage or even preventing purpose." °|ªø¬O¦b»¡the result phase 3 in taiwan¤w¸gµ²§ô ,It shows very effective .......¨ìeven preventing purpose." ³£¬O¦b»¡¥xÆW¤T´Á ( ¥½´Á¦³®Ä,±À½×¦´Á§ó¦³®Ä, ¹w¨¾·íµM¬O¥¼µo¯f´N«g¼Ä©ó¥ý ·íµM¤]¬O¤ñ¦´Á§ó¦, ¦b¼v¹³¥¼µo²{«e¥ý¥´¬Ì],±À½×¤]·|¦³®Ä) its probably much more long-lasting Ó¤H»{¬°¬O«üÀù¯g§K¬ÌÀøªkªº¯S©Ê OS ¸û¦³Àu¶Õ |
|
|
·|û¡G·Q·Q10140340 µoªí®É¶¡:2016/3/17 ¤U¤È 01:03:00²Ä 1183 ½g¦^À³
|
¤pªº«Øij...¯uªº¬O¤Íµ½«Øij³á... ¤§«eS¤p©jªºÁy®Ñ¦³Ãþ¦ü´£¨ì»¡¥[¥L¦n¤Íªº¤H(«öÆgªº¤H)³£Åܦh¤F ¦Ó¥L¤]·Q»¡³o¥i¯à¸ò·Qn¤F¸ÑOBI822¦³Ãö(¬Æ¦Ü¦³°Ó·~¥Øªº..Ãþ¦ü) §Úªº·N«ä¬O...·íµM°ÝÂk°Ý¬O¦Xªk¦X²zªº... ¦ý¬O§_¥Î¤ñ¸û°ûÂà,¶¡±µ...ªº¤è¦¡¤ñ¸û¦X©y... ²¦³º¬O±wªÌ,¬O¯f¤Í..¥L̪º¤º¤ß...¤Î¦P¼Ë¥´822¦³®ÄµL®Äªº¤ß²z(¦pªG¥L̪¾¹D¬O¹êÅçor¹ï·Ó) ±N¤ß¤ñ¤ß³á~ :) ¬ü°ê¦³ºô¯¸¤À¨É¤@¨ÇÀøªk,¸Ì±¦³822ªº³¡¥÷, ¦ý¦]¬°¥þ¬ü¤]¤~20¤H°Ñ»P ¦Ó¤S¥¼¥²¨CÓ¤H³£·|¤W¦¹ºô¯¸, ¬G¦³¨Çµu¼È¤ù±ªº822¤À¨É, ¶i¥h·j´M¤@¤UÀ³¸Ó·| ¥xÆW..¤p§Ì´N¤£ª¾¹D¤F~¥H¤W³ø§i |
|
|
·|û¡G¤p¹xµ£10141398 µoªí®É¶¡:2016/3/17 ¤U¤È 01:02:37²Ä 1182 ½g¦^À³
|
¥xÁÞ¤j¤j±z¦n: ¨Ì¤p§ÌÅ¥¯Î°|ªøºtÁ¿ªº·Pı,À³¸Ó¬O«ü¨ä¦pªG¥Î¦bearly stageªº±wªÌ¸Ó¬Ì]·|¦³§óªøªº®ÄªG(long-lasting) À³¸Ó¤£¬O«ü³o¦¸ªº¹êÅçµ²ªG. ³o¬O¤pªº²z¸Ñ,¦pªG¦³¿ù½Ð¨£½Ì !! |
|
|
·|û¡G·Q·Q10140340 µoªí®É¶¡:2016/3/17 ¤U¤È 12:44:30²Ä 1181 ½g¦^À³
|
«e±¸ÑÄÀÁÞ¦X¦¨ì²z, ¤@Áçªkµ¥µ¥... ¬ù1:00:00¤§«áªººë±mªº¨Ó¤F, ¸ÑÄÀ¬Ì]ªº³]p, ¤Î¬Ý®Ä¥Î¬On¤À:¦³§ÜÅé ¤Î ¨S¦³§ÜÅ骺 ¦Ó³Ì¤U±ªº¹Ï»¡©ú¦pªG¥Î¶Ç²Îªº¤è¦¡¨Ó¬Ý, ¥L·|Åܦ¨Ãþ¦ü(¦³§ÜÅé+¨S¦³§ÜÅé)ªº¥§¡È ¦ý¦pªG¬Ý¦³§ÜÅ骺, ¨º®ÄªG«Ü¦n (¥LÁٸɥR»¡©úhercepin¥u20%for HER2+¾A¥Î, ¦ÓPD-1¤]¤j¬ù¥u¦³20%¾A¥Î) ¤§«á¤U¤@¶´£¨ìMSKCCªº¬Ì]¸ò822¬Ì]¤£¦P(C34³sµ²ªº822°O¾Ð§óªø¦³IGg, MSKCC¬OQS21¥DnIgM) ³Ì«á¸É¤@¥y, ³oÓ2/3´Áªº¸ÕÅçÅã²{¥X³o¬Ì]¬Oeffectiveªº ¯Î°|ªø: This one has gone from phase 1 to phase2/3. The result of phase 3, the result was just disclosed.. it shows very effective if patients has immune response to vaccine. And I think it¡¦s much more long lasting and effective for early stage or even for preventive purpose!!! :), ³oÓ¤@¤p®ÉªººtÁ¿,¬Ý°_¨Ó´N¬O¦b¾Q¦¨³o¬Ì](822)«ç»ò¨Óªº, ì²z, ¤Î¥Ø«eªºª¬ºA!! Æg §Úı±o...¬Ý¬Ý¥x¤UÅ¥ºtÁ¿ªº³£¬O¾ÇªÌ±M®a ³s¥L̤§±M·~ªº¾ÇªÌ,³£¨Ó²âÅ¥¤Î¾Ç²ß, ¥LÌ¥¼¥²³£Å¥±oÀ´(¯E¤Í4ª©¥i¯à¤j¤è¦V¤F¸Ñ§ó¦h?!) §ó¦óªp¬O´CÅé¸ò»Ê¼L... ¤µ¤Ñ¤£è¤½¥¬, ¥²n®É¥H«á¤½¥¬¦¹Ãþ°T®§¥i¥HÁܽЪk¤H¸ò§ë¸ê¤H°Ñ¥[ ¨ì®É«á°OªÌ¤jô¤j©n̯uªº·|«Ü²Ö, ¦]¬°§ë¸ê¤H°Ýªº°ÝÃD, ¥LÌ»Ýn°µ«Ü¦h¥\½Ò¤~·|À´ ¤£µM¨ì®ÉÔ¤S¥HÁq°Êªº¼ÐÃD¨Ó¶Ã¤U¼Ð..¯uªº¬O¦¾·l®ö¶O³o»ò¦h¤H¬ã¨s¹êÅ窺µ²ªG¸ò»·¤jªvÀøÀù¯gªº¥Ø¼Ð!! |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/17 ¤U¤È 12:29:44²Ä 1180 ½g¦^À³
|
ÁÂÁ¤j®aªº«ü¾É¤Î½Ķ ¤p§ÌÀ´¤F ÁÂÁÂ! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/17 ¤U¤È 12:28:15²Ä 1179 ½g¦^À³
|
CCC¤j ©Ò¥H¤£¥ÎÅç§Üì+¤£¥ÎÅç¨ÅÀù¨È«¬ ( ¤T³±©Ê HER2¦]³±¶§©Ê ¶Pº¸»X³±¶§©Ê)+¤£·|¶Ë¥¿±`²ÓM + ¦³Äè·À¨ÅÀù·F²ÓM¼ç¤O+ °ª¥Í¬¡«~½è+°ª¦w¥þ©Ê+ ¤£·|«Ü°ªªºÃÄ»ù+ ¯à¹ï¬Ì]²£¥Í§K¬Ì¤ÏÀ³·|¦³Àø®Ä +³h§x¯f±w§K¿ú+¦´Á¨ÅÀùªºªvÀø»P¹w¨¾¤]¥i¯à¤]¦³®Ä + .... |
|
|
·|û¡Gccc10136060 µoªí®É¶¡:2016/3/17 ¤U¤È 12:15:13²Ä 1178 ½g¦^À³
|
1:02:33 Breast cancer patients :98% one or more Gb5,Globo H and SSEA4 |
|
|
·|û¡G561910141205 µoªí®É¶¡:2016/3/17 ¤U¤È 12:14:27²Ä 1177 ½g¦^À³
|
¬Ý¤F«e±©M«á±¡A«D±`·P°Ê¡C¯Î°|ªø¤Ó´Î¤F¡C»OÆWªº¹qµø·s»DÀ³¸Ón³ø¾É¡]«Ü°Q¹½¤K¨ö¦æ¨®°O¿ý¾¹¼v¤ù¥R¥¸¹qµø·s»D¡^ ¦p¹xµ£¤j©Ò¶K¡A¯Î°|ªø´£¨ì¤F822ªºÀø®Ä¡A³o¦b»OÆWÁÙ³Q§ðÀ»©O¡C ¯Î°|ªø説¤F¤@Ó¡§¯º¸Ü¡¨¡C»OÆWªº°ê·|±`±`fight¡A¦ý¨Sresult¡C¥H¦â¦C°ê·|¤]±`fight¡A¦ýÁ`¦³result¡C ¦~«×·R¦]´µ©ZÁ¿®y¦³¦h¤HÀò±o¿Õ¨©º¸¼ú¡A¯¬Ä@¯Î°|ªø±o¼ú¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/17 ¤U¤È 12:11:48²Ä 1176 ½g¦^À³
|
¤p¹xµ£¤j the result phase 3 in taiwan was disclosed. It shows very effective,if the patients has a immune response to the vaccine. and i think its probably much more long-lasting and could be very effective for early stage or even preventing purpose." °|ªø¤w¸g¦bºtÁ¿»¡¥X¤T´ÁÁ{§É¯f±w¯à¹ï¬Ì]²£¥Í§K¬Ì¤ÏÀ³·|¦³Àø®Ä,¥¦»{¬°³oÓ§ÜÅé¤ÏÀ³¥i¯à·|¬Oªø´Á«ù¤[ªº,( À³¬O«üOS ) ¥t¥~¹ï¦´Á¨ÅÀùªºªvÀø»P¹w¨¾¤]¥i¯à¤]¦³®Ä ( ¹ï¦´Á¨ÅÀùªºªvÀø»P¹w¨¾¤]¥i¯à¤]¦³®Ä³o¬O²Ä¤@¦¸Å¥¨ìªº«GÂI) |
|
|
·|û¡Gnina999910139545 µoªí®É¶¡:2016/3/17 ¤U¤È 12:04:26²Ä 1175 ½g¦^À³
|
²q·Q¤j: 1. ¥k¤U¨¤¦³¤@ÓO¶ê°é(³]©w)«ö¥ªÁä--¦b(¦r¹õ-Ãö³¬)«ö¥ªÁä--¿ï¾Ü(^¤å-¦Û°Ê²£¥Í) 2.¦A¦^O¶ê°é(³]©w)-- 3.µM«á«½Æªº¦A¦¸«öO¶ê°é«ö¥ªÁä¶i¤J--¦b(¦r¹õ--^¤å¦Û°Ê²£¥Í) «ö¥ªÁä--¿ï¾Ü¦Û°Ê½Ķ---¿ï¾Ü¤¤¤å( ÁcÅé) |
|
|
·|û¡G¤ß»·¦a¦Û°¾10141241 µoªí®É¶¡:2016/3/17 ¤U¤È 12:01:49²Ä 1174 ½g¦^À³
|
¤j®a¥i¥H±q50¤À¥ª¥k¶}©lÅ¥ ¦³´£¨ì833, ¤]¦³´£¨ì¸ò¶PÀù¥ªº¤£¦P, ¦ý¾ã½g§Ú·Q¹ïª©¤Í³Ì«nªº´N¬O³Ì«á°|ªø»¡ªº ¤p¹xµ£¥´¥X¨Óªº¨º¥y¸Ü ¥t¥~, ¬Ý¨Ó833«D±`¥i¥H´Á«Ý |
|
|
·|û¡G¤p¹xµ£10141398 µoªí®É¶¡:2016/3/17 ¤W¤È 11:42:00²Ä 1173 ½g¦^À³
|
¥xÁÞ¤j¤j: "the result phase 3 in taiwan was disclosed. It shows very effective,if the patients has a immune response to the vaccine. and i think its probably much more long-lasting and could be very effective for early stage or even preventing purpose." ´N¬O³oÓ. ½Ð°Ñ¦Ò ! |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/17 ¤W¤È 11:36:10²Ä 1172 ½g¦^À³
|
ccc¤j ÁÂÁ§Aªº§Ö»¼ ½Ðª©¤Í¯d¾Ç¬ü°ê^¤åÅ¥¤O¦nªº¤À¨É¤@¤U |
|
|
·|û¡G¤p¹xµ£10141398 µoªí®É¶¡:2016/3/17 ¤W¤È 11:32:04²Ä 1171 ½g¦^À³
|
the result phase 3 in taiwan was disclosed. It shows very effective,if the patients has a immune response to the vaccine. and i think its probably much more long-lasting and could be very effective for early stage or even preventing purpose. ²q·Q¤j¤j: §Úè観ť,§â¯Î°|ªø»¡ªº¥´¦¨¤å¦rÅý±z°Ñ¦Ò ^^ |
|
|
·|û¡G¥Ó¥|®ü10139653 µoªí®É¶¡:2016/3/17 ¤W¤È 11:23:45²Ä 1170 ½g¦^À³
|
²q·Q¤j±z¦n¡A¦b¥k¤U¨¤ªº³]©w¶µ¥Ø¡A§ä¦r¹õ¡A¦A§ä¤¤¤å¡C |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/17 ¤W¤È 10:59:26²Ä 1169 ½g¦^À³
|
ÁÂÁ nina9999 ªº«ü¾É ¤£¹L¤p§Ì²Â©å ¥u¯àÅã¥Ü^¤å¦r¹õ ¦ý^¤å¦r¹õ ¦ü¥G©M»yµ°Â¤£Ãl? ¤p§Ì¥u¯à±æ¤å¥Í¹Ä¤F ÁÂÁ¤j®a! |
|
|
·|û¡Gnina999910139545 µoªí®É¶¡:2016/3/17 ¤W¤È 10:29:59²Ä 1168 ½g¦^À³
|
²q·Q¤j: ¯Î°|ªøºt»¡µø°T,¥i«ö¥k¤U¨¤³]©w¦r¹õ§ï¦¨¤¤¤åÁcÅé§Y¥i |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/17 ¤W¤È 10:08:11²Ä 1167 ½g¦^À³
|
ÁÂÁÂc c c¤j ´£¨Ñ°|ªø¦b·R¦]´µ©ZÁ¿®y ºt»¡ªºµø°T ¤p§Ì¬Ý¹L¤@¦¸ ¦ý¦]^¤å¤Î±M·~µ{«×¦³ ¦³Å¥¨S¦³À´ ¤£¹L¥þ½g¤¤ 822¬ÛÃö¦ü¥G¬O¥D¨¤¤§¤@ ¦b1:03:20 ªþªñ ¤p§Ì¨Ìµ}Å¥¨ì(¤£©ú½T) "°²¦p±wªÌ¹ï¬Ì]¦³§K¬Ì¤ÏÀ³ ®ÄªG«D±`¦n( very effective)"? ½Ð^¤å¦nªº¤j¤j ½T»{¤@¤U¦p¦ó? ÁÂÁ¤j®a! |
|
|
·|û¡Gccc10136060 µoªí®É¶¡:2016/3/17 ¤W¤È 08:27:36²Ä 1166 ½g¦^À³
|
¯Î°|ªø¦b¥H¦â¦CªººtÁ¿ https://www.youtube.com/watch?v=wxBu2QvD_KQ |
|
|
·|û¡G¤p¤p¦Ï¨ànªø¤j10141203 µoªí®É¶¡:2016/3/16 ¤U¤È 10:20:29²Ä 1165 ½g¦^À³
|
¦U¦ì¤j¤j¦n è·Q¨ì...¸Ñª¼«á½T»{¤F¾÷Âà¸òY¤z¥Ø«e¤£¥i»¡¤§¨Æ, ¨º§Ú̦³¥i¯à±q¤½¶}¸ê®Æ¥h§ä¥¦ÀùªºÁ{§É³]p¬O§_¤v¦³©Îpµe½Õ¾ã?Ä´¦p°¨°ºªº±_Àù©Î¥x¤jªºªÍÀù(¬OªÍÀù§a?)Yªñ¦³½Õ¾ã©Î§ïÅÜ,¬O§_¯à±q®Ç±ÀºV¥X¤@¨Ç¥Ø«eÁÙ¤£¥i»¡ªº½u¯Á©O? ¤p¤p¦Ï¬O«Ü¥~¦æªº¥~¦æ,Y¬O³o°ÝÃD«Ü²Â©Î²ö©ú©_§®,½Ð¦U¦ì¤j¤j¸õ¹L´N¦n,ÁÂÁ¤j®a!! ^^ |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/15 ¤U¤È 09:34:06²Ä 1164 ½g¦^À³
|
¥Xª©¤j¡G ¤p§Ì¦A«×«·sÅ¥¹L¤@¦¸2/22¤U¤Èªºªk»¡·|ùتº¿ýµ¡Aªº½T±i¸³»¡¬O75±ø¡A쥻¦³150±ø®e¶q¡A¬ùÁäµ²¤F¤@¥b¡A³o¶µ»P¥ý«eµo²{ªº¸ê®Æ°Â¤£°_¨Ó¡C2015¤WÂd«eªk»¡·|¤WAmy»¡¬O1500±ø¡A·|¤£·|¬OÁäµ²¤À¤l¶qªº¤ñ¨Ò¡H»PÁäµ²±ø¼Æªº®t²§¡H¥Ø«e¤p§Ì©|¥¼§ä¨ìµª®×¡C |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2016/3/15 ¤W¤È 01:30:04²Ä 1163 ½g¦^À³
|
«z..«e¤@½g¶K¿ùª©¤F..Cliff¤j±z´N·í¨S¬Ý¨£§a.. |
|
|
·|û¡G°e³øªº10135990 µoªí®É¶¡:2016/3/15 ¤W¤È 01:03:38²Ä 1162 ½g¦^À³
|
Hi Cliff¤j.. ¦³ÓºÃ°Ý·Q³Â·Ð±z.. ·Q½Ð°Ý..»¡©ú·|¤W©Ò´£Áäµ²75Ó.¦ü¥G©M¥»ª©·í®É°Q½×(WO2015159118)±M§Q¤ºªº GH¡GKLH=¡u1050~1950¡v¡G1 ®t¶Zº¡¤jªº¬O¤£¤@¼ËªºªF¦è¶Ü??ÁÙ¬O?? ÁÂÁ±z |
|
|
·|û¡Gªü®¶10139782 µoªí®É¶¡:2016/3/12 ¤W¤È 09:57:20²Ä 1161 ½g¦^À³
|
¤p¤¡¸õ¼Ù¡A°|ªø¦ó¶d¡H¦]¬°éwª½¡B©¾©ó¬ì¾Ç¡A´Nn©Ó¨üÁֽצp¦¹µL²z½î½ñ¡H ¦Aµo¤@¨ç®¼°|ªø¡C+1 ¤Hµ½Á`¬O³Q¤H´Û §Y¨Ï§ÚÌ¥u¾Ö¦³1ªÑ¯E¹© ¤]¥NªíµÛ§Ú֦̾³µÛ¯E¹©ªº¬ÛÃöÅv§Q»PªÑªFÀ³ºÉªº¸q°È ¯E¹©¹J¦¹¦h¨Æ¤§¬î »Ýn§ÚÌ..... |
|
|
·|û¡G¦Ñ¥v10140531 µoªí®É¶¡:2016/3/12 ¤W¤È 08:21:39²Ä 1160 ½g¦^À³
|
²q·Q¤jô §Ú¥u¬Oè¦n¬Ý¨ì³o½g¤å³¹Ä±±o«Ü¦³½ì è¦n¤S©M§ÚÌÃö¤ßªºASCO¦³Ãö ´N©ñ¤W¨Ó½Ð¤j®a¤@°_¬ã¨s¬ã¨s ÁÂÁ±z¦^õXTrop2ªº¤å³¹ §Æ±æ§Ú̶°²³¤§¤O¯à§ó«ÈÆ[©úÁA¦¹¥Í©R¤§¯«¸t·µ°ó |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/11 ¤U¤È 08:08:38²Ä 1159 ½g¦^À³
|
¦Ñ¥v¤j ÁÂÁ±z¤Sµ¹¤j®a·sª¾ÃÑ Trop2²Ä¤@¦¸Å¥¨ì Å¥±zªº´yz Åý¤H¤£±o¤£¦h¬Ý´X²´ ¦b³o½g¤å³¹¤¤ http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4426947/#R18 ¦³³o¼Ëªº´yz " ER-negative/HER2-positive tumors have higher Trop2 levels than ER-positive/HER2-negative cases. " ©Ò¥H IMMU-132 Phase I/II ªºÁ{§É ¤]¯S§O¹ïTNBC ªº¸ÕÅçµ²ªG ¦³©Ò»¡©ú http://meetinglibrary.asco.org/content/150673-156 ¤j®a¦³ªÅ¥i¦Û¦æ°Ñ¦Ò Y±z¦³§ó¦hªºÁ{§É¸ê®Æ ½Ð¤£§[¤À¨É ÁÂÁ¤j®a! ¦A¦¸·PÁ¦ѥv¤j! |
|
|
·|û¡G¹x¥Û10140865 µoªí®É¶¡:2016/3/9 ¤U¤È 10:11:52²Ä 1158 ½g¦^À³
|
¤Ñ©R¤j¡A ¤À¤l³sµ²¶q¤»¿¡A¤£¤@©w³o»òºâ¡C¦³¥i¯ànpºâKLH¸ò¥Õ³ïÃþ¬r¯Àªº¤À¤l¶q¤ñ¡C ª½Ä±¤W¡A¤½¥qªº·N«äÀ³¸Ó¬O¦³¼Ð¹v®Ä¥Îªº Globo H ¤ñ¨Ò§ó°ª¡A¦Ó¯Âºé¿Eµo§K¬Ì¤ÏÀ³¦ýµLÀø®Äªº²§½è¤À¤lªº¤ñ¨Ò¤p¡C¦ý¬O¯A¤Î¼Æ¶q¤Æªº³¡¥÷¡A¨¥µü¤W¨Ã¤£ºë½T¡C |
|
|
·|û¡G²L¯ó¦Ï10141546 µoªí®É¶¡:2016/3/9 ¤U¤È 02:00:43²Ä 1157 ½g¦^À³
|
¤p©_¤j¡A¬Oªº¡A¾ÇµL¤î¹Ò¡A¦ýÁÙ¦n¦¹ª©¦³±z¡A±z¬OºÓ¯Z¡A§Ú¬O¤p¾Ç¥Í¡A¦³±z¦b«e¤è¤Þ¾É¡A¬O¤j®aªººÖ®ð¡I ¤]ÁÂÁ±z¹ïLRªº»¡©ú! §Ú¥u¬O¸T¤£¦í¦n©_¡A¤£ª¾Y´«¦¨CRªº¸Ü²Îpµ²ªG¬O§_·|¦n¬Ý¨Ç¬Æ¦Ü´N¹LÃö¤F? ¬Q¤Ñ§ÚÁÙ¯S¦a¥´¹q¸Ü¨ì¤½¥q°Ý¬O§_¤w¦³CRªº²Îp¼Æ¾Ú¡A·í®É§õµo¨¥¤H»¡«Ü¦h´CÅé¦b§ä¦o¡A®É¶¡«æ¢¡AÃö©ó¸ÕÅ窺¨Æ¥Ø«e¤£¤è«K¦A³zÅS¡A¬Ý¨Ó¤½¥q¬°¤F³Ìªñªº¨Æ¤j®a³£¦£¡A´N¤£¦n¦A¥h¹q°l°Ý¤F! µ¥¹L¤@¬q®É¶¡¦A¥h¤F¸Ñ¬Ý¬ÝÅo~ |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/3/9 ¤U¤È 12:30:39²Ä 1156 ½g¦^À³
|
²L¯ó¤j¡A ¤p§Ì¤]¬O¨Ó³o¸Ì¾Ç²ßªº CRªº¸ê®Æ¤Ó¯Ê¥F ¥B187©M229³£¬OLR ¤½¥q2/21¸Ñª¼¤]¬OLR 3/15«e°eASCOªº¸ê®Æ¤]¬OLR ¥B¤½¥q»{¬°OS§ó¬O¥¼¨Ó¤T´Áªº«ÂI ¦]¦¹¤p§Ì¥u§âª`·N¤O©ñ¦bLR¡A ¥H¤ÎLRªºPFS¼Æ¾Ú¥¼¨Ó¦p¦ó¼vÅTOSªº¼Æ¾Ú ¨Ñ±z°Ñ¦Ò¡C |
|
|
·|û¡G¥xÁÞ10138776 µoªí®É¶¡:2016/3/9 ¤W¤È 11:55:49²Ä 1155 ½g¦^À³
|
¯Î°|ªø¦b¤G¤ë¤Ü¤@¤é¤Î¤Ü¤G¤é¬ÛÃö½Í¸Ü§¡¬O³Q°Ê±µ¨ü´CÅé¸ß°Ý¡A¶È¥H¬ì¾Çªº¨¤«×¸àÄÀ¸Ñª¼µ²ªG©Ò¥Nªíªº·N¸q¡C ³Q°Ê«D¥D°Ê ¦³´CÅé¸ß°Ý°|ªø·íµMn¦^µª ³o¨Ç°OªÌ°Ý¹ï¤H¤F °Ý¨ìÁ޾Ǯõ¤æ https://www.sinica.edu.tw/manage/gatenews/showsingle.php?_op=?rid:8071 |
|
|
·|û¡G¶À§õ10141253 µoªí®É¶¡:2016/3/9 ¤W¤È 11:00:15²Ä 1154 ½g¦^À³
|
¦³¤Hª¾¹D¯Î°|ªøªº¤@Áçªk(©Î»Ã¯Àªk)¦b¹êÅç«Ç¤@¦¸¥i¥H»s³y¥X¦h¤Ö¶qªºGLOBO-H¶Ü? |
|
|
·|û¡GCliff10135274 µoªí®É¶¡:2016/3/8 ¤U¤È 02:00:11²Ä 1153 ½g¦^À³
|
¤p¤¡¸õ¼Ù¡A°|ªø¦ó¶d¡H¦]¬°éwª½¡B©¾©ó¬ì¾Ç¡A´Nn©Ó¨üÁֽצp¦¹µL²z½î½ñ¡H ¦Aµo¤@¨ç®¼°|ªø¡C |
|
|
·|û¡Gªü®¶10139782 µoªí®É¶¡:2016/3/8 ¤W¤È 11:34:55²Ä 1152 ½g¦^À³
|
¹ïªü http://www.appledaily.com.tw/realtimenews/article/new/20140502/390706/ Å¥¨ì¯Î ±i ¨º»ò§À°Ï¥i¼¦ ¯uªºÅý¤H«D±`ªºÃø¹L ¯Î¤£·R¿ú ±i¬°¤F¹D¼w²z©À nÀ°§U¥xÆW¨«¥X°ê»Ú «o±o¨ì¦p¦¹¤£¤½¥ªº¹ï«Ý F¦A¥ÍÀ°¦£I®Ñ °ò¨È§ó¬O19®Ú¶^°±¤]À°¥L §Ú«D±`¥Í®ð èè¤]¥´¹q¸Ü¨ì´¿»Ê©vªº¿ì¤½«Ç ¥Lªº§U²z±µªº ©m¯Î §ÚªººA«×´N¸ò¥ß©e¦b½è¸ß©xû¤@¼Ëªº¾÷¨® ¨Ã½Ð¥LÂà¹Fµ¹´¿n¥L»¡©ú¦^´_²M·¡ ¥L ¥²¶·n§ä¨ì¤@ӯ໡ªA§Úªº²z¥Ñ ¤£µM§Ú¤£·|¤z¥ð ³o¨âªÌ¦ì¦ó®t²§¨º»ò¤j?¥L»¡©ú¬O¨Ì¾Ú¤°»òÅÞ¿è §Ú¤@±ø¤@±ø¸ò¥L¹ï ¨Ã¤Ï»Ä¤@¥y"´¿¥ß©e¬O¾Ç°]°Èªº¶Ü?¤½µM»¡³o¨â®a°]³ø¨S°ÝÃD.«ç¼Ëªº¨S°ÝÃDªk" "¯E¹©¥L¤F¸Ñ²M·¡«á.©ÎASCO«á¯Î±Ò´f³Q¥L»~¸Ñ¤F,¥L¬O§_¸Ó¤½¶}µoªí§ó¥¿Án©ú?Y¤£.¬O©~©ó¤°»ò²z¥Ñ?»¡²M·¡.¦AªÌ¦pªG¦o¨S¤@¼Ë´À¯E¹©¦p¤Wz¨â®a¯ëI®Ñ,§Ú·|°Ý¥L¤£I®Ñªº²z¥Ñ¦ó¦b?" §Ú¯d¤F¥»¦W¦ý§Ú¤@¤H¯à¤O¦³ ©IÆ~¤j®a¦³¥¿¸q·PªºªB¤Í¤]¤@°_¥XÁn§a! Åý¥¦¨C³q¹q¸Ü³£n¦^´_ ¥ßªk°|¹q¸Ü:02-23585858#6321 ¦Û¤vªº¯E¹©¦Û¤v½Фj®a¨Ñ¬Û²±Á| ·P®¦ |
|
|
·|û¡Gmouth10141177 µoªí®É¶¡:2016/3/8 ¤W¤È 10:25:42²Ä 1151 ½g¦^À³
|
¬Ý¨ìªü®¶¤jªº¹Ú¹Ò ¤j®an§ó±`µo«Hµ¹¯Eô¹Î¶¤¹ªÀy ¥¿±·Å·xªº¤O¶q¤~¬O³oÓªÀ·|»Ýnªº ¯Eôµ¹§Ú̪º«K¬O³o¼Ë¤@Ó¼¥¼© ¯Eô¥[ªo¡A¤j®a¥[ªo |
|
|
·|û¡G¤p®æ10136562 µoªí®É¶¡:2016/3/8 ¤W¤È 10:25:08²Ä 1150 ½g¦^À³
|
¯uªº¦³°÷¤ßµh,³o¨Ç½è¸ß¦pªG¬O¥t¤@ӥߩe¤]´Nºâ¤F,徧徧¬O¤@Ó´¿·í¹L°ê¦w°òª÷¾Þ½L¤âªº´¿¥D©e. ¬O§_²_¬°É¨éªÌ¥´¤â,À˽Õn¤£n½Õ¬d.¥ß©e¤£n³oÓ¸ú¦b¨¥½×§K³dÅvªº«ÎßM¤U,¦³¥»¨Æ®³¥XÃÒ¾Ú¨Ó ,§Ú®¼¬°°ê®a¥Í§Þ©^Ämªº¯Î°|ªø,¥[ªo!¯Î°|ªø¤@©wn®¼¦í. |
|
|
·|û¡G¤pcc10140141 µoªí®É¶¡:2016/3/8 ¤W¤È 10:17:25²Ä 1149 ½g¦^À³
|
°ß¤jªº©ú¨¥~¤H¶¡¥¿¹D¦h·É®á ¸Ó³Q·q«ªº±M®a,«o³Q¤@¸s¥u¬°·iª©±ªº¤H½î½ñ..¯u¥O¤HÃø¹L ±Ð¥D¥[ªo!!°|ªø¥[ªo!!¯E¹©¥[ªo!! |
|
|
·|û¡GºÃ´bªÌ10140504 µoªí®É¶¡:2016/3/8 ¤W¤È 10:15:38²Ä 1148 ½g¦^À³
|
¤ß¯k°Ú¡I |
|
|
·|û¡G¤p¤á10140918 µoªí®É¶¡:2016/3/8 ¤W¤È 10:04:56²Ä 1147 ½g¦^À³
|
µh¤ß!! ¬°¦ón³o¼Ë©Ù¶Â¥´À£Ä@·N¬°¥xÆWªº¥¼¨ÓÄ묹©^Ämªº¤H©O!!?? |
|
|
·|û¡G·Q·Q10140340 µoªí®É¶¡:2016/3/8 ¤W¤È 10:04:07²Ä 1146 ½g¦^À³
|
¼µ¹L³o¤@¬q, ¤j¹Ù¥[ªo! ¤@¦ì¬ã¨sÁÞ¾Ç30¾l¦~, ¦b°ê»Ú¶¡·QºÉ¦WÅA, ¬°¤F¦Û¤v°ê®a°^Äm, ¾D¨ì¦p¦¹¹ï«Ý, µh¤ß¯eº. ¤@¦ì³sÄò³Ð·~¦¨¥\, ÁÙ§â·s²£«~±a¦^¥xÆW´¿¦]¦¹»X¨ü¦¾öG, ©~µM¦b±µªñ¦¨¥\ªº¥ú©ú¤j¹D«e, ¦A¦¸¾D¨ü¦Û¤v¤H²_¬°¬FÄÒ½ü´À¤Uªº¥X®ð... xxÄÒ, §A̳o¼Ë¤Ó¹L¤À !! ´Û¤H¤Ó¬Æ !!! ¶Â¥Õ¤£¤À!! ´L«¤@¤U±M®a¾ÇªÌ !! §Ú̶R§Ú̦ۤv·RªºªÑ»ù, Ãöë¦ó¨Æ !! |
|
|
·|û¡G±Û«a10139522 µoªí®É¶¡:2016/3/8 ¤W¤È 10:02:34²Ä 1145 ½g¦^À³
|
©ú¯]»X¹Ð¡A¤ß¸ÌµÛ¹êÃø¨ü¡AÅý§Ú¤]¦ªµÛ¤Q¦r¬[¡A¦³©¯¤@°_³µÛ±zÌ©¹«e¦æ¡C |
|
|
·|û¡Gjm042310140224 µoªí®É¶¡:2016/3/8 ¤W¤È 09:48:23²Ä 1144 ½g¦^À³
|
¤ßµh!!! |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/3/8 ¤W¤È 09:44:43²Ä 1143 ½g¦^À³
|
¯u¥O¤H¤ßµh¡I |
|
|
·|û¡Gªü®¶10139782 µoªí®É¶¡:2016/3/8 ¤W¤È 09:35:59²Ä 1142 ½g¦^À³
|
¬Q¤Ñ°µ¹Ú ¹Ú¨ì.... ¯Î±Ò´f¨ü¶Ë«Ü« ¦Ó±i©À·O ¥~ªí¨è·N¸Ë°µ¨S¨Æ ¦ý¬O ¬Ý°_¨Ó¦Ñ¦n¦h.¤]«Ü¼¬±| ¤H®a°Ý¥LÁÙ¦n¶Ü? ¥L¦^µª"´N·í§@¦ªµÛ¤Q¦r¬[©¹«e¦æ......." |
|
|
·|û¡G²L¯ó¦Ï10141546 µoªí®É¶¡:2016/3/7 ¤U¤È 10:35:27²Ä 1141 ½g¦^À³
|
²q·Q¤j¡B¤p©_¤j¡A¬Ý¨ì±z̺ܺɤ߼{¡B°l¨Dµª®×ªº¹êÅçºë¯«¡A¤£½×³Ì«á»P¯u¬Û®t¶Z¦p¦ó¡A³£¥O¤H·P¨ìÆg¨Ø! ¤p¦Ï¬O¨Ó³o¸Ì¾Ç²ßªº¡A°l¤£¤W¦U¦ì¤j¤jªº¸}¨B¡A¥u¯àºCºC¦a§l¦¬¡A¦bªù¥~¬Ý¤j¤j̪íºt¤F! ¥H«e¤j¾Ç¨SײÎp¡A²{¦b·Q¨Ó¹ê¦b¬O¤£´¼ù! ¥t¥~¡A·Q¨ìÃö©ó¹êÅç²Õ¥¼PD(LR)ªÌ¡A¤p¦Ï¥H¬°¥un¤H¼Æ¸¨¦b¬ù70-25¤H¤§¶¡¡AÀ³¸Ó³£¦³¾÷·|²Å¦X100¤H¥¼PD(CR)ªº«e´£¡A©Ò¥H¡AYP¤´¤p©ó0.05¡A¹w¦ôÀ³ÁÙ¦³ªÅ¶¡¥i¥H±NPDªº¤H¼Æ©¹¤U½Õ¾ã¡AY¦³«ä¼{¤£©P¤§³B¡A¦A·Ð½Ð¤j¤jÌ«ü¥¿¤F! |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/7 ¤U¤È 03:42:14²Ä 1140 ½g¦^À³
|
¤p©_¤j , ±z¤Ó¥Î¥\°Õ! ¥»¥H¬°¨S¤H·|¥h¬Ýâ¶Ãªº¼Æ¾Ú ·Q»¡¥´²V¤@¤U , ¥¼®Æ±zÅÞ¿è¤@¬y , ¤p§Ì¥u¦n¦Û©Û¤£¬O¤F ¤p§Ì°_¥ý¥u¬O¦b·Q¦LÃÒ¹Ú¹Ò100ªº¥i¯à©Ê?! ¤§«e´¿´£¤Î "¦bn²Å¦X¹Ú¹Ò100 ªº±ø¥ó¤U , ¥d¤èÈn¤p©ó3.841 ( ¬ù·í¤@ºûPȪº 0.05 )´X¥G¤£¥i¯à , °£«D¹ï·Ó²Õªº¦s¬¡¼Æ¾Ú»·Àu©ó¤åÄm©Ò¸ü ¦ý³oºØ¹ï·Ó²Õªº°²³] , ¤Ó¤£«O¦u " ´N¬O¦]¬°³oÓì¦] , ¸Õ¤F¤Ó¦h¼Æ¾Ú , ³£µLªk¹F¨ìn¨D ¥u±o¥´¯}¹Ú¹Ò100 ©¹¤U×¥¿ ¨Æ¹ê¤W , ±z´£¥Xªº°ÝÃDÂI , ¤p§ÌÀ£®Ú¨à¦h¨S·Q¨ì( ¦]¬°¦n´X¤p®Éªº§@·~ , ºë¯«¤£ÀÙ , «äºü³B©ó²V¶Ã) ¥u¦Ò¼{2015 , 5/25 ªºPD229 , ÁÙ¦³°h¥Xªº37 ( ¸ÕÅç²Õ15 , ¹ï·Ó²Õ22 , ¸m©ó«e± ) ¦b¤wPDªÌ156«O«ù¤£Åܪº«e´£¤U , Y§â«e±ªºPD±wªÌ ©Ô¦Ü«á±( §Y±N¤wPDªÌªºPFS©Ôªø) ³o¼Ë¥d¤èȱNÅܤj , ·|¤j©ó3.841( ¥i¯à¤j©ó10 , P±N¤p©ó0.001) Yn¦p¦¹½Õ¾ã , ¥B¥d¤èȤp©ó3.841 , °ß¦³±N¤wPDªÌªº¤H¼Æ¦A¼W¥[ , ¤è¯à²Å©ó©Ò¨D ³o¼Ë¤@¨Ó , ¥¼PDªº¤H¼Æ±N³Q¢´î¤Ö ¦p¤U¦C¼ÒÀÀªí©Ò¥Ü , ¸ÕÅç²Õ¥¼PD¼Æ´î¬°51¤H , PD¼Æ167¤H , ³o¼Ëªº¥d¤èȫܱµªñ3.841 ¤p§Ì¤w¤O¦³¥¼¶e , ¦¬®×®É¶¡ªºÅÞ¿è«ä¦Ò¤wµLªk¦Ò¼{©P¸Ô¤F ¬Ý±z©M¯E§J¤jªº¨ô§@¤F ÁÂÁ±z! ²Ä¤@¦¸ªº¼ÒÀÀK-M¹Ï , µe¥X¨Óªº±¡ªp »¡©ú¦p¤U: 26¶g¤§«e , Ãþ¦ü±i¸g²z°²·Q¹Ïªº«e¬q ( ¹ï·Ó²Õ¦b¤W ¸ÕÅç²Õ¦b¤U ) 27¶g~51¶g(¬ù , ) ¨â²Õ«Ü¶Kªñ (ªñ¦üª½½u) 52¶g«á¤~©Ô¶}®t¶Z ¤p§Ì¬O¥Î¨â²ÕªºÁ`¦s¬¡¾÷²v·í¼Æ¾Ú , ¥ÎEXCELø»s ²Ä¤G¦¸¼ÒÀÀªí 0 233 0 1.000 1.000 0.000 0.000 0.000 0 0 116 0 1.000 1.000 2 233 0 1.000 1.000 0.000 0.000 0.000 1 2 116 0 1.000 1.000 2 231 0 1.000 1.000 0.000 0.000 0.000 2 3 114 0 1.000 1.000 2 229 5 0.978 0.978 0.017 4.017 1.983 3 2 111 1 0.991 0.991 2 222 5 0.977 0.956 0.018 4.041 1.959 4 3 108 1 0.991 0.982 2 215 5 0.977 0.934 0.018 4.036 1.964 5 2 104 1 0.990 0.972 2 208 10 0.952 0.889 0.034 7.414 3.586 6 3 101 1 0.990 0.963 2 196 10 0.949 0.844 0.036 7.405 3.595 7 0 97 1 0.990 0.953 1 184 10 0.946 0.798 0.038 7.358 3.642 8 0 96 1 0.990 0.943 0 173 10 0.942 0.752 0.043 7.886 4.114 9 0 95 2 0.979 0.923 0 163 10 0.939 0.706 0.045 7.746 4.254 10 1 93 2 0.978 0.903 0 153 5 0.967 0.683 0.027 4.457 2.543 11 0 90 2 0.978 0.883 0 148 5 0.966 0.659 0.029 4.407 2.593 12 0 88 2 0.977 0.863 0 143 5 0.965 0.636 0.030 4.390 2.610 13 1 86 2 0.977 0.843 0 138 3 0.978 0.623 0.022 3.122 1.878 14 0 83 2 0.976 0.823 0 135 3 0.978 0.609 0.023 3.122 1.878 15 0 81 2 0.975 0.802 0 132 3 0.977 0.595 0.023 3.125 1.875 16 1 79 2 0.975 0.782 0 129 3 0.977 0.581 0.024 3.128 1.872 17 0 76 2 0.974 0.761 0 126 3 0.976 0.567 0.024 3.146 1.854 18 0 74 2 0.973 0.741 0 123 2 0.984 0.558 0.020 2.520 1.480 19 1 72 2 0.972 0.720 0 121 2 0.983 0.549 0.021 2.523 1.477 20 0 69 2 0.971 0.699 0 119 2 0.983 0.540 0.026 3.184 1.816 21 0 67 3 0.955 0.668 0 117 2 0.983 0.530 0.027 3.199 1.801 22 1 64 3 0.953 0.637 0 115 2 0.983 0.521 0.028 3.232 1.768 23 0 60 3 0.950 0.605 0 113 2 0.982 0.512 0.029 3.286 1.714 24 0 57 3 0.947 0.573 0 111 2 0.982 0.503 0.029 3.324 1.676 25 1 54 3 0.944 0.541 0 109 2 0.982 0.493 0.024 2.691 1.309 26 0 50 2 0.960 0.520 0 107 2 0.981 0.484 0.025 2.742 1.258 27 0 48 2 0.958 0.498 0 105 2 0.981 0.475 0.019 2.071 0.929 28 1 46 1 0.978 0.487 0 103 2 0.981 0.466 0.020 2.086 0.914 29 0 44 1 0.977 0.476 0 101 2 0.980 0.457 0.020 2.102 0.898 30 0 43 1 0.977 0.465 0 99 2 0.980 0.447 0.021 2.104 0.896 31 1 42 1 0.976 0.454 0 97 2 0.979 0.438 0.021 2.106 0.894 32 0 40 1 0.975 0.443 0 95 2 0.979 0.429 0.022 2.124 0.876 33 0 39 1 0.974 0.431 0 93 2 0.978 0.420 0.022 2.127 0.873 34 1 38 1 0.974 0.420 0 91 2 0.978 0.410 0.023 2.130 0.870 35 0 36 1 0.972 0.408 0 89 2 0.978 0.401 0.024 2.150 0.850 36 0 35 1 0.971 0.397 0 87 1 0.989 0.397 0.016 1.435 0.565 37 0 34 1 0.971 0.385 0 86 1 0.988 0.392 0.017 1.438 0.562 |
|
|
·|û¡G¤p©_10138298 µoªí®É¶¡:2016/3/7 ¤U¤È 01:07:50²Ä 1139 ½g¦^À³
|
²q·Q¦Ñ¤j(«¢¡AÁÙ¬O¸T¤£¦í·Q¥s¤@Án¦Ñ¤j)¡A ¤p§Ì¹ï±z¨Dª¾¨D¯uªººë¯«¨ØªA±o¤Åé§ë¦a ¤p§Ì¤w¸g§ÖÅܦ¨ÀrÆj¤F ¦b¯E«È¤jÁæ¦Ó¤£±Ëªº¼ÒÀÀ¤U ¶ZÂ÷0.05ÁÙ¦³¤@¬q¸ôn½Õ¾ã µL½×¦p¦ó¤@©wn¨Ï©R¥²¹F¡I ¤p§Ì«_¬N·Q½Ð±Ð±z ±z¼ÒÀÀ¥Xªº -13.783 13.783 (¨â²Õªº¹ê»Ú´î´Á±æ) ¥d¤èÈ 3.579 < 3.841 ¬O§_¤w¸gµe¥XK-M¥Í¦s¹Ï ¹ï¤wª¾ªº½u¯Áªº¸ÑÄÀ¤O´ú¸Õ°_¨Ó¦p¦ó¡H ¨Ò¦p2014/12¦³187¤HPD/26¤Hdrou out 2015/5¦³229¤HPD/ 37¤Hdrou out ¦¤¤±ß´Áªº¦¬®×±wªÌªºPFS¼Æ¾Ú¤jP¬Û¦P¡¦ µ¥µ¥¡K ¤p§Ì¦³ÓºÃ°Ý½Ð±Ð±z ¹êÅç²Õªº¼Æ¦C¤¤¡A 52¶g¥H«áªº³£¨S¦³PDªº¼Æ¾Ú ¤p§Ì¸ÑÄÀ°_¨Ó¬O ¹ï©ó¦¤¤´Á¦¬®×ªº±wªÌ ¦pªG¤£¬O¦b52¶g«e´NPD¡A´N¬O·|¶W¹L24+(20¦ì) ¦Ó2014¦~¥H«á±ß¦¬®×ªº¤j¬ù60¤H¹êÅç²Õ±wªÌ ¦³·¥¤j¤ñ¨Ò41/60=68%³£³B©ó¥¼PDªºª¬ºA ¡K¡r¹êÅç²Õ±ß¦¬®×ªº±wªÌPFSªí²{»·¤j©ó¦¤¤´Á¦¬®×ªº±wªÌ ±z»P¯E«È¤j¤À§O¼ÒÀÀ¥XPȤj©ó0.05ªº¼Æ¾Ú©M¹Ï«¬ ¯u¬O¥O¤H®¶¾Ä ¦ý±z¼ÒÀÀªº¼Æ¾Ú ¤p§Ìı±o¤´¦³¤£¦X²z¤§³B ¤£¹L±zªº¼Æ¾Ú´£¿ô¤F¤p§Ì nÅýPȤj©ó0.05 ¥²¶·Åý¹êÅç²ÕPFS¦³¦nªºªí²{ªº¤H¼Æ¦b¤U°¤@¨Ç ¨ÃÅý¹ï·Ó²ÕPFS¦³¦nªí²{ªº¤H¼Æ¦A¤W¤É¤@¨Ç ÁÂÁ±z¡I |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/7 ¤W¤È 08:32:50²Ä 1138 ½g¦^À³
|
ÁÙ¯u¤j ÁÂÁ±zªº¸ê®Æ! ²L¯ó¤j ¤p§Ì¬Q±ß¤Sµoı ¦b¥d¤èÈ¥²¶·¤p©ó3.841ªº±¡ªp ¼Æ¾Ú©Î¦ì¸mªº·L´T½Õ¾ã , ¥d¤èȪºÅܰʲv«Ü¤j ©Ò¥H , ¥H¤Uªº¼Æ¾Ú±Æ¦C°²©w( ¥ÎEXCELpºâ) , ¥u¬O°ò©ó¦n©_¦nª± , ¥²©w»P¹ê»ÚªÌ¬Û¥h¬Æ»· ©Î³\¥u¦b©ó´ú¸Õ¹Ú¹Ò100ªº¬O§_¥i¹F¦¨? ´N¦pFaith¤j©Ò¨¥ " ³o¤@¦¸ªº¸Ñª¼µ²ªGµo²{¡A¤p§Ì»{¬°ÁöµMPFS¨S¹F¼Ð¡BpÈ¥¼ÅãµÛ⋯⋯ ¦ý¡A¤è¦V½T»{¤F¡B¾÷Âà½T©w¤F¡B¤]½T¹ê¬Ý¨ì§K¬Ì²áªk¦bOS¤Wµo´§Àø®Ä...¡]¤@¤Á¨Ì¤½§i¼Æ¾Ú¬°·Ç¡^ §ó«nªº¬O¡u³ºµM¤£¥Î¤À±Ú¸s¡v.....«z¡ã¿³¾Ä¡I " ³o¬O³Ì«nªº ¶È¨Ñ°Ñ¦Ò ÁÂÁ¤j®a! ªþµù : ¼ÒÀÀ¼Æ¾ÚªºK-M¦s¬¡¹Ï¦b¦¹µLªkÅã¥Ü ½Ð¦³¿³½ìªº¤j¤j¦Û¦æ¥ÎEXCELø»s »¡©ú : ²Ä¤@¦æ : ¸ÕÅç²Õ (G1) ³]²{¸ê®Æ¼Æ ²Ä¤G¦æ : ¸ÕÅç²Õ (G1) n ( at risk ) ²Ä¤T¦æ : ¸ÕÅç²Õ (G1) PD¼Æ[ P1(i) ] ²Ä¥|¦æ : ¸ÕÅç²Õ (G1) ¦s¬¡¾÷²v ²Ä¤¦æ : ¸ÕÅç²Õ (G1) Á`¦s¬¡¾÷²v ²Ä¤»¦æ : PD·ÀIÈ ²Ä¤C¦æ : ¸ÕÅç²Õ (G1) PD´Á±æÈ( E1 ) ²Ä¤K¦æ : ¹ï·Ó²Õ (G2) PD´Á±æÈ( E2 ) ²Ä¤E¦æ : ®É¶¡ ( ¶g ) ²Ä¤Q¦æ : ¹ï·Ó²Õ (G2) ³]²{¸ê®Æ¼Æ ²Ä11¦æ : ¹ï·Ó²Õ (G2) n ( at risk ) ²Ä12¦æ : ¹ï·Ó²Õ (G2) PD¼Æ[ P2(i) ] ²Ä13¦æ : ¹ï·Ó²Õ (G2) ¦s¬¡¾÷²v ²Ä14¦æ : ¹ï·Ó²Õ (G2) Á`¦s¬¡¾÷²v 0 233 0 1.000 1.000 0.000 0.000 0.000 0 0 116 0 1.000 1.000 2 233 0 1.000 1.000 0.000 0.000 0.000 1 2 116 0 1.000 1.000 2 231 0 1.000 1.000 0.000 0.000 0.000 2 3 114 0 1.000 1.000 2 229 5 0.978 0.978 0.017 4.017 1.983 3 2 111 1 0.991 0.991 2 222 5 0.977 0.956 0.018 4.041 1.959 4 3 108 1 0.991 0.982 2 215 5 0.977 0.934 0.018 4.036 1.964 5 2 104 1 0.990 0.972 2 208 10 0.952 0.889 0.034 7.414 3.586 6 3 101 1 0.990 0.963 2 196 10 0.949 0.844 0.036 7.405 3.595 7 0 97 1 0.990 0.953 1 184 10 0.946 0.798 0.038 7.358 3.642 8 0 96 1 0.990 0.943 0 173 10 0.942 0.752 0.043 7.886 4.114 9 0 95 2 0.979 0.923 0 163 10 0.939 0.706 0.045 7.746 4.254 10 1 93 2 0.978 0.903 0 153 5 0.967 0.683 0.027 4.457 2.543 11 0 90 2 0.978 0.883 0 148 5 0.966 0.659 0.029 4.407 2.593 12 0 88 2 0.977 0.863 0 143 5 0.965 0.636 0.030 4.390 2.610 13 1 86 2 0.977 0.843 0 138 3 0.978 0.623 0.022 3.122 1.878 14 0 83 2 0.976 0.823 0 135 3 0.978 0.609 0.023 3.122 1.878 15 0 81 2 0.975 0.802 0 132 2 0.985 0.599 0.019 2.500 1.500 16 1 79 2 0.975 0.782 0 130 2 0.985 0.590 0.019 2.502 1.498 17 0 76 2 0.974 0.761 0 128 2 0.984 0.581 0.019 2.524 1.476 18 0 74 2 0.973 0.741 0 126 2 0.984 0.572 0.020 2.535 1.465 19 1 72 2 0.972 0.720 0 124 2 0.984 0.563 0.020 2.545 1.455 20 0 69 2 0.971 0.699 0 122 2 0.984 0.553 0.026 3.212 1.788 21 0 67 3 0.955 0.668 0 120 2 0.983 0.544 0.026 3.228 1.772 22 1 64 3 0.953 0.637 0 118 2 0.983 0.535 0.027 3.261 1.739 23 0 60 3 0.950 0.605 0 116 2 0.983 0.526 0.028 3.315 1.685 24 0 57 3 0.947 0.573 0 114 2 0.982 0.516 0.029 3.353 1.647 25 1 54 3 0.944 0.541 0 112 2 0.982 0.507 0.024 2.714 1.286 26 0 50 2 0.960 0.520 0 110 2 0.982 0.498 0.025 2.765 1.235 27 0 48 2 0.958 0.498 0 108 2 0.981 0.489 0.019 2.089 0.911 28 1 46 1 0.978 0.487 0 106 2 0.981 0.480 0.019 2.104 0.896 29 0 44 1 0.977 0.476 0 104 2 0.981 0.470 0.020 2.120 0.880 30 0 43 1 0.977 0.465 0 102 2 0.980 0.461 0.020 2.122 0.878 31 1 42 1 0.976 0.454 0 100 2 0.980 0.452 0.021 2.125 0.875 32 0 40 1 0.975 0.443 0 98 2 0.980 0.443 0.021 2.143 0.857 33 0 39 1 0.974 0.431 0 96 2 0.979 0.433 0.022 2.146 0.854 34 1 38 1 0.974 0.420 0 94 2 0.979 0.424 0.022 2.149 0.851 35 0 36 1 0.972 0.408 0 92 2 0.978 0.415 0.023 2.169 0.831 36 0 35 1 0.971 0.397 0 90 2 0.978 0.406 0.024 2.173 0.827 37 0 34 1 0.971 0.385 0 88 2 0.977 0.397 0.024 2.177 0.823 38 0 33 1 0.970 0.373 |
|
|
·|û¡GÁÙ¯u10138289 µoªí®É¶¡:2016/3/7 ¤W¤È 02:37:03²Ä 1137 ½g¦^À³
|
´£¨Ñ¤@Ó¸ê°T°Ñ¦Ò: ¬ü°Ó¥²ªv§´¬I¶QÄ_(Bristol-Myers Squibb)©ó¤µ¦~2¤ë27¤é¦VFDA´£¥X¥Ó½Ð§ÜÀù·sÃÄOpdivoªº·sÃĬdÅçµn°O(NDA)¡A¶È¶È4¤Ñ´N®³¨ìÃÄÃÒ¡A³Ð¤U¦³¥v¥H¨Ó³Ì§Ö®Öã³t«×¡A¤]»·¦©ó6¤ë22¤é¤~¯à¨ú±oÃÄÃÒªº¹w´Á¡COpdivo¬OFDA®ÖãºÓ¹ïªÍÀù¦³®Äªº§ÜPD-1ÃĪ« http://www.cnyes.com/report/rsh_article.aspx?id=195543 ¤p§Ì¬Ý¤F¤@¤U¤j·§ªº·N«ä¬O¦bÁ{§É¤G´ÁªºOS«ÜÅåÆv, FDA´Nµ¹ÃĤF ¤¤¦ìÁ`¥Í¦s´Á´£°ª3.2Ó¤ë¡]9.2个¤ë vs 6.0个¤ë¡^, p-value: 0.00025, ¨ä¥L¤p¬Ý¬Ý¤£À´°Õ ...(¦bPDFÀÉ 20¶) http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/125527s000lbl.pdf ¥Ø«eÁÙ¤£ª¾¹D¯E¹©¼Æ¾Ú, ¦pªG¯u¯à¶^¯}FDA²´Ã誺¸Ü ... ÁÙ¯u·íµM´N¬O¤ä«ù¥xÆW¯S¦³¤å¤Æ, ¬G¨Æ¥D¨¤´N¤j®a¦Û¤v¥hgoogle§a ¦WºÙ·íµM¦³¥L¦Û¤vªº·N¸q, Ĭõ³£¥X²{¤F ... |
|
|
·|û¡G²L¯ó¦Ï10141546 µoªí®É¶¡:2016/3/7 ¤W¤È 12:39:10²Ä 1136 ½g¦^À³
|
²q·Q¤j¡A·PÁ±z±a¨Óªº°T®§! ¨Ì±zªº°²³]PÈ¥i¥H¤j©ó0.05¶Ü? ¨Ì¤p¦Ïªº¦ôp¡Aªø§Àªºrange ¨ÌCR»PLR§PÂ_ªº»~®t¦Ó¥i¯à¦s¦b¤£¤pªº®t²§¡C¥ý°²³]Y¹Ú¹Ò100¤H(CR)¥¼PD±µªñ¹Ú¿ôª¬ºA¡A«h¤wPD¤Îdrop out ¦@p133¤H¡A°²³]drop out ¦ôp¥e¹êÅç²Õ233¤Hªº10%-15%¡A¬ù23-35¤H¡A¨ú¨ä¥§¡È29¤H¡A«h¤wPD(CR) ¦@p 133-29=104¤H¡A¥H¦¹¦^±À¤wPD(LR)¤H¼Æ¡C¤@¯ëCR»PLRªº»~®trange 25%-40%(ª©¤W´£¹L25%¡A²Î¤@±i¸g²z¦ô¬ù40%) ¡A¬G¤wPD(LR)¤H¼Æ¬ù¦b139¤H~ 173¤H¡A¨º»ò¡A¥¼PD(LR)«hÀ³¸¨¦b(233-139-29)=65¤H ¦Ü (233-173-29)=31¤H¤§¶¡¡C¥i¬Ý¥X³oÓªø§À¤H¼Æªº°Ï¶¡®t²§»á¤j¡AÀ³»PLR»PCR§PÂ_ªº»~®t¦³®¼¤jªºÃö«Y¡A³o¬O¤p¦Ïªº²q´ú¤F¡A½Ð±z«üÂI¡A¦¹¥~¤]®¼¦n©_¤£ª¾¤½¥q¤è±¬O§_¦³CRªºK-M curve ©O? |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/6 ¤U¤È 05:11:59²Ä 1135 ½g¦^À³
|
ÁÙ¯u¤j , ÁÂÁ±zªº¸ê°T ±zªº¦W¦rÁÙ¯u¯S§O ©M¤p§Ì¬G¶m¥¬³UÀ¸¸Ìªº¨k¥D¨¤¦P¦W ±zªº¥\¤ÒÀ³¤]¤£¨È©ó¸Ó¥D¨¤³á! ¥ÑCliff¤j©M¤p©_¤jªº¸ê®Æ GH(¨t¦C)§Üì , ¦ü¥G¤£ÀHÀù²ÓMªº¤£¦P¶¥¬q ¦Ó§ïÅÜ (%¦³§_§ïÅÜ , ¥¼ª¾) ©Î³y´N822¥i¥HÁa¦VÂX¥R¾AÀ³±wªÌ , ¤£½×¦´Á©Î±ß´Á ¥Ñ³o¦¸¸Ñª¼±i¸³ªº»¡ªk , ¥un¦³§ÜÅé , ¦³§Üì´N¦³®Ä , ´N¤£©È¥´ªÅ¥]¼u¨Ó¬Ý 822¹ï¨ä¥L¸~½F©Î¦³¾÷·|µo´§Àø®Ä ´N¹³«Ü¦h¤j¤j©Ò¨¥ , ¤£¦PÃþ§O¸~½F , ¯S©Ê¤£¦P , ©Î«ÝÁ{§É¨ÓÅçÃÒ ¦A¦p999¤jªº®ø®§ , ¯E¹©©Î±N±ÂÅv¨ä¥L¤¤¤p«¬Ãļt , ¹ï¤£¦P¾AÀ³¯g¦P®É®i¶}Á{§É ³o±N¸`¬Ù«Ü¦hÁ{§É®É¶¡ , ¦P®É¤]¦³±ÂÅvñ¬ùª÷ªº¦¬¤J ¬O§_¦p²q´ú , ¤@Ó¾AÀ³¯g±ÂÅv¤@®a¼t°Ó , Åý¤j®a«BÅS§¡ÀL , ¦P®É¤]¹F¤À´²·ÀIªº¥Øªº ³Ì«áÁÙ¬On¨ú¨M©ó822Á{§É¼Æ¾Úªº¨}æÕ ¬°¦¹ , ¤p§Ì¤µ¤éªá¤F¦n¦h®É¶¡ , ©ó¼ÒÀÀ822¸ÕÅ窺K-M¥Í¦s¹Ï ¦bn²Å¦X¹Ú¹Ò100 ªº±ø¥ó¤U , ¥d¤èÈn¤p©ó3.841 ( ¬ù·í¤@ºûPȪº 0.05 )´X¥G¤£¥i¯à , °£«D¹ï·Ó²Õªº¦s¬¡¼Æ¾Ú»·Àu©ó¤åÄm©Ò¸ü ¦ý³oºØ¹ï·Ó²Õªº°²³] , ¤Ó¤£«O¦u ¥u¦n½Õ¾ã¹Ú¹ÒÈ , J´ê¼Æ¾Úªºµ²ªG ¥u´ê¥X¸ÕÅç²Õ¥¼PD¼Æ 61( 24+ ªÌ °²³] 20 Ó 63¶g~103¶g 41Ó) , PD¼Æ 156 , ¹ï·Ó²ÕPD¼Æ 91 ¸ÕÅç²Õ»P¹ï·Ó²Õªº mPFS , ¤À§O°²³]¬° 26 ¶g ¤Î 27 ¶g ¬Ý¬Ý¯E§J¤j¼ÒÀÀ¤p©_¤jªº¼Æ¾Ú¦p¦ó , ¦A¨Ó¤ñ¸û·Q©w ·PÁ¤j®aªº¤À¨É J´êªº¼Æ¾Ú¤Î±À´ú ¶È¨Ñ°Ñ¦Ò ÁÂÁÂ! |
|
|
·|û¡GÁÙ¯u10138289 µoªí®É¶¡:2016/3/6 ¤W¤È 05:56:23²Ä 1134 ½g¦^À³
|
²q·Q¤j, ³oÀ³¸Ó¥s°µ CAR-T §K¬ÌÀøªk http://iknow.stpi.narl.org.tw/post/Read.aspx?PostID=10533 ¹ï¦åÀù¡B²O¤ÚÀù¡B¦×½FÃþªºÀù¯g¡A®ÄªG«D±`¦n¡A¦ý³¡¤À¨ü¸ÕªÌªº°Æ§@¥Î«D±`¤j¡C ¥Ø«e§K¬ÌÀøªk¬¡Â۶øõ, ¥i±Ïªv«Ü¦h¤H, ¯E¹©n»°§Ö¤W¥«±Ï¤H http://cincia0816.pixnet.net/blog/post/444570782-%e5%85%8d%e7%96%ab%e7%99%82%e6%b3%95%e6%87%b6%e4%ba%ba%e5%8c%85 |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/5 ¤U¤È 07:14:45²Ä 1133 ½g¦^À³
|
ÁÂÁÂÁÙ¯u¤j©Ò´£¨ÑªºÄ_¶Q·N¨£ ¦nÆg! ¤p§Ìªº·Pı 1. ¶ZÁ{§ÉÁÙ¦³¬q¸ô , ÀRÆ[¨äÅÜ 2. ³o§Þ³NÃþ¦üCAR-T , Ó¤H¤Æ¿@ , ¥i¯àµLªk¤j³W¼ÒÀ³¥Î , °£«D¥i»s¦¨¬Ì] ¤£¹L¨Ì³ø¾É , ¨ä¥iÀ³¥Î¦b©TÅé¸~½F , ¤£¹³ CAR-T ¥i¯à¶ÈÀ³¥Î¦b«D©TÅé½F 3.³ø¾ÉÁÙ»¡ , T²ÓMÂê©wªº"¼Ðªº"¦b¨CÓÀù²ÓM³£¦³(?) ³o´N±j¤F ´N¦n¹³GH¨t¦C§Ü쪺Àù²ÓM%Y±µªñ100 , ¥i±NÀù²ÓM¥þ±þ¤@¼Ë 4.ì¤åªº³ø¾É¤¤ , ¹ï·í«e§K¬ÌÀøªk , ¦³¤@µf¤¶²ÐµûªR 5. ¨äµn¸ü¦b"¬ì¾Ç"ªº½×¤å , ¶È¥i¬Ý¨ìºKn , µLªk¸Ô²Ó¾\Ū , Ãø¿s¨ä¥þ»ª ¤p§Ì·N¦bª¾¤vª¾©¼ Áٱ河«e½ú ¥ý¶i ¤j¤j «ü¥¿¸É¥R ÁÂÁ¤j®a! |
|
|
·|û¡GÁÙ¯u10138289 µoªí®É¶¡:2016/3/5 ¤W¤È 11:19:21²Ä 1132 ½g¦^À³
|
²q·Q¤j, ¤p§Ì«DÂå¾Ç±M·~I´º, ¶È´N¤@ÂI·Qªk´£¨Ñ, ¦p¦³¤£¥¿½T¤§³B, ÁٽЫü±Ð. ´N³o¤W±½×z¦Ó¨¥, ¤Þ¾É§K¬Ì²ÓM®Ú¾Ú¦¹ºØ¿W¯S¼Ð°O¥h·Ç½T§ðÀ»Àù²ÓM¡A¥HªvÀø¬Æ¦Üªv¡Àù¯g¡C¤£¹L³oºØ¶q¨¥´³yªº¡u²©R©Ê¡vÀøªk ... ¥Ln¥ý¤HÅé±Ä¼Ë, µM«á¤ÀªR, µM«á°ö¾i§Ü¯f²ÓM, µM«á¦Aª`®g¦^¤HÅé ... ¤p§Ì»{¬°¯ÊÂI¦h¦h ... 1. ±q±Ä¼Ë¨ì°ö¾iª`®g¦^¤HÅé, ®É¶¡¤£ª¾¹Dn¦h¤[(À³¸Ón¥H¤ëpºâ§a), Àù¥½¯f¤H¯àµ¥¶Ü ? 2. ¶q¨¥´³y, ´N¦n¤ñ¶R©Ð¤ln«È»s¤Æ®a¨ã, ¤u¤Hn¥ý¨ì§A®a¤V¶q, µM«á¦^¥h§ä§÷®ÆÁÙn°t¦â, µM«á¦A¨Ó¬I¤u, Á`nªá¨Ç®É¤é, ªp¥B¥Î¦b§A®a, ¹j¾À®a®£©È´N¤£¤@©w¾A¦X§a, ³o¼Ën¤j¶q¥Í²£¥i¯à·|¬OÓ°ÝÃD 3. ±Ä¼Ë¨ì°ö¾iª`®g¦^¤HÅé, ³o¨ä¤¤¦pªG¦³²ÓM¦¾¬V©Î¸ü¨ã¤£¼ä, ¥´¦^¤HÅ鮣©È·|¤Þµo¨ä¥L°ÝÃD, ªp¥B±q±Ä¼Ë¨ì°ö¾iª`®g¦^¤HÅé³o´Á¶¡, ¦pªGÀù²ÓM¤S¬ðÅÜ, ¯à§_100%ªvÀø®£©È¤]¬O¦³ºÃ¼{ ¥H¤W´N«D±M·~I´ºÆ[ÂI, ¦p¦³¤£¥¿½T¤§³B, Áٽнç±Ð |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/5 ¤W¤È 10:36:04²Ä 1131 ½g¦^À³
|
^§ä¨ìÀù¯gn®` ¤Þ¾É§K¬Ì²ÓMª½§ð http://udn.com/news/story/7266/1542662 New immunotherapy discovery could give treatments the precision they need http://scienceblog.cancerresearchuk.org/2016/03/03/new-immunotherapy-discovery-could-give-treatments-the-precision-they-need/ ¤p§Ìµ{«×¦³ Ãø¥HÂç²M ¯à§_½Ð¥ý¶i «e½ú ¤j¤j ¨ôµû ÁÂÁ¤j®a! |
|
|
·|û¡G¦³«í10141521 µoªí®É¶¡:2016/3/4 ¤U¤È 06:03:34²Ä 1130 ½g¦^À³
|
µ½¤H¤j ±z¤Ó«È®ð¤F,¦bª©¤W¤p§Ì¯à°µªº¦³,¦³¾÷·|´NºÉ¶q°µ,ÁÂÁ±zµ¹¤p§Ì³oÓ¾÷·| ¹ï§Ú³oÓ¥Ípªù¥~º~¨ÓÁ¿,¯à°µ±o¶V¦h,¾Çªº´N¶V¦h,·P®¦ |
|
|
·|û¡GIriswu10136250 µoªí®É¶¡:2016/3/4 ¤U¤È 12:01:45²Ä 1129 ½g¦^À³
|
¦hÁ¤j®aªº¬Ýªk,¬Ý¨Ó³o¦ì±Ð±Â¤»¦~«e´N¤w¸gºb¤W¥Í§ÞÂåÃÄ°ê®a«¬pµe,²{¦bÀ³¸Óºâ¬O¨£Á_´¡°w. |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/4 ¤W¤È 10:44:53²Ä 1128 ½g¦^À³
|
¶Â½ü§B¤j ¦nºëªö ³Ì«á¨º¤@¥y ¤]¤Ó¦³¤~¤F «¢! ÁÂÁ±z! |
|
|
·|û¡G¶Â½ü§B10141808 µoªí®É¶¡:2016/3/4 ¤W¤È 10:35:21²Ä 1127 ½g¦^À³
|
http://www.storm.mg/article/84065----¡Ö ³o½g¤å³¹ ¥un¬O¨CÓŪ¹L§K¬Ì¾Çªº¤H ³£·|°Ý±o°ÝÃD ¬Ý¦ü±M·~ ¨ä¹êÁÙ¬O¥u¬O¤ñ¨S¾Ç¹L§K¬Ì¾Çªº¤H¦n¤@ÂIªº ªù¥~º~¡ã 1.ÁÞ¤À¤l ¿E¤£¥XIgG ¬O°ò¥»·§©À ¦ýÁÙ¬O¦³¨Ò¥~ 2.¦³§ÜÅé ¤£¤@©w¦³®ÄªG ³o¤]¬O°ò¥»·§©À µn²¼ö¯f¬r¤]¬O¦³§ÜÅé ¦ý¤Ï¦Ó¹ï¤HÅé¶Ë®`§ó¤j 3.¥L´£ªº³£¥u¬O «Ü°ò¥»°ÝÃD ©P±Ð±Â¦pªG¯uªº»{¯u ´NÀ³¸Ó¥h¦n¦n¬ÝOBI822©Ò¦³ªº¬ã¨s¤åÄm©Î³ø§i ¨Ó´À¤j²³¸ÑÄÀ ©Î´£¥X§ó¦³¨£¸Ñªº°ÝÃD ¦Ó«D©À¤F§K¬Ì¾Ç´N¥H¬°¤°»ò°ÝÃD³£ª¾¹D §Ú§ó¬Û«H¥H¥Lªº±M·~ nÁA¸Ñ³o¨Ç¥L©Ò´£ªº°ÝÃD ¤ñ§Ṳ́@¯ë¤j²³§ó¨Óªº«Ü®e©ö¡ã 4.¨ä¹ê¥L°Ýªº°ÝÃDªºµª®× ³£¦b³oÃ䪺°Q½×°Ï³£§äªº¨ì ©Ò¥H ´N§O¾á¤ß¤F ©Î³\ ³o¦ì±Ð±Â n°µ²y µ¹¤½¥q±þªü XDDD |
|
|
·|û¡GºÃ´bªÌ10140504 µoªí®É¶¡:2016/3/4 ¤W¤È 10:32:09²Ä 1126 ½g¦^À³
|
Iriswu ¤j §Úèè§âªk»¡·|¿ý¼vÀÉ«e15¤ÀÄÁ¦AÅ¥¤F¤G¦¸ ±i¸³«Ü²M·¡¦aªí¹F ¥´822«á·|²£¥Í§ÜÅé ²£¥Í§ÜÅé«á´N·|¦³Á{§ÉÀø®Ä ¬O¥i¥H±þ¦ºÀù²ÓMªº §Ú«Ü¿ò¾Ñ ³o¦ì©P±Ð±Â¨S¦³Å¥ªk»¡·|ÁA¸Ñ¤@¤Á ´N¦k°µµû½× |
|
|
·|û¡G¶Â½ü§B10141808 µoªí®É¶¡:2016/3/4 ¤W¤È 10:19:37²Ä 1125 ½g¦^À³
|
I¤j©Ò´£¤§ºÃ°Ý http://www.storm.mg/article/84065 ·¶Ç´C¦ü¥G¨C¤Ñ§äÃD§÷¨Ó¥´À»¤½¥q.¤£ª¾¹D¦U¦ì¤j¤j¹ï³o½gªº¬Ýªk? ========================================================= ¤p§Ìªº¬Ýªk¬O ³Ìªñªº®ø®§³£¬O§QªÅ´ú©³ ¤£¥Î²z·|¥L̤F ²{¦b¤½¥q°ò¥»±¸ê®Æ ¤w¸g°÷Â×´I °÷²M·¡ °÷Åý¤HÀY©ü¸£µÈ ¦ý¹ï¤p§Ì¨Ó»¡ ¥u¦³¤@Ó«ÂI ´N¬O ¦pªG¤£«H¤¤¬ã°|ªø ´N½ÐÉ¨é ©ÎÂ÷³õ ¬Û«Hªº¸Ü ´N¬O §QªÅ´ú©³®É ¦n¦n«ØÜ ¥t¥~¡A·PÁ³o¸Ì³\¦h°ª¤âªºÀqÀq¯Ñ¯Ð §Ą¯W¤F¡ã ¤j®a¥[ªo³á¡I¡I |
|
|
·|û¡G²q·Q10136148 µoªí®É¶¡:2016/3/4 ¤W¤È 10:17:19²Ä 1124 ½g¦^À³
|
¤p§Ì·Q ©P±Ð±ÂªºÆ[ÂI ¥Dn¦b»¡822"I«á§K¬Ì¾Çªº°ò¦¨Ã¤£²Ï¹ê" Cliff¤j§ä¥Xªº¤@³s¦ê¤¤¬ã°|ªº¬ã¨s ³ø§i Ãø¹D³£¬O°²ªº?! ¥u¬On¥Î³o¦¸ªºÁ{§É¸ÕÅç ¨ÓÅçµý¦b¤HÅ骺Àø®Ä¬O§_¤]¦p¬ã¨sªºµ²½×? Ó¤Hı±o ©P±Ð±Â¨Ã¨S¦³¬Ý¨ì¼Æ¾Ú ¹ê¤£¯à¥H°¾·§¥þ ¦b³o·¥·sªºÁÞ§Üì¸ÕÅç ®í¤£ª¾¦Û¤v¥i¯à¤]±w¤F ¤F¸Ñ¤£²`¤J´N§å§Pªº»~ÂÕ? ©P±Ð±Â¬O±M·~³Õ¤h ¤p§Ì¥®¸X¶éµ{«×³£¤£¦p ¹ê¤]¤£¸Ó¹ï¤H»¡¤T¹D¥| ²`²`¤@Áù°` »¡Án¹Dºp ¹ï¤£°_¤F ¤j®a ¶È¨Ñ°Ñ¦Ò ÁÂÁÂ! |
|
|
·|û¡Gkokfish10140320 µoªí®É¶¡:2016/3/4 ¤W¤È 10:07:23²Ä 1123 ½g¦^À³
|
·s¤â¤j±z¦n Ãö©ó§A´£¤Î¡ã±i¸³¹ï©ópfs¥¼¹FÅãµÛªº²Ä¤GÓ²z¥Ñ¡A¦b©ó¬°¿z¿ïglobal h§Üì¡A(¨Ì¾Ú±i¸³¦^µª¶¶§ÇÅÞ¿è¡A³oÓ¦]¯À¬Æ¦Ü¤ñ²Ä¤TÓì¦]¡A¹ï·Ó²Õ¤]²£¥Í§K¬Ì¤ÏÀ³·Ó¦¨µ²ªG¤£ÅãµÛ¨Óªº«n)¡A¦ý¤§«áÃö©ó¦pªG¦³²Ä¤T´ÁÁ{§É¡A»Ýn´úGlobal H¶Ü¡A±i¸³«o¤S¦^µª¤£»Ýn¡A¤j®a¨Sµo²{³oÃ䦳¤@Ó«Ü¥Ù¬ÞªºÅÞ¿è¶Ü? §Ú©Mªø½u¤jªº·N¨£¦P¡A¹ï°Ñ¥[±wªÌ¥´°w¡A¦A¬Ýªì´Áªº§ÜÅé¶q¬O§_¥i¹F¥|¿¶q¡A¤ñÀˬd±wªÌªºGLOBO H ·N¸q§ó¤j¡K ¦]¬°´Nºâ§AÀˬd¤Fgloboh¡AÁÙ¬O·|¦³³¡¥÷¤HµL®Ä¡A¦ý¤µ¤Ñª½±µ¿ï¨ú¦³®Äªº¤H¶i¹êÅç²Õ¡K µ¥¦Pª½±µ§âªø§ÀÅܹêÅç²Õ¡K ©Ò¥H¯E¹©¹Î¶¤¹ï¤T´Á¹êÅç·íµM¦³«H¤ß~ «e´£¬Oªø§À¼Æ¦rn¦n! (¥tªk»¡·|·|«á¡A¦³Å¥yk»¡¨ì¡A¥xÆW¤Hªºgloboh©M¬ü°ê¤H¤ñ°_¨Ó¬Û¹ï§C¡A³o¨ä¹ê¤]¥i¯à¬O³o¦¸¹êÅç¼Æ¾Ú®t¤@ÂIªºì¦]) |
|
|
·|û¡GIriswu10136250 µoªí®É¶¡:2016/3/4 ¤W¤È 09:43:34²Ä 1122 ½g¦^À³
|
http://www.storm.mg/article/84065 ·¶Ç´C¦ü¥G¨C¤Ñ§äÃD§÷¨Ó¥´À»¤½¥q.¤£ª¾¹D¦U¦ì¤j¤j¹ï³o½gªº¬Ýªk? |
|
|
·|û¡Gµ½¤H10137888 µoªí®É¶¡:2016/3/4 ¤W¤È 08:42:51²Ä 1121 ½g¦^À³
|
¦³«í¤j, ÁöµM¨S¦³µª®×, ÁÙ¬O«Ü·PÁ±z. |
|
|
|